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ABSTRACT 
C-reactive protein (CRP) is a member of the pentraxin family which opsonises S. 
pneumoniae through its binding to phosphorylcholine. In addition, CRP binds to Fcy 
receptors: FcyRI with high affinity and, probably, FcyRIIA with lower affinity. 
Binding to FcyRIIA was suggested to depend on a polymorphism at residue 131 of 
the receptor, HH individuals being poorer binders compared to RR. To clarify the 
role of CRP binding to FcyRHA and functional activities upon interaction, 
neutrophils from HH and RR individuals were incubated with CRP in the presence or 
absence of pneumococci type 3. No difference in activation as determined by IL-8 
synthesis, respiratory burst and phagocytosis were seen between HH and RR donors. 
Since CRP increases its serum concentration up to 1000 fold above the normal level, 
we also compared acute-phase concentrations of CRP with normal levels for 
neutrophil functions. Normal (: 510 ýtg/ml) and acute-phase (10 - 100 4g/ml) levels 
increased IL-8 production in the presence or absence of pneurnococci. A similar 
pattern was seen for extracellular reactive oxygen. There was a five-fold increase in 
DHR oxidation in neutrophils when CRP at 10 ýLg/ml was used, although this was 
reduced when CRP at 50 and 100 ýLg/ml was used in both HH and RR donors. 
Recombinant CRP also gave a similar pattern in which higher MIFIs for DHR 
oxidation were obtained for CRP at 10 ýtg/ml. On average a two-fold increase in 
phagocytosis of pneumococci serotype 3 was obtained for both type of donors for 
CRP at 10 ýtg/ml. This effect was also reduced at acute-phase levels of CRP. The 
down-regulatory effects of CRP are thus selective for certain responses but do not 
require phagocytosis since CRP at 50 - 100 ýtg/ml could also inhibit PMA activation. 
The ability of CRP to bind to Fc7-receptors using surface plasmon resonance was 
evaluated, but there was no evidence of CRP binding to Fc7RIIA, RIIIB or RIM 
Serum arnyloid P component showed strong binding to Fc7RIH and weak binding to 
Fc7RIIA and RIEB. A glycosylated form of the Fc receptor may be required for 
binding. 
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RESUMEN 
La proteina C reactiva (CRP) es miembro de la farnilia de las pentraxinas. CRP 
opsoniza, en forma dependiente del ealcio, el Streptococcus pneumoniae a traves de 
la union con el residuo fosforilcolina el cual es expresado en la pared celular de la 
bacteria. Ademas la CRP se fija a los receptores Fc7 con afinidad diversa; asi se fija 
al FcyRI con alta afinidad y probablemente al FcyRIIA con afinidad mas baja. La 
uniOn de la CRP al FqRIIA se ha sugerido que varia de acuerdo al polimorfismo 
expresado en el residuo 131 del segundo dominio extracelular del FcyRHA, los 
individuos que son homocigotos para arginina (RR) en dicha posiciOn se fijan mejor 
a la CRP comparados con los que son homocigotos para histidina (HH). 
Para clarificar la union de la CRP al FcyRIIA y las actividades funcionales que 
surgen de esta uniOn, neuträfilos de individuos tanto HH como RR fueron cultivados 
con diversas concentraciones de la CRP en presencia o ausencia del Streptococcus 
pneumoniae serotipo 3. No hubo diferencia en la activaciOn del neutr6filo 
detenninada por la sintesis de EL-8, la explosiOn respiratoria y la fagocitosis entre los 
dos tipos de individuos (HH y RR). 
Debido a que la CRP incrementa su concentracion serica hasta 1000 veces por 
encima de su valor nomal, tambie comparainos los efectos que concentraciones 
nonnales y concentraciones agudas de la proteina tuvieran sobre la funciOn del 
neuträfilo. Concentraciones norinales de CRP (menores de 10 gg/ml) y 
concentraciones agudas (entre 10 y 100 ýtg/ml) incrementaron la producciOn de EL-8 
en presencia o ausencia del pneumococo. Este efecto fue mas pronunciado cuando el 
EFNy estaba tambien presente. Un paträn de aumento similar se observO con la 
sintesis extracelular de compuestos derivados del oxigeno. 
Hubo un incremento de 5 veces en la oxidaciOn de la dihidrorodarnina (DHR) 
cuando la CRP se uso a 10 kig/ml, sin embargo ese efecto se redujo cuando se uso 
CRP a 50 y 100 ýig/ml tanto en los neutrofilos de donantes HH como RR. La CRP 
recombinante tambien produjo un patron similar en el que mas alta oxidaciOn de la 
DHR se obtuvo al usar CRP a 10 ýtg/ml. Se observO un incremento al doble en la 
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fagocitosis del pneumococo serotipo 3 en ambos tipos de neutrofilos al usar CRP a 
10 ýig/ml. Este efecto se redujo en fonna similar cuando se usaron concentraciones 
altas de la CRP. Por tanto, los efectos reguladores negativos de la CRP son selectivos 
para ciertas respuestas y no requieren fagocitosis dado que CRP a 50 y 100 ktg/ml 
tambien inhibieron la activacion promovida por PMA. 
Investigamos la capacidad de la CRP para f1jar receptores Fcy usando el Biacore, 
pero no pudimos demostrar union ni al Fc7RIIA ni RHB ni al RIII. La proteina 
Amiloide A serica (SAP) mostro, alta afinidad por el Fc7RIII, pero baja afinidad por 
los receptores Fc7RIIA y Fc7RIEB. La fonna glicosilada del receptor Fc puede ser 
requerido, para demostrar union en este tipo de experimentos. 
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1. INTRODUCTION 
Human C-reactive protein (CRP) is an acute phase protein the concentration of 
which increases once an inflammatory response has initiated, in severe cases by up to 
1000 fold. CRP has a number of effects on the immune system. Among its functions, 
it activates the classical complement pathway upon binding to Clq, helps in the 
clearance of apoptotic cells and material derived from necrotic cells such as nuclear 
components and opsonises micro-organisms such as Streptococcus pneumoniae and 
Leishmania donovani promoting their phagocytosis. This can occur through 
complement receptors or directly through binding to Fc7 receptors (Fc7Rs). 
Of the major phagocytic cells, neutrophils are cells that actively participate in the 
inflammatory response removing debris and micro-organisms either opsonised or 
non-opsonised. However, neutrophils are powerful producers of oxidative radicals 
derived from the respiratory burst that occurs in order to eliminate various micro- 
organisms, which once liberated can cause damage to the surrounding tissue. For this 
reason, a chronic inflammatory response may be associated with continuous 
production of oxidative radicals and other factors that may contribute to the 
pathogenesis of some autoimmune diseases. 
CRP and neutrophils could have many different opportunities to interact during the 
inflammatory response; therefore it is possible that CRP exerts different effects on 
the function of these cells under different conditions. CRP effects on phagocytic cells 
have been explored by many groups around the world; however, it is still not clear 
how the interaction occurs and what the outcome of the neutrophil response might 
be. 
We have chosen the interaction of CRP with Fc7 receptors in human neutrophils as a 
way to explore the responses that different concentrations of CRP can have and to 
clarify which of these Fc7 receptors is preferentially used in the context of the 
function of the cell. Streptococcus pneumoniae has been chosen as the working 
model; however its complexity may at the same time influence the final outcome 
obtained in the function of the neutrophils. 
16 
1.1 Streptococcuspneumoniae 
S. pneumoniae (pneumococcus) is a diplococcus, gram-positive, aerophilic bacterium 
which despite antibiotic treatment and an improved vaccine is still one of the major 
pathogens all over the world. 
Pneumococci cause disease more frequently in both extremes of life, with young 
children and the elderly being the most susceptible to it. The respiratory tract is the 
primary organ affected and is the one which this bacterium uses to gain access to the 
rest of the body, for this reason its main mechanism of transmission is airborne. In 
children, diseases commonly associated with the pneumococcus include otitis media, 
sinusitis, pneumonia and meningitis. 
Pc. in A 
Capsular 
Aysaccharides 
C-polysac, 
Proteases 
Figure 1.1 Structure of Streptococcus pneumoniae. Pneumococcus contains 
pneumolysin in the cytoplasm; LTA is formed from the cell membrane, whereas C- 
polysaccharide is the main structure found on the cell wall. On the surface some 
proteins such as pspA and proteases are present and finally a thick capsular 
polysaccharide surrounds the bacteria. LTA: lipoteichoic acid, pspA: pneumococcal 
surface protein A. 
One child in three asymptornatically carries the pneumococcus in the nasopharynx at 
any given time. This bacterium is still a significant cause of acquired hearing loss 
resulting from both otitis media and meningitis. According to figures from the World 
Health Organisation (WHO), pneumococcus causes over I million deaths per year in 
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children younger than 5 years of age. In Europe and the USA pneumococcal 
pneumonia affects approximately 100 per 100000 adults each year. In these countries 
the mortality rate caused by pneumococcal pneumonia is 10% - 20% which may 
exceed 50% in the high-risk groups. (Anonymous, 1999) 
This micro-organism has many different ways to deal with the complex defences of 
the immune system; thus, it has been able to survive through evolution. Some of the 
structures involved in pneumococcal pathogenesis include: 
1.1.1 Capsule 
Pneumococci are characterised by the presence of a thick polysaccharide capsule, 
which is made of repeating oligosaccharides that are covalently bound to 
peptidoglycan and the cell wall (C-) polysaccharide. The capsule is located on the 
surface and has been postulated to play a role in avoiding phagocytosis. More than 
90 different serotypes have been identified according to the type of polysaccharide 
present in the capsule, but of these about 15 generate the majority of the disease 
burden in humans, the only species that pneumococcus affects. In Latin America the 
Pan American Health Organization developed a study to analyse the frequency of 
serotypes involved in invasive pneumococcal. infections in children younger that 5 
years of age; the serotypes in order of the most commonly associated were 14,5,1, 
6B9 23F, 19F, 6A, 19A, 7F, 9V, 18C, 3,4,16F, 9N and 15B (Kertesz et aL, 1998). 
The morphology of the colony also changes according to the thickness of the 
capsule: bacteria that colonise the nasopharynx and remain there for long periods of 
time appear not to have a capsule (transparent colonies) that facilitates binding to the 
epithelium through binding to platelet activating factor (PAF) receptor (Cundell et 
al., 1995) or to polymeric immunoglobulin receptor (pIgR), whereas when the 
bacteria invades, capsule is present (opaque colonies), which among other factors 
allows dissemination of the bacteria. Capsule is required to prevent lysis or 
phagocytosis through complement, natural antibodies or pattern recognition 
receptors. 
An interesting finding is that the pneumococcus can switch the type of 
polysaccharide expressed in the capsule if needed (capsular transformation), perhaps 
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as a way to avoid recognition by specific antibodies triggered by the polysaccharides 
present. It is known from studies in vivo and in vitro that penicillin resistance can be 
transferred from one bacterium to another by genetic exchange. DNA exchange can 
also be the cause for capsular transformation observed in vitro from clinical isolates 
and in vivo in both mice and man usually involving type 23 which is converted into 
types 3,9N, 14 and 19F (Ottolenghi-Nightingale, 1972; Nesin et aL, 1998). 
Although immune responses to the various components of the pneumococcus differ, 
traditionally capsular polysaccharide has been considered aT independent type 2 
antigen (Pecanha et aL, 1991), this means that it is not presented in the context of 
MHC class I and also that the help from T cells required for the production of 
specific antibodies is minimal. Studies in mice, however, have challenged this 
concept by showing that CD40L expressed on CD4+ T cells was essential for the 
production of the IgM and IgG antibodies specific for pneumococcal capsular 
polysaccharide (Jeurissen et al., 2002). It appears that presentation on CDI might be 
possible to induce recognition of polysaccharides by T cells. Dendritic cells pulsed 
with whole bacteria could promote certain isotypes of IgG for capsular 
polysaccharides when transferred into recipient mice (Colino et al., 2002) 
IgG antibodies to capsular polysaccharide are known to confer protection against 
invasive pneumococcal infections. These antibodies can recognise oligosaccharides 
expressed on the capsule, for that reason it is possible that these antibodies can cross- 
react with different pneumococcal serotypes expressing the same carbohydrate 
sequence. On the other hand, IgA antibodies to capsular polysaccharides might be 
effective at the mucosal level and thereby confer protective activities against otitis 
media caused by the pneumococcus. 
In humans, it is clear that B cells require some signals for production of these anti 
capsular antibodies, and among them the interaction of CD40-CD40L appears to be 
of particular importance. Messenger RNA (mRNA) expression of CD40L 
determined by polymerase chain reaction (PCR) in peripheral blood mononuclear 
cells (PBMC), was increased after immunization with the 23-valent pneumococcal 
vaccine concomitantly with IL-4 (Leiva et al., 2001), which helps in the synthesis of 
antibodies. Although CD40 ligation on B cells is normally associated with CD40L 
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expression by T cells, CD40L has also been reported on human dendritic cells 
(Pinchuk et aL, 1996); this mechanism could be useful to bypass T cell help (Wykes 
and MacPherson, 2000). 
IgG1 and IgG2 antibodies confer protection against specific types of S. pneumoniae 
(Freijd et aL, 1984, Barrett and Ayoub, 1986) by opsonising the micro-organism and 
facilitating phagocytosis by neutrophils or macrophages (Gordon et aL, 2000). 
Individuals who lack specific antibodies against pneumococcal polysaccharides 
(specific antibody deficiency) (Sorensen et aL, 1998) or those who have IgG2 
deficiency are susceptible to pneumococcal infections. With age, there is a tendency 
to have more IgG2 that IgG1 (Lottenbach et aL, 1999), the increased importance of 
IgG2 which binds better to Fc7R11A with histidine in position 131 implies that 
individuals with this polymorphism are less likely to get infection than those with 
arginine in the same position. 
In the mucosa, other factors have been associated with resistance to the 
pneumococcus through binding to its capsular polysaccharide, e. g. IgA antibodies 
which in combination with complement components helps in opsonisation and 
phagocytosis of S. pneumoniae (Janoff et al., 1999). Moreover, Od fragments of 
complement associated with pneumococcal capsular polysaccharides have been 
found to bind CD21 (CR2 receptor) on B cells. This has the ability to increase the 
production of specific antibodies (Griffioen et al., 1991). CD21 is expressed mainly 
by B cells and follicular dendritic cells on the marginal zone of the spleen (Peset 
Llopis et al., 1996), cells which are lacking in patients who suffer from sickle cell 
disease or who have had a splenectomy, conditions that predispose to pneumococcal 
infections. 
1.1.2 Cell wall and membrane 
The cell wall consists of a peptidoglycan and teichoic acid. The peptidoglycan 
consists of long chains of alternating N-acetyl-D-glucosamine and N-acetylmuramic 
acid from which extend chains of four to six amino acids called stem peptides. C- 
polysaccharide is composed of two parts: 1) teichoic acid, which is able to protrude 
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into the capsule (Musher, 2000), is a phosphory1choline (PCh) containing polymer of 
low molecular weight carbohydrates such as N-acetylglucosamine joined together 
through diester linkages to ribitol phosphate residues and; therefore, classified as 
ribitol teichoic acid and 2) fragments of peptidoglycan (Sorensen, 1995). 
Presence of PCh on the pneumococcal surface confers ability to bind to CRP, 
myeloma proteins and PAF receptors (Bruyn et al., 1992). PCh binding to PAF 
receptors is important since when PCh binding to PAF receptors was blocked, 
markers of inflammation such as leukocyte migration were decreased in a rabbit 
model of pneurnococcal meningitis and pneumonia (Cabellos et al., 1992). This 
finding is highlighted by the activity of pneumococcal phosphory1choline esterase 
that removes up to 30% of the PCh present. When this enzyme is inactivated, an 
increase in the virulence of mutated pneumococci in a mouse model is observed, 
apparently due to more pneumococcal adherence to PAF receptors (Vollmer and 
Tomasz, 2001) or possibly due to an increased attachment of other virulence factors 
to the bacteria. However the clinical implication of this enzyme in clinical isolates 
remains to be seen. Adding to this, increased expression of PCh on H. influenzae was 
shown to lead to reduced virulence in rats (Humphries and High, 2002). 
An immunogenic component of the membrane of the pneumococcus is lipoteichoic 
acid which together with teichoic acid is able to promote an inflammatory response 
by interaction with toll-like receptor 2 (TLR2) and CD14 (Yoshimura et al., 1999). 
Proinflammatory cytokines induced by these molecules increase the migration of 
leukocytes to the affected tissue and are partially involved with symptoms associated 
with pneurnococcal infections. IgG antibodies to cell wall polysaccharide were 
shown not to protect against the progression of acute pneurnococcal infection from 
colonisation to acute purulent bronchitis, which is due to encapsulated bacteria 
(Musher et al., 1990). Although this study did not analyse phagocytosis of opsonised 
pneumococcus with these antibodies, the implication is that antibodies directed to 
non-encapsulated bacteria do not protect against encapsulated pneurnococcus. 
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1.1.3 Pneumolysin 
Pneumolysin is a 53 kDa, polypeptide member of the family of thiol-activated 
cytolysins ubiquitously present in all clinical pneumococcal isolates. This haemolytic 
toxin is a le to lyse all cells that have cholesterol in their membranes and therefore it 
is one of the main virulence factors involved in pathogenesis (Mitchell, 1999). 
Pneumolysin is located in the cytoplasm and can be liberated after lysis of the micro- 
organism. Its gene was characterised in 1986 and mutants lacking the gene have been 
constructed, shown to have reduced virulence and used to analyse the role of this 
protein in the ability of the pneumococcus to cause infection (Berry et A, 1989). 
Pneumolysin activates the classical complement pathway in the absence of specific 
antitoxin antibodies, apparently upon non-specific binding to the Fc portion of 
antibodies. Complement activation was determined by detecting cleavage of C3 by 
radioimmunoassay. Mutations of pneumolysin in amino acid residues 384 and 385 
cause a decrease in the ability of the toxin to bind antibody and hence activation of 
the classical pathway (Mitchell et A, 1991). 
Previously pneurnolysin was reported to decrease the respiratory burst of neutrophils 
(Paton and Ferrante, 1983), however, recent studies with recombinant pneurnolysin 
have shown increased phospholipase A2 activity, associated with increased 
expression of CR3 and enhanced superoxide production. These effects were 
explained by an increased calcium influx due to a pore forming mechanism 
(Cockeran et aL, 2001). Recently, pneumolysin has been shown to induce production 
of TNFcc and IL-6 by macrophages through TLR4. Mice with a mutation on TLR4 
were more susceptible to pneumococcal infection than wild-type mice (Malley et aL, 
2003). These data suggest that pneumolysin also contributes to the innate immune 
response against pneumococei. 
Pneumolysin has been evaluated for its ability to act as a pneumococcal vaccine in 
mice. Alexander et aL, (1994) used mutated pneumolysin to induce production of 
IgGl, different mice strains were then challenged against nine different 
pneurnococcal serotypes showing some protection to most of the serotypes used, 
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although responses were variable among the mice used (Alexander et aL, 1994). 
Pneumolysin and choline binding protein A (CbpA) or the combinations of both 
have also been tested in mice providing better survival when the combination is used 
(Ogunniyi et aL, 2001). In humans, a conjugated vaccine that involves both a 
pneumococcal. capsular polysaccharide and pneumolysin might be useful since both 
components are from S. pneumoniae whereas currently conjugated vaccines use the 
pneumococcal polysaccharide conjugated to a protein from a different micro- 
organism. 
1.1.4 Surface proteins and enzymes 
Proteins expressed in the surface of the pneumococcus may be either anchored via 
the attachment motif LPXTG and protein attached to peptidoglycan (transpeptidase 
activity) (Lee et aL, 2002). Alternatively, they may be non-covalently associated 
with choline; these proteins are called choline binding proteins and include CbpA, 
PspA and N-acetylmuramoyl-L-alanine amidase (LytA) (see below). Some enzymes 
like neuraminidase enzymes and hyaluronidase also contain the LPXTG motif 
(Mitchell, 2000). 
CbpA is important for adherence of the bacteria to the nasopharyngeal epithelium as 
has been shown for transparent colonies, which have an increased expression of this 
protein (Kim and Weiser, 1998). Interestingly, CbpA binds to the secretory 
component of IgA (Hammerschmidt et aL, 1997), probably interfering with IgA 
function, but also it might be associated with binding to pIgR. 
PspA is a lactoferrin-binding protein ((Hammerschmidt et aL, 1999), (Hakansson et 
aL, 2001)) that allows the bacteria to have access to iron that is captured by 
lactoferrin found in human milk or produced by neutrophils. In addition, this protein 
has been shown to inhibit complement activation by S. pneumoniae (Tu et A, 1999). 
Enzymes that participate in the pathogenesis of invasive pneumococcal infections 
allowing disruption of the connective tissue include neuraminidase enzymes (NanA 
and NanB) and hyaluronidase that are able to induce local inflammation. Models that 
use pneumococcal strains with mutated fonns of these enzymes have shown less 
virulence when compared to the wild type strains (Mitchell, 2000). 
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Autolysins are enzymes that degrade the cell wall of micro-organisms. Based on the 
chemical bond that these enzymes break down in the peptidoglycan substrate, they 
are classified as glycosidases (muramidases or lysozymes, glucosaminidases and 
transglycosylases) arnidases or endopeptidases (Garcia et al., 1999b). One of the first 
characterised autolysins of the pneumococcus is LytA which is a choline-binding 
protein (Garcia et al., 1999a). 
Presence of choline residues in the cell wall teichoic acid is essential for the 
sensitivity to LytA, LytB (endo-p- N-acetyl-glucosaminidase) and LytC; by the 
action of these enzymes, the cell wall is fragmented and each fraction becomes 
highly proinflammatory, for example inducing production of IL-1, IL-6 and TNF(x 
by human monocytes (Riesenfeld-Om et A, 1989; Heumann et aL, 1994). 
Some of these proteins have been suggested as potential candidates for vaccination, 
however the practical effectiveness for this or other strategies remains to be seen. In 
the meantime, the pneumococcus continues to be an important human pathogen. 
1.2 Neutrophils 
Neutrophils are granulocytes produced by the bone marrow in humans. The bone 
marrow weighs about 2500g as compared to liver which weighs 1500g; up to 60% of 
the cell production of the bone marrow is dedicated to them with the result that they 
are the most numerous blood cell. Neutrophils are characterised by nuclei segmented 
into 3 to 5 interconnected lobes, hence they are known as polymorphonuclear 
(PMNs) cells. Also because of the presence of multiple granules in their cytoplasm 
they are also considered a type of granulocyte (Bainton, 1999). Once in the 
circulation, the half-life of neutrophils is approximately 10 hours, but once they 
reach the tissue they can live up to 2 days. To reach its maximum maturation 
neutrophils start from a myeloblast stage, which contains no granules, are 
transformed into a promyelocyte, then myelocyte, metamyelocyte, bands and finally 
the mature form. 
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During acute inflammation the release from bone marrow is increased to generate the 
leukocytosis seen. This is under the control of cytokines such as G- and GM-CSF 
which, in conjunction with EL- 1P and TNFoc, influence the production of these cells 
in the bone marrow and are associated with the accumulation of neutrophils in the 
lungs and other tissues observed with different stimuli such as LPS and EL-17 (Laan 
et aL, 2003) 
During these changes the neutrophil acquires the characteristic primary or 
azurophilic granules named because of their affinity to azure dye. Primary granules 
appear for the first time in the promyelocyte stage which are characterised by the 
presence of myeloperoxidase. Thereafter, secondary or specific granules appear 
which contain lactoferrin and collagenase among other substances important in the 
function of these cells. Tertiary or gelatinase granules have a high concentration of 
this enzyme and secretory vesicles that contain plasma proteins endocytosed by 
neutrophils (Table 1.1) (Burg and Pillinger, 200 1). 
Elie Metchnikoff first described neutrophils at the end of the nineteenth century from 
their ability to phagocytose. It is now clear that neutrophils are not only phagocytic 
cells, but they have also the capacity to influence the inflammatory response and are 
important in connecting innate immunity with the adaptive immune response through 
the production of MCP-l and IFNy. MCP-1 is important in delayed-type 
hypersensitivity reaction and the production of IFN7 a key cytokine in the Thl 
response (Yamashiro et al., 2001). Neutrophils are the first leukocytes to go to an 
inflammatory site and they are the hallmark of acute inflammation. 
Neutrophils synthesise a range of enzymes and substances that are effective 
in 
destroying ingested micro-organisms. However some secreted molecules have also 
an immunomodulatory role once released to the external environment. 
Some of these 
proteins are the neutrophil-derived serine proteases stored 
in the primary granules: 
elastase, cathepsin G and proteinase 3. These proteins are active at neutral pH and 
besides their ability to participate in the degradation of the extracellular matrix may 
also catalyse the activation of cytokines such as EL-lP and 
TNF(x (Bank and 
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Ansorge, 2001). This is one example of other potential functions of neutrophils on 
the immune system besides their phagocytic capacity. 
Some of the functional activities of neutrophils are as follows: 
Chemotaxis: Neutrophil binds to a chemoattractant, which provide a chemical 
gradient that allows the cell to follow it. Many different substances have the 
ability to attract them including C5a (derived from complement activation), PAF, 
fMLP (only produced by bacteria), LTB4, and a number of chemokines of which 
IL-8 appears to be the more important (Walz et A, 1987). Neutrophils express 
receptors for each of these chemokines to allow binding to them. 
Migration: Chemotactic substances and different cytokines are able to induce the 
expression of adhesion molecules (integrins, selectins and immunoglobulin 
superfamily members) on both endothelial cells and neutrophils which facilitate 
the interaction between these cells. The expression of E-selectin on endothelial 
cells and L-selectin on neutrophils is important for rolling of the latter cells. This 
event has been called margination of neutrophils from free flow to the 
endothelium (Picker et al., 1991). 
If the stimuli (such as TNFcc production) persists, the expression of adhesion 
molecules differs from the one described above. Neutrophils are induced to 
express P2-integrins, LFA-1 (CDlla/CD18) mac-1 (CDllb/CD18) and 
pl50/95(CDllc/CD18) which are ligands for ICAM-1 and -2 expressed on 
activated endothelial cells; this allows a firm adhesion of neutrophils to the 
endothelium. Then, through a process still not well understood, the neutrophil 
extends pseudopods to migrate to the site where the chemotactic stimulus is 
being produced. For this late event, there is a role for some P1 -integrins, such as 
oc9pl, inhibition of which is able to block the migration of neutrophils to the 
tissue (Butcher, 1991). 
Endocytosis and degranulation: The recognition of micro-organisms by neutrophils 
can be either direct through specific receptors or indirect, binding first to 
opsonins (Christiansen and Skubitz, 1988) 
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Table 1.1 Proteins found in human neutrophil granules and secretory vesicles. Modified from Bainton (1999). 
Azurophil granules Specific granules Gelatinase 
granu es 
Secretory 
vesicles 
CD63, CD68 CDl lb, CD15 CD1 lb Alkaline 
V-type H+-ATPase CD66, CD67, TNF- Cytochrome b558 phosphatase 
R, fMLP-R 
Dyacylglycerol- 
deacylating CR1, CD I lb Cytochrome b558 
enzyme Cytochrome 
Fibronectin-R b558 
Laminin-R fMLP-R 
G-protein subunit Urokinase-type 
CD14 
Plasminogen CD16 Thrombospondin-R activator -R 
Vitronectin-R fMLP-R 
Rap 1, Rap2 VAMT-2 V-type H+- ATPase 
Urokinase-type 
Plasminogen V-type H+- 
activator -R 
ATPase 
Acid P2-microgloblin Acetyltransferase CD10 
glycerophosphate Gelatinase P2-microglobulin CD13 
Acid Lysozyme Gelatinase CD45 
mucopolysaccharide Collagenase Lysozyme C1 q-receptor 
cc 1- antitrypsin Gelatinase DAF 
Histaminase Albumin 
cc- mannosidase Heparanase Tetranectin 
P-glycerophosphate Lactoferrin, 
Heparin- binding protein 
Lysozyme, 
Sialidase 
Bactericidal permeability Vitamin B 12- increasing protein binding protein 
P-glucuronidase 
Cathepsins 
Defensins 
Elastase, Sialidase 
Lysozyme 
Myeloperoxidase 
N-acetyl-P- 
glucosaminidase 
Proteinase-3 
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Killing: Killing occurs as a result of a combined effect of superoxide anion 
production, the activity of proteases and possibly removal of factors needed for 
microbial growth or survival (Reeves et A, 2002). 
1.2.1 Cytokine production by neutrophils 
Although many cytokines have been reported to be produced by neutrophils, these 
data should be considered with caution due to the contribution of contaminating 
eosinophils or basophils which are particularly difficult to separate from neutrophils. 
More recent papers based on FACS analysis of intracellular production have 
provided more reliable data. 
Requirements for the production of these or other cytokines may vary from study to 
study, but it is clear that in most conditions production of these cytokines are higher 
after priming the neutrophils with a stimulant. That is, ability to produce a particular 
cytokine like TNFcc may require pre-incubation with GM-CSF or IFN7 to respond to 
LPS or fMLP to a greater degree. 
In some reports it is not clear which type of priming has been used, but even the type 
of blood anti-coagulation used may have an effect, for example the use of heparin 
might prime neutrophils since they express a receptor for it (table 1.1). Use of foetal 
calf serum (FCS) or other supplements during culture procedures may provide the 
elements required for priming. 
Neutrophils are reported to synthesise proinflammatory cytokines such as EL-1p, 
TNFa and IL-6, are able to stimulate their own chemotaxis and activation through 
the production of IL-8 and may also have the capacity to influence the adaptive 
immune response by the synthesis of IFNy which then may influence T cells to 
become Thl (Yeaman et aL, 1998). 
IL-8 is an autocrine cytokine produced by neutrophils in higher concentration 
compared to other proinflammatory cytokines. mRNA for IIL-8 was found in non- 
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stimulated neutrophils whereas mRNA for IIL- 1 P, IEL-6 and TNFcc only appeared 
after stimulation (Altstaedt et al., 1996). IL-8 is a CXC chemokine initially shown to 
be synthesized by mononuclear cells (Matsushima et al., 1988; Peveri et al., 1988), 
later neutrophils were also shown to produce this chemokine (Bazzoni et al., 1991). 
IL-8 promoted migration of neutrophils 4-6 hours after instillation into the skin of 
rabbits (Colditz et al., 1990). However, IL-8 not only attracts neutrophils to the site 
of inflammation but also at higher concentrations induces their adherence, 
degranulation, respiratory burst and lipid mediator synthesis (Baggiolini et al., 1994). 
At high cell density IL-8 synthesis is regulated, after increasing neutrophils up to 6x 
107 cells/ml production of IL-8 was reduced concomitantly with the secretion of IL- 
1RA and soluble TNF receptor (sTNFR) (Hattar et al., 2001). Another cytokine that 
can be immunomodulatory is TGFP, which also has been shown to be synthesised by 
human neutrophils (Chu et al., 2000). TGFP1 does not activate neutrophils as shown 
by superoxide generation but it induces chemotaxis provoking polymerisation and 
redistribution of F-actin. This effect is neither dependent on influx of calcium nor 
GTPase activity (Reibman et al., 199 1). 
Neutrophils are also reported to induce migration of mononuclear cells as has been 
shown by the secretion of MIP-1 cc. Different micro-organisms are able to induce the 
production of EL-8 or MEP-loc to different degrees: Pseudomonas aeruginosa and 
Staphylococcus aureus induced both IL-8 and MIP-l cc; Streptococcus pneumoniae, 
Staphylococcus epidermidis and Candida albicans induced both but to a lesser 
extent; Saccharomyces cerevisiae and zymosan induced IEL-8 but not MIP-lcc. 
(Hachicha et aL, 1998). 
1.2.2 Phagocytosis 
Phagocytosis is a phylogenetically ancient response to particles adopted by 
phagocytes such as neutrophils and macrophages. It requires the recognition of small 
particles exceeding 0.5ýim (the size of Mycoplasma, the smallest microbe known to 
stimulate phagocytosis), the formation of pseudopods which are extensions of the 
cytoplasm rich in filaments that are part of the cytoskeleton (e. g. Filamentous actin 
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(F-actin), vinculin and talin) and temperature, the lowest temperature that allows 
phagocytosis is between 13 and 18T (Greenberg, 1999a). 
In vivo before the real contact between the particle and the phagocyte certain steps 
have to be accomplished which briefly are chemotaxis and opsonisation of the 
particle. The recognition of micro-organisms by neutrophils can be either direct 
through specific receptors, for instance through scavenger receptors or indirect, with 
pathogen binding first to opsonins (Christiansen and Skubitz, 1988). Opsonins which 
include immunoglobulins, some complement fragments such as Ob and C4b and 
various acute phase proteins such as MBL and CRP, are very important in protection 
against encapsulated bacteria such as pneumococcus and any defect in these proteins 
may result in an increased frequency of bacterial infections (see sections 1.3.1 and 
1.3.2). 
Neutrophils contain specific receptors for opsonins such as immunoglobulin Fc 
receptors which include Fc receptors for IgG (Fc7Rs) and complement receptors 
CRI, CR3, CR4. These receptors allow recognition of encapsulated bacteria, 
subsequently the neutrophil may extend pseudopods all around the opsonised 
bacteria, engulfing it and fon-ning a new organelle called a phagosome. 
Two types of phagocytosis have been described, depending on the opsonins that are 
bound to the particle: Type I phagocytosis is characterised by pseudopodia extension, 
is mediated by Fc7Rs and requires the two Rho family Guanosine triphosphatases 
(GTPases): Rac, Cdc42. Type I phagocytosis induces an inflammatory response 
whereas type II phagocytosis, which is CR3-mediated, occurs through sinking of the 
Obi-coated particle into the cell, requires only RhoA but not Rac and Cdc42 and 
does not induce an inflammatory response. This second type might be relevant to 
phagocytosis, of apoptotic cells (Caron and Hall, 1998; Fadok et al., 1998). 
Recently, phagocytosis through CR3 of opsonised and non-opsonised zymosan was 
compared; under non-opsonic conditions zymosan was phagocytosed 
in a type I 
manner, whereas serum-opsonised zymosan induced a type H phagocytosis 
by 
human neutrophils and macrophages. Since these cells do not express the mannose 
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receptor it was assumed that internalisation was performed through CRI However, 
the action of other receptors involved in the recognition of zymosan such as TLR2 
and P-glucan receptor was not ruled out (Le Cabec et A, 2002). Thus, CR3 may be 
able to mediate both types of phagocytosis through different mechanisms. 
Probably, the more important factor related to the receptor that was used for 
phagocytosis is the type of signal that is induced in the neutrophil. The fact that 
phagocytosis by Fc7Rs generates a different outcome when compare to phagocytosis 
through CR3 suggests different signal molecules are induced in the neutrophil and in 
the past decade it has become clear that this is the case. This topic will be discussed 
in section 1.2.4. 
1.2.3 Respiratory burst 
One of the more remarkable functions of neutrophils is the production of radicals 
derived from oxygen which include superoxide, peroxide hydrogen, hydroxyl 
radicals and singlet oxygen by the action of the enzymatic complex NADPH oxidase. 
This enzyme is not only present in neutrophils but also in eosinophils, macrophages 
and B lymphocytes where the function is not well clarified. Because of the high 
consumption of oxygen this chain of events is also known as the respiratory burst. A 
variety of stimuli that activate neutrophils are able to induce the respiratory burst, 
including complement components such as C5a, PAF, IL-8, IFNy, fMLP, PNIA and 
phagocytosis. 
NADPH is composed of five components: the membrane bound cytochrome 
b558; the 
cytosolic factors p47 
phox, 
p67 
phox, p4ophox, and the GTPase Rac2. Cytochrome 
b558 
itself is a complex of two subunits gpglphox and p22 
phox. Upon cell activation, the 
cytosolic components move to the membrane to form an electron-transfer system. 
The electrons are carried by the cytochrome 
b558 from NADPH in the cytosol, across 
the membrane, and delivered to oxygen present in an intracellular compartment such 
as a phagosome or in the extracellular milieu (Dahlgren and 
Karlsson, 1999). 
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Chronic granulomatous disease (CGD), a primary immunodeficiency where NADPH 
oxidase is defective is characterised by recurrent fungal (e. g. Aspergillusfumigatus) 
and bacterial (e. g. Staphylococcus aureus) infections. The cause is a defective gene 
in the gpq I phox (two thirds of cases and linked to the X-chromosome) or in p22 phox or 
other components (autosomic recessive). Studies in those patients affected by this 
disease have helped to understand the composition and actions of NADPH oxidase 
(Geiszt et al., 2001). 
NADPH oxidase catalyses the following reaction that leads to the production of 
superoxide anion(02-): 202+ NADPH -)ý202-+ NADPH+ + H+ 
Superoxide dismutase (SOD) is useful to degrade 02- especially at low 
concentrations. At higher concentrations dismutation may happen spontaneously, 
through the catalysis of the following reaction that leads to the synthesis of peroxide 
hydrogen (H202): 202-+ 2H+->02+ H202 
Peroxide hydrogen can reduce metals such as iron or copper to form hydroxyl radical 
(OH), which is one of the most reactive radicals produced during the respiratory 
burst, the reaction that occurs to fon-n hydroxyl is: H202+ Fe 
2+_40H* 
+ Off + Fe 
3+ 
Myeloperoxidase, which is a heme enzyme that is characteristic of azurophilic 
granules, converts H202 into a more potent toxic agent through the following 
reaction: Cl- + H202 -> OCI- + 
H20 
In a further reaction singlet oxygen radicals (102) are forined. They have been 
attributed to the damage that neutrophils may cause to the normal tissue when the 
respiratory burst occurs: H202+ 
OCI- -> 
102+ H20 +Cl- 
Two different reactions help to decrease the amount of peroxide hydrogen produced. 
These reactions, which are very important as anti-oxidative pathways and limit 
ffirther damage to normal tissue (Forman and Torres, 2002), are: 
H202-ý H20+02mediated by catalase (present in peroxisomes) 
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H202 + Glutathione (2GSH) -> 2H20 + (Glutathione disulfide)GSSG 
(this reaction is catalysed by Glutathione peroxidase). 
The respiratory burst participates in killing micro-organisms that have been 
phagocytosed. Initially it was accepted that oxidative changes in different structures 
and enzymes of the microorganism was enough to induce killing. However, this was 
challenged recently, when in a mouse model that lacks proteases but with proper 
NADPH oxidase activity, killing was affected. The explanation for this lies in the 
"L. 0 - to induce potassium influx into the cells and a rise in the pH important '111"'ilitY Of 02 
for the activity of proteases (Reeves et al., 2002). 
Different ways have been used to determine the respiratory burst in neutrophils; 
some of the common ones are described in Table 1.2. 
Table 1.2 Techniques commonly used for measuring oxygen radicals at intra or 
extracellular level (adapted from (Dahlgren and Karlsson, 1999)) 
Measuring principle Technique Metabolite detected 
SOD- inhibitable reduction of 
Photometry Superoxide 
cytochrome c 
Peroxidase-dependent 
Fluorometry Peroxide hydrogen 
oxidation of scopoletin 
Peroxide-dependent 
isoluminol-amplified Luminometry Superoxide 
chemiluminescence 
Precipitation 
NBT reduction Superoxide(9) 
reaction 
Peroxidase-dependent luminal 
Luminometry Superoxide 
amplified chemiluminescence 
Oxidation of DHR123 FACS Peroxide hydrogen 
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1.2.4 Fc7Rs 
Fc7Rs are members of the immunoglobulin superfamily which contain two or three 
extracellular domains. Three different classes have been described: FC7RI (CD64), 
Fc7RII (CD32) and Fc7RIII (CD16). 
FC7RI is a 72kDa glycoprotein, comprising a 55kDa protein core and a number of N- 
linked glycosylation modifications potentially at positions 59,78,152,159,163,195 
and 240. FC7RI is often referred to as the high affinity IgG receptor which is capable 
of binding monomeric IgG by its Fc region. It is encoded by three different genes: A, 
B and C, all located in humans on chromosome lq2l. Of the three genes, only A 
encodes an integral receptor, B and C contain stop codons that might translate a 
soluble form of the receptor. 
Fc7RI has three extracellular domains (Figure 1.2) and is expressed in monocytes, 
macrophages, eosinophils, mast cells and dendritic cells (DCs). Fc7RI is poorly 
expressed on resting neutrophils, but expression is increased upon activation of the 
neutrophil (Shen et al., 1987). Cytokines able to induce the expression of Fc7RI 
include IFN7, IL-10 and G-CSF, whereas treatment of neutrophils with IL-4 
decreases it (Hulett and Hogarth, 1994). Fc7Rl, the high affinity IgG receptor, binds 
to monomeric IgG through the third domain and to CRP, in the presence of calcium, 
with high affinity (0.81 x 10-9M) (Bodman-Smith et al., 2002) 
Fc7RI 
FC7RIIA 
H131 
R131 
ITAM 
Human IgG 
Binding 
I ý3>4>>2 
Affinity 10-1-10-Im 
ITAM 
Fc7RIlB 
ITIM 
3ý! 1,2>>4(HH) 3ý: 1>4>2 
3>1>>2>4(RR) 
lo-Im lo-Im 
Figure 1.2 FcyRs Structure and binding to human IgG. 
FcyRIll 
ITAM 
1,3>>2,4 
2xlO-'M 
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Murine FcyRI (mFcyRI) has the same structure as the human protein, although its 
ability to bind IgG is different from humans since it has a higher affinity for IgG2a, 
Kd = 10-7 _ 10-8M, than all the other subclasses. It is well expressed on monocytes, 
macrophages and neutrophils (Hulett and Hogarth, 1994). No crystal structure or 
functional FcyRI (or other FcyRs) has yet been expressed in a recombinant form in 
usable amounts. 
Human FcyRI1 has three different genes: FcyRIIA, FcyRIIB and FcyRIIC, all located 
in chromosome lq23-24. Fc7RI1A is a 40kDa glycoprotein, with a protein core of 36 
kDa. There are two potential N-glycosylation sites in positions 97(Asn) and 
178(Asn). It is expressed on NK cells, DCs, Langerhans cells (LCs), macrophages, 
eosinophils, basophils, platelets and neutrophils (Takai, 2002; Kepley et al., 
2000). E1, -4 has been shown to decrease the expression of Fc7RI1A (Hulett and 
Hogarth, 1994) whereas EL-4 increases the expression of FcyRIEB on monocytes 
(Tridandapani et al., 2002a). 
FC7RHA has been crystallised and its structure determined, revealing the presence of 
several loops in the second domain of the receptor which are important for binding to 
IgG1 and IgG2 which bind to different regions of the domain (Maxwell et A, 1999). 
Initially, it was reported that some individuals bound better to murine IgGl (m1gGl) 
than others through Fc7RIIA, they were described as high responders and low 
responders respectively (Van de Winkel et al., 1987). Subsequently, it was shown 
that this characteristic was related to a polymorphism in the position 131 of the 
second domain of Fc7RIIA where arginine or histidine can be present. Receptors of 
individuals who are homozygous for histidine (H131) bind better to IgG2 than 
individuals homozygous for arginine (R131) (Figure 1.2) (Warmerdam et al., 1991). 
The opposite was described for CRP, that is, CRP binds better to R131 than H131 
(Stein et al., 2000b), mimicking the pattern for mIgG1 binding (see section 1.3.2.2). 
In the same way, neutrophils from H131 individuals have been shown to 
phagocytose IgG2-opsonised group B type III Streptococcus strain M732 (Sanders et 
aL, 1995) and IgG2-opsonised Neisseria meningitidis (Fijen et aL, 2000) more 
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effectively than neutrophils from R131 individuals. This is thought to be the reason 
why R131 homozygous individuals are more frequently found to suffer recurrent 
pneumococcal infections (Sanders et aL, 1994). 
FcyRI11B is a 40kDa glycoprotein, with a protein core of approximately 29 kDa. It has 
three different potential N-glycosylation (N-acetylglucosamine) sites: 106 (Asn), 
180(Asn) and 187(Asn). During transcription alternative splicing gives rise to two 
products RHB 1 and RIEB2. FcyRHB is expressed by B-and T-lymphocytes, mast 
cells, basophils, eosinophils, DCs and LCs (Takai, 2002; Kepley et al., 2000). 
Recently, FcyRI11B was shown to be expressed on monocytes in an EL-4 dependent 
way; previously mRNA for FcyRI11B was shown on neutrophils (Cassel et al., 1993; 
Tridandapani et al., 2002a). 
FcyR][IC represents a cross-over between FcyR]IA and FcyRIEB, that is, the 
extracellular domains, transmembrane domain and the first intracellular domain are 
from IEB, the other two intracellular domains are from IIA (Warmerdam et aL, 1993). 
FcyRlIC is expressed on monocytes, neutrophils and four different transcripts on NK 
cells (Metes et aL, 1998). 
Mice only express Fc7RI113 and no Fc7RIIA, which is more heterogeneous in size 
than in humans, with a molecular weight ranging from 40 to 60 kDa. The 
extracellular and transmembrane domains are highly conserved between humans and 
mice, but both species have isoforms that differ in the intracytoplasmic domains. The 
affinity for the murine IgG subclasses is the same (,,: ý 10-7 M) for IgGl, 2a and 
2b and 
lower for IgG3. This receptor is expressed in monocytes, mast cells, macrophages, 
platelets, neutrophils and B cells (Hulett and Hogarth, 1994) 
FcyRIII is also heterogeneous in size with a molecular weight range 
from 50 to 80 
kDa. This heterogeneity is generated by N-linked glycosylation of both Fc7FJIIIA and 
Fc7RIIEB with five: (positions 53,63,92,180,187) and six (positions 56,63,82,92, 
180,187) potential residues respectively. The latter receptor is the only membrane 
Fc7R that is not an integral part of the membrane but is attached by a 
glycosylphosphatidylinositol (GPI) moiety. Fc7RIIIA 
is expressed on monocytes, 
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macrophages, NK cells, mast cells, eosinophils, DCs, LCs, and Y/6 T cells, whereas 
FcyRI11B is found on neutrophils and eosinophils. TGFP increases FcyRIIIA 
expression. EFNy, GM-CSF and G-CSF induce the expression of FcyRHIB, on the 
other hand IL-4 decreases Fc7RIIIA and TNFcc decreases FcyRI11B expression on 
neutrophils; soluble Fc7RIII has been found in the serum of infected patients as a 
consequence of cleavage from neutrophils by serine proteases (Khayat et al., 1987). 
C -j 2-A 2 -B 
CY3-8 
Figure 1.3 The overall structure of the sFcyRIII- human Fc1 complex. The 
crystal structure of the soluble FcyRIII with the monoclonal human Fc fragment of 
IgGI(hFcl) is shown. Stereo ribbon representation with the dimer axis of hFc1 (red 
and blue) orientated vertically. The 'proline sandwich' consisting of Pro 329 of the 
C-y2-A domain and Trp 87 and Trp 110 of sFc7RlII (green) is shown in ball and stick 
fashion together with the carbohydrate residues of the Fc fragment and the interchain 
disulphide bridge (yellow) of the Cys 229 residues. The potential N-glycosylation 
sites in sFc7RIII are shown as cyan balls. Taken from Sonderman et al., (2000). 
X-ray crystal structures of Fc7Rlll with IgG have also been reported (Figure 1.3). 
Soluble FcyRI11B bound to the second domain of the Fc poition of the IgGI 
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molecule by its second domain, ensuring a 1: 1 stoichiometry of the complex 
(Sondermann P et al., 2000). 
Two allelic forms of Fc7RIIEB have been described and are designated as 
neutrophil-specific antigen (NA) NAI and NA2 which differ by five nucleotides and 
four amino acids, with NA2 containing two additional N-linked glycosylation sites 
(six versus four). Neutrophils from individuals homozygous for NA1 exhibit better 
phagocytosis of IgGl-opsonised Staphylococcus aureus, Haemophilus influenzae 
type b and Neisseria meningitidis as well as IgG3 anti Rhesus D-opsonised 
erythrocytes than NA2-homozygous donors (Bredius et A, 1994). There are also 
changes in FcyRIIIA at position 48 which generates 3 different allotypes with the 
presence of either leucine, arginine or histidine (de Haas et al., 1996) and at position 
158 which may contain either valine or phenylalanine and may have functional 
consequences because it alters IgG binding and has been associated with an elevated 
risk for systemic lupus erythernatosus (Deo et al., 1997; Koene et al., 1998). 
In contrast to human FcyRHI only one isoform has been described in mice for this 
receptor. The extracellular region of mFcyRIII is highly conserved with mFcyR]Ilb 
(95% amino acid identity). The transmembrane and intracellular domains are more 
similar to human FcyRIIIA. It has the same affinity (Kd<l 0-7M) for IgGl, 2a and 2b, 
but lower affinity for IgG3 (Hulett and Hogarth, 1994). 
The main human neutrophil Fc7Rs, which are constitutively expressed, are Fc7RIELA 
and Fc7RIIEB. Decreased levels of FcyRlll]B are usually found on neutrophils 
spontaneously suffering apoptosis (Homburg et aL, 1995). Fc7RI is inducible on 
normal neutrophils and may reach up to 15000 receptors per cell after the cells are 
cultured in the presence of 1001U IFN7. The same treatment did not alter 
expression of Fc7RIIA (about 25000/cell) or Fc7RIIIIB (about 200000 molecules per 
cell) as analysed by FACS (Hoffineyer et aL, 1997). 
Fc7RI and FC7RIIII in both human and mouse co-ligate with a 7-chain that contains an 
immunoreceptor tyrosine-based activation motif (ITAM), whereas Fc7RIIA contains 
an ITAM in its cytoplasmic domain. It has been shown that there is co-operation 
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between the Fc7Rs expressed on neutrophils as has been shown for Fc7RI11B which 
enhances phagocytosis when it is cross-linked with FcyREA (Salmon et al., 1995). 
More recently Fc7RI has been shown to be able to signal through FcyRIIA in U937 
cells differentiated to a macrophage-like phenotype with dibutyryl cAMP (Cameron 
et al., 2001). Dr Bodman-Smith in our laboratory has shown that this can lead to 
phagocytosis (unpublished data). 
On the other hand, Fc7RrIB in humans and mice contains an immunoreceptor 
tyrosine-based inhibitory motif (ITIM) which down-regulates phagocytosis. Co- 
transfection of Fc7RIEB was able to decrease phagocytosis of IgG-opsonised sheep 
red blood cells (SRIBC) by Cos cells which were transfected with a chimeric receptor 
containing the extracellular portion of Fc7RI and the intracellular domain of 
Fc7RIIA. Co-transfection with a mutant RIEB lacking the intracellular domain did not 
inhibit phagocytosis, stressing the importance of the presence of ITIM (Hunter et aL, 
1998). 
In phagocytes, the initial ITAM phosphorylation is due to the action of the family of 
Src tyrosine- kinases which include Fgr, Fyn, Hck, Lyn, Yes and Src, which then 
phosphorylate the important tyrosine kinase Syk. In monocytes, Hck and Lyn have 
been associated with Fc7RI, whereas only Hck has been associated with Fc7R][IA 
(Gerber and Mosser, 2001). In neutrophils, Fgr has been found in association with 
Fc7RIIA (Hamada et al., 1993). 
Tyrosine kinases remain inactive until there is interaction of a phosphorylated 
tyrosine with its own Src-homology domain (SH2) (Garcia-Garcia and Rosales, 
2002). Receptor cross-linking allows further phosphorylation of tyrosines located 
nearby (Figure 1.3). Phosphorylated ITAMs become a docking site for the SH2 
domains of Syk. Syk is important in transmitting the phagocytic and respiratory burst 
signal after engagement of ITAM-containing Fcy receptors (Kiefer et al., 1998; 
Greenberg, 1999b). 
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Transfected Cos-7 cells have been widely used to analyse the effect of different 
Fc7Rs in the wild type form or mutated in different regions as has been the case for 
Fc7RIIA or mutations on the 7-chain for studies on Fc7RI and IIEB. These cells can 
be studied with or without co-transfection with Syk. Syk was shown to increase 
phagocytosis of IgG- opsonised particles when present with an appropriate ITAM 
containing receptor (Indik et al., 1995). 
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Figure 1.4 FcyR-mediated signalling to provoke phagocytosis. AA: Arachidonic 
acid; DAG: diacylglycerol; ERK: extracellular signal-regulated kinase; EP3: inositol 
1.4,5-trisphosphate; ITAM: immunoreceptor tyrosine-based activation motif; MLCK: 
myosin light chain kinase; PAP-1: phosphatidic acid-phosphatase-1; PI 3-K: 
Phosphoinositol-3 kinase; PKC: protein kinase C; iPLA2: Inducible phospholipase 
A2; cPLA2: constitutive phospholipase A2; PLCy: Phospholipase Cy; PLD: 
Phospholipase D. Taken from Garcia-Garcia and Rosales, (2002) 
The downstream pathways stimulated by active Syk involves calcium, Protein kinase 
C (PKC), phospholipase A2 (PLA2), Phospholipase Cy (PLC7), Phospholipase D 
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(PLD), Phosphoinositol-3 kinase (PI-3K), GTPases of the Rho family and the 
mitogen-activated protein kinases (MAPKs) (Figure 1.4). 
Once phosphorylated, "Ks phosphorylate specific serine and threonines of 
substrates including protein kinases, phospholipases, transcription factors and 
cytoskeletal proteins. MAPKs serve as phosphorylation substrates for MAPK kinases 
(NIKKs) which are highly selective in phosphorylating specific MAPKs. "K 
kinase kinases (MKKKs) are the third component of the phosphorelase system which 
phosphorylate and activate specific NIKKs. Scaffolding proteins organise their 
interaction (Johnson and Lapadat, 2002). 
There are three well characterised pathways of NLkPKs including the extracellular 
signal-regulated kinases (ERK1 and ERK2), the c-Jun NH2-tenninal kinases (JNKI 
JNK2 and JNK3) and four p38 enzymes (cc, P, 7,6). Other MAPK pathways may exist 
as ERK5 and ERK7 have recently been identified but still are not well characterised 
(Johnson and Lapadat, 2002). 
Both Fc7RIIIB and Fc7FJ: IA mediate biological activities such as degranulation, 
phagocytosis, Antibody-dependent cell-mediated cytotoxicity (ADCC) and 
superoxide generation. Phagocytosis is mediated by both receptors after activation of 
NLA, PKs and subsequently ERK2, which links the MAP kinase pathway to the 
activation of cytoskeletal components through phosphorylation of myosin light chain 
(Mansfield et aL, 2000). The p38 MAP kinase pathway is important for chemotaxis, 
superoxide generation and synthesis of IL-8 by neutrophils (Zu et aL, 1998). 
Although early reports have shown that clustering of Fc7Rs is necessary to increase 
the concentration of intracellular calcium of human neutrophils, a more recent study 
shows that intracellular increase of the concentration of calcium is a late event that 
occurs after phagolysosome fusion (Worth et aL, 2003). When an antibody IV. 3, 
which binds all Fc7RII receptors, was used to activate human neutrophils through 
FcyRIIA, levels of calcium were lower when compared to levels reached when both 
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FcyRIIA and FcyRIII were targetted using both IV. 3 and an antibody that binds 
FcyRIII (3G8 F(ab')2)or when cells were stimulated at the same time using immune 
complexes (Hundt and Schmidtl 1992). FcyR]IIA has the L-T-L motif that 
participates in the calcium mobilisation within the cell that has been described as a 
46wave propagation of calcium" (Worth et aL, 2003), thus looking at the 
phagolysosomal. formation in conjunction with mobilisation of calcium would be a 
more physiological way to study the role of FcyRs on neutrophil fimction. 
Cross-linking of FcyRIIIB alone using 3G8 F(ab')2 in neutrophils stimulates an 
increase of intracellular calcium, activates actin polymerization, respiratory burst 
activity, degranulation and phagocytosis. These activities are further amplified when 
there is cross-linking with CR3 or with FcyRIIA (Ohkuro et aL, 1995). Both 
receptors activate N4APKs with different efficacy; both stimulate ERK which is 
necessary for actin polymerization, but act as negative regulators of respiratory burst 
activity. Activation of p38 is necessary for respiratory burst activity stimulated by 
FcyRlIIB but not by FcyFJ: IA (Coxon et aL, 2000). 
Mechanisms of control of the signal transduction in neutrophils induced by cross- 
linking Fc7Rs or other molecules exist and involve different regulatory molecules 
such as CD45, CD148 and CD47. CD45 is a protein tyrosine phosphatase (PTP) with 
two PTP domains. CD148 (also known as human PTP or DEP-1 (Density enhanced 
protein tyrosine phosphatase-1)) contains only one PTP domain. Both CD45 and 
CD148 are able to decrease Fc7RIIA mediated effects in neutrophils. These 
molecules interfere with the phosphorylation of Syk and PLC7 induced by Fc7RIIA 
and therefore alter the respiratory burst, and the increment in the intracellular 
concentration of calcium (Hundt and Schmidt, 1997). 
CD47 expressed on neutrophils is able to control transmigration and chemotaxis of 
these cells upon interaction with signal regulatory protein (SIRPcc) which is 
expressed on monocytes, DCs, and also on neutrophils. SIRPcc contains an ITIM 
domain transducing a regulatory signal into the cell, although SIRPcc-independent 
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regulatory signals have been obtained upon interaction with thrombospondin, 
probably through PI-3K or tyrosine kinases (Liu et aL, 2002). 
The better known ITIM-containing molecule with ability to down-regulate cell 
function is FcyRII]3. The ITIM motif binds and activates the SH2-containing inositol 
5' phosphatase (SHIP). The SH2 domain present in SHIP also associates with 
phosphorylated Shc a proline-rich protein that constitutively associates with Grb2 (an 
adapter protein). SHIP hydrolyses phosphatidylinositol -3,4,5 triphosphate, a product 
of PI-3K (Damen et A, 1996; Kavanaugh et A, 1996). This down-regulates 
activation of neutrophils and monocytes. 
To our knowledge only expression of mRNA for FcyRIEB has been shown in 
neutrophils (Cassel et aL, 1993). Since both Fc7RIIA and RIEB have identical 
extracellular domains it is difficult to show expression of RIBB on the surface of 
phagocytic cells. Direct activation of SHIP by FcyRI and RIIIA has been suggested 
(Tridandapani et aL, 2002b; Cameron and Allen, 1999) and the presence of other 
receptors on neutrophils that contain ITIM might also be mechanisms by which 
phagocytosis or other activities induced by Fc7Rs on neutrophils are regulated. 
1.2.5 Apoptosis of neutrophils 
A *%optoSiS is a word derived from the Greek used to describe the process of leaves r'1F 
falling from tree or petals from flowers. It describes cells that shrink and fall away 
from tissues with little damage to the main organism. Apoptosis has been shown not 
only in mammalian cells but also in birds, amphibians, and insects, as a development 
process as well as one that controls the number of immune cells (Martin, 1998). 
An apoptotic cell characteristically condenses its nucleus and cytoplasm as a result of 
dehydration, the staining intensity of chromatin increases because of condensation, 
there is marked blebbing of the plasma membrane and in the final stages, the cell 
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collapses into multiple fragments (apoptotic bodies) that are taken up by phagocytes. 
This process affects cells individually and does not lead to an inflammatory response 
(Martin, 1998). On the contrary the process of necrosis involves different events, the 
nucleus typically swells to occupy most of the cytoplasm, the staining intensity of 
chromatin decreases, the content of the cytoplasm is liberated to the extracellular 
medium, and this affects groups of contiguous cells. Necrosis promotes a strong 
inflammatory response (Martin, 1998). 
One of the hallmarks of apoptosis is DNA cleavage which occurs randomly in 
necrotic cells whereas in apoptotic cells there is generation of more homogeneous 
DNA fragments. In most cells, two stages of DNA degradation are observed: 
initially, DNA is cleaved at the sites of attachment of chromatin loops to the nuclear 
matrix, which results in 50- to 300 kilobase size fragments. Later, DNA is cleaved at 
the internucleosomal sections, giving DNA fragments of approximately 180bp 
(Wyllie, 1980; Cohen and Duke, 1984). The enzyme caspase-activated 
deoxyribonuclease (CAD) is involved in the production of nucleosomal DNA 
fragments. Other enzymes such as endonuclease G also contribute to the cleavage of 
DNA, especially for the bigger fragments (Samejima et al., 2001). 
Earlier events are described in apoptotic cells, one of them is the alteration of 
phospholipid expression in the outer leaflet of the plasma membrane which changes 
from choline phospholipids such as phosphatidy1choline and sphingomyelin to 
arninophospholipids such as phosphatidylserine (PS) and phosphatidylethanolamine 
(Schlegel and Williamson, 2001). 
Seigneuret and Devaux showed that an analog of PS introduced into the outer leaflet 
of erythrocytes was transported to the inner leaflet in an ATP-dependent way. This 
transport activity was termed the arninophospholipid translocase (Seipeuret and 
Devaux, 1984). Increased concentrations of calcium inactivate the translocase, and 
activate a non-specific, bidirectional lipid flipsite, distinct from the translocase called 
scramblase, which brings PS to the surface (Schlegel and Williamson, 2001). 
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PS contributes to the recognition of apoptotic cells as was shown on apoptotic 
lymphocytes that were phagocytosed by macrophages, (Fadok et al., 1992) whose 
expression of a PS receptor: a class B scavenger receptor type I (SR-BI) has been 
demonstrated (Figure 1.5) (Shiratsuchi et al., 1999). Integrins also are involved in 
the recognition of PS expressed on apoptotic neutrophils; for instance the receptor 
complex (xvP3/CD36 on macrophages binds to thrombospondin which binds to PS 
(Figure 1.5). Recently, it has been shown that protein S, which participates in the 
coagulation cascade as an anticoagulant, binds to PS and promotes phagocytosis of 
apoptotic cells by macrophages (Anderson et al., 2003). 
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Figure 1.5 Some molecules involved in recognition and phagocytosis of apoptotic 
cells. ABC-1: ATP-binding cassette transporter 1; p2gpl: P2 glycoprotein 1; PS: 
Phosphatidyl senne SR: Scavenger receptor; TSP: thrombospondin. Modified from 
Gregory (2000). 
Another early event is a decrease in mitochondrial transmembrane potential, which is 
reflected by a loss of the ability of the cell to accumulate certain dyes 
in the 
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mitochondria such as rhodamine, this event is associated with a leakage of 
cytochrome c from the mitochondria to the cytoplasm, increased production of 
superoxide anion and increased content of the reduced form of cellular glutathione 
(Darzynkiewicz and Bedner, 2000). The enzymes responsible for these events 
described in apoptotic cells are the result of the activation of the caspase (cysteine- 
dependent aspartate -specific proteases) cascade (Cohen, 1997). See below and 
Figure 1.6. 
The rapid turnover of neutrophils ends with apoptosis of the cell and non- 
inflammatory uptake by macrophages. Some cytokines are very important in 
preventing apoptosis in neutrophils and they include IFN7, IL-2 and GM-CSF (Liles 
and Klebanoff, 1995). When neutrophils are incubated with an inhibitor of the 
protein synthesis such as cycloheximide, protection against apoptosis induced by 
these cytokines is lost (van den Berg et A, 2001). 
One possible mechanism for prevention of apoptosis induced by cytokines is the 
induction of the expression of CD 11 b/CD 18 (Mac- 1) which after ligation generates a 
minor increase of the concentration of calcium that has been shown to decrease 
apoptosis on neutrophils (Fanning et A, 1999). 
Although not all the mechanisms that regulate apoptosis are known, some of the 
ways that induce apoptosis in neutrophils are beginning to be elucidated. The 
complex Fas- FasL is recognised as one of the pathways that induces apoptosis in 
neutrophils (Liles et al., 1996). Fas (CD90), a type I membrane receptor, is a 45-kDa 
member of the TNF receptor family which also includes CD40, CD27, CD30 and the 
receptor for lymphotoxin-P. Fas is expressed on various cells such as lymphocytes, 
monocytes-macrophages, eosinophils and neutrophils (Fanning et al., 1999). 
FasL is a type 11 membrane receptor, that is, its N-terminus is in the cytoplasm and 
its C-terminal region extends into the extracellular space. FasL is a 40kDa protein 
member of the TNF family of proteins that includes TNFcc, lymphotoxin, TNF- 
46 
related apoptosis inducing ligand (TRAIL), CD40L and CD30L. FasL is 
predominantly expressed on activated T- and NK-cells, whereas its expression is 
constitutive on neutrophils (Nagata, 1997). 
It has been shown that T-cells secrete a soluble form. of FasL that can induce 
apoptosis in surrounding cells (Tanaka et al., 1995); this soluble form is produced by 
the action of a metalloproteinase which also has the ability to induce soluble fonns of 
TNFa and CD40L (Tanaka et al., 1996). Moreover, FasL which also can be secreted 
by neutrophils was found to be chemotactic for neutrophils (Ottonello et al., 1999). 
FasL can induce apoptosis in neighbouring neutrophils in a way to control the 
inflammatory response. 
Bacterial ingestion may induce neutrophil apoptosis via an oxygen dependent 
mechanism (Watson et A, 1996). Neutrophils from CGD patients have been allowed 
to phagocytose heat-killed Staphylococcus aureus, apoptosis was analysed and 
compared with neutrophils from normal donors. Phagocytosis of bacteria induced 
apoptosis in both groups of neutrophils, but neutrophils from CGD patients showed 
reduced apoptosis analysed by Annexin V, which suggests that oxygen radicals have 
a role in neutrophil apoptosis (Yamamoto et A, 2002). Furthermore, antioxidants 
such as taurine, N-acetylcysteine and glutathione also decrease Fas-mediated 
apoptosis (Fanning et al., 1999). On the other hand, members of the Bcl-2 family 
protein regulate apoptosis in neutrophils (Iwai et A, 1994; Liles and Klebanoff, 
1995). 
Complexes of Fas occur in the plasma membrane spontaneously, but upon binding of 
FasL, a more stable structure forms, called death-inducing signalling complex 
(DISC). The Fas DISC contains the adaptor protein Fas-associated death domain 
protein (FADD) and caspases 8 and 10, which can initiate the process of apoptosis 
(Figure 1.6). In some cells, caspase-8 is sufficient to directly activate other members 
of the caspase family. In other cells, proper activation of effector caspases by Fas 
depends on an amplification loop that depends on the activation of caspases 3 and 9 
which in turn activate caspase 8 (Wajant, 2002). 
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TNFcc appears to have a divergent effect; at low concentrations (0.1 -I ng/ml) 
survival of neutrophils increases, whereas at higher concentrations (10 - 100 ng/ml) 
via binding to the type I TNFR (TNF-Rl), accelerates neutrophil apoptosis at early 
time points (van den Berg et al., 2001). After 6 hours 4.6% of neutrophils at 5x 
106/Ml were apoptotic, whereas in the presence of 25ng/ml TNFa this had increased 
to 17.2%. In contrast at 20 hours the same amount of neutrophils in the presence of 
the same concentration of TNF(x displayed 46.9% apoptosis compared to 55.9% 
suffered by neutrophils alone (Murray et al., 1997). Induction of apoptosis by TNF(x 
can be increased by the addition of gliotoxin, an inhibitor of NFKB (Ward et al., 
1999). 
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Figure 1.6 FasL-induced apoptosis occurs by autoproteolytic processing of 
caspase-8. Note that caspase 8 is composed of three subunits (DED, p18 and pIO). 
Taken from Wajant (2002) DED: Death effector domain; FADD: fas- associated 
death domain protein, 
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Recently, TRAIL has been shown to induce apoptosis of neutrophils after ligation of 
TRAEL-R2 rather than TRAIL-Rl. This apoptotic phenomenon was not dependent 
on NF-KB but was inhibited by addition of GM-CSF (Renshaw et aL, 2003). 
In order to determine apoptosis in a cell, frequently used assays are based on the 
concentration of particular caspases, expression of PS in the membrane of the cell, or 
the extension of DNA fragmentation. The concentration of Caspases can be 
determined by ELISA, expression of PS by binding to Annexin V conjugated to a 
fluorescent compound like FITC, and DNA fragmentation by electrophoresis which 
shows the formation of DNA "ladders". Alternatively, fragmented DNA ends can be 
detected by attachment of modified nucleotides that can be detected by FACS or by 
confocal microscopy (Darzynkiewicz and Bedner, 2000). 
The majority of studies so far have been performed in vitro. Apoptosis in vivo is 
more difficult to visualise because apoptotic neutrophils, once phagocytosed by 
macrophages, are destroyed within the next 20 minutes. In 1992, it was shown that 
macrophages isolated from synovial fluid from inflamed joints of patients suffering 
acute sterile arthritis, preferentially phagocytosed ageing neutrophils rather than non- 
apoptotic neutrophils (Savill et aL, 1989). Later by electron microscopy apoptotic 
neutrophils obtained by bronchoalveolar lavage from lungs of neonatal babies with 
airway inflammation were also shown to be ingested by macrophages (Grigg et aL, 
1991). 
Little is known about the mechanisms that control apoptosis in vivo. EL-10 has been 
shown to help in the resolution of inflammatory airways in rats treated with LPS by 
clearing neutrophils more rapidly than the rate observed in untreated rats (Cox, 
1996). More work is needed to clarify the role of different cytokines and molecular 
pathways involved in apoptosis by using models of inflammation in which specific 
genes have been targeted to study their function. 
LOW) 
49 
1.3 Acute phase proteins with innate immune function 
The innate immune response can be defined as the ability to recognise a particular 
substance as foreign without previous contact with it. This capacity can be 
accomplished taking into account motifs that are commonly expressed in particular 
micro-organisms but not by our own cells, known as pathogen associated molecular 
pattems (PAMPs) (Medzhitov and Janeway, 1997). 
The immune system has taken advantage of PAMPs and has created proteins and 
receptors that allow it to recognise a potential pathogen; these are called pattern 
recognition receptors (PRRs) (Medzhitov and Janeway, 2000). PRRs are important 
members of the innate immune system which also involve the role of cells such as 
DCs, NK cells, macrophages and neutrophils and also make an important connection 
with the adaptive immune system. 
Once a PRR has identified a foreign particle through its binding properties, a 
sequence of events amplifies the immune response in terms of quality and quantity 
and adjustments at endocrine, metabolic, haematopoietic levels occur. This chain of 
events is known as the acute phase response. 
During the acute phase response the concentration of some proteins (acute phase 
proteins - APPs) increase (positive acute phase response) whereas others decrease 
(negative acute phase response) (Table 1.3). In the fon-ner group, there are proteins 
the concentration of which increase up to 1000 times and therefore are considered 
major APPs. This group includes CRP and acute phase- serum amyloid A (A-SAA). 
Others do not increase at the same proportion but can reach levels up to 3 times, e. g. 
mannose binding lectin (MBL), ccl-acid glycoprotein (AGP), ecl-antitrypsin (AAT) 
and complement proteins, among others, although these proteins represent a greater 
synthetic proportion of hepatocyte output (Table 1.3). 
Many of these proteins are components of the innate immune system with ability to 
recognise PANTs. Some have the capacity to opsonise micro-organisms or 
altered/damaged cells facilitating their removal and clearance by phagocytic cells. 
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For some APPs specific receptors are found to promote interaction of APPs with 
neutrophils, macrophages and dendritic cells. For example, MBL interacts with CR1, 
a complement receptor expressed by neutrophils and macrophages; CRP interacts 
with Fc7 receptors in phagocytic cells and activates complement. Cc2macroglobulin 
interacts with CD91 (the receptor for the heat shock protein gp96) to promote more 
efficient presentation (Binder et al., 2001) 
Table 1.3. Biochemical characteristics of some human acute-phase proteins 
Protein Molecular Normal values Increase Proposed function 
weight/ Gene 
Location 
CRP 118 kDa I -10 jig/mL Up to 1000 Innate immunity 
lq2l-23 fold 
A-SAA 12.5 kDa 1-5 ýLg/mL Up to 1000 Metabolism 
llpl5.1 fold Innate immunity 
MBL 780 kDa 1-20 gg/mL Up to 3 fold Innate immunity 
I Oq I 1.2-q2l Lectin pathway 
AGP 41 - 43 kDa 0.36-1.46 Up to 5 fold Immunomodulation 
9q3l-32 mg/mL 
AAT 60kDa 1.5 - 3.2mg/mL Up to 4 fold Serine proteinase 
14q32.1 inhibitor 
Fibrinogen 23.9kDa 1.5 -4 mg/mL Up to 4 fold Coagulation 
4q28 
Haptoglobin 36.8kDa 0.3 -2 mg/mL Up to 4 fold Metabolism of 
16q22.1 Haemoglobin 
C3 195kDa ca. 1.3 mg/mL 50% Complement 
19p3.2-3.3 Cascade 
C4 206kDa ca. 0.6 mg/mL 50% Complement 
Cascade 
AAT: ccl-antitrypsin, AGP: al-acid glycoprotein, A-SAA: acute -serum arnylold A, 
CRP: C-reactive protein, MBL: Mannose binding lectin 
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Table 1.4. Pattern Recognition Receptors (PRRs) and Pathogen- associated 
molecular patterns (PAMPs). 
Protein Soluble proteins Receptor PAMP 
Family 
C-type lectins MBL Mannose, fucose, N-acetyl 
amine, glucose 
Mannose Mannose, fucose, N-acetyl 
receptor amine, glucose 
Surfactant protein A Preference for fucose 
Surfactant protein D Preference for maltose 
DEC-205 
Leucine-rich Soluble CD14 LPS 
proteins 
TLR2 LTA, zyrnosan and 
peptidoglycan 
TLR4 LPS, pneurnolysin 
TLR5 Flagellin 
TLR9 CpG 
CD14 LBP-LPS 
Pentraxins CRP Phosphorylcholine, 
phosphorylated galactose, 
lysophospholipids and 
phosphorylated 
polysaccharides 
SAP Phosphoethanolaraine, 
sulphated polysachharides 
Pentraxin 3 Galactans, fungi 
Scavenger CLASS A LPS, LTA 
receptor 
CLASSB Plasmodium infected 
erythocytes 
CLASS C P-glucan 
NIARCO 
When two or more PRR bind to the same pathogen a synergistic response can be 
observed. As an illustration, Toll-like receptor 
4 (TLR-4, Table 1.4) is able to bind to 
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lipopolysaccharide (LPS), and CD14 binds to lipopolysaccharide binding protein 
(LBP) that interacts with LPS. When these two receptors both recognise LPS on the 
surface of the same cell the activation of the cell is increased exponentially. 
Upon binding, usually to more than one PANT structure, and thereby facilitating 
high affinity interactions with the micro-organism, the phagocytic cell becomes 
activated and engulfs it. After processing and presentation of specific fragments 
(epitopes) to T cells, amplification of the immune response occurs. In this way, a 
connection between the innate and adaptive immune systems is accomplished; thus, 
APPs play an important role in this process. In addition to complement mediated 
effects, the mannose receptor has been shown to improve presentation by antigen 
presenting cells (Prigozy et aL, 1997). 
A similar effect might be assumed to occur for other APPs and complementary 
receptors that have the capacity to bind to the same ligand and therefore reinforce the 
function of the cell. On the other hand, these interactions might be useful as 
immunomodulatory signals. For instance, some APPs instead of promoting a 
particular function may actually decrease it, in order to exert a regulatory effect over 
the immune response 
1.3.1 Mannose Binding Lectin 
MBL is a protein of the collectin family, which consists of a collagen-like region, a 
neck region and a lectin domain (Figure 1.7). The lectin is found at the C-terminal 
region and contains a calcium dependent carbohydrate recognition domain (CRD) on 
each subunit chain (Kawasaki et al., 1978). Other members of the collectin family 
include surfactant protein A (SP-A) and surfactant protein D (SP-D). 
MBL is synthesised by the liver, its functional form is a multimeric protein of up to 
six 96 kDa subunits, each consisting of 3 identical polypeptide chains of 
approximately 32 kDa. MBL recognises facose, mannose and N-acetyl-glucosamine 
oligosaccharides present in a wide range of bacteria (e. g. Salmonella montevideo), 
viruses (e. g. Influenza virus), fungi (e. g. Cryptococcus neoformans) and parasites 
(e. g. Leishmania major) (Turner, 1996; Petersen et aL, 2001). 
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Figure 1.7 MBL Structure. a) Diagram of the human MBL trimer showing the 
crystallographic CRD domain with the collagen tail. Taken from Ezekowitz (2003). 
b) Schematic diagram of a tetramer of MBL; note that each of the four subunits is 
composed of three CRDs. The collagenous regions are known to be involved in 
interactions with MASP. The regions encoded by the four exons of the human MBL 
gene are also indicated. Taken from Turner (1996). 
In circulation, MBL is able to associate with MASP-lý MASP-2, MASP-3 and a 
truncated form of MASP-2 known as MApl9 or small MBL associated protein. It 
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has been shown that the complex MBL-MASP-2 is capable of degrading C4 and C2. 
This new way to activate the complement cascade is called the lectin pathway. Both 
MASP-I and -2 are able to cleave C2, whereas the complex MBL-MASP-1-NlApl9 
is able to cleave C3 directly. Therefore MBL can, directly through MASP-1 or 
indirectly through MASP-2, activate C3 (Reviewed by Gadjeva et A, 2001). 
It has been reported that when MBL and CRP are working together in the same cell, 
CRP regulates MBL- initiated cytolysis by modulating alternative pathway 
recruitment through factor H. This suggests a co-ordinated role for these proteins in 
complement activation and consequently in the acute phase response (Suankratay et 
aL, 1998). 
Interestingly, it has been demonstrated that MBL binds in a calcium dependent way 
to IgA which also links the innate and the adaptive immunity. The binding was 
inhibited by the pre-incubation of MBL with mannose or facose but not in the 
presence of N-acetylgalactosamine (Roos et al., 2001). Binding of MBL to IgA was 
able to promote activation of the lectin pathway, a mechanism that might be 
important in the mucosa where most of the IgA is concentrated. 
The human MBL gene lies on chromosome 10. The normal and most common 
sequence is called allele A, whereas polymorphisms in exon 1 are known as alleles 
B, C and D. These three single polymorphisms are: at codon 52 (allele D: Arginine 
replaced by cysteine), 54 (allele B: Glycine replaced by aspartic acid) and 57 (allele 
C: Glycine replaced by glutamic acid) (Mead et aL, 1997; Madsen et A, 1998). 
These polymorphisms disrupt the assembly of MBL peptide trimers or accelerate the 
MBL degradation, and result in profoundly reduced serum levels of functional 
polymeric MBL (Garred et aL, 1992b). 
Considering only the allele A, the mean MBL concentration in a Danish caucasian 
population was reported as 1.2 ýig/ml (range 0-5 ýig/ml) (Garred et aL, 1992a), but 
taking into account an allele- mixed population without the allele A levels range 
from 0 to 1.2 ýLg/ml in plasma. In heterozygous mutants expressing B or C alleles the 
serum levels of MBL are reduced to about 1/8 of the wild type level. In contrast, 
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presence of mutant D reduces MBL to 50% of the wild-type concentration. Subjects 
homozygous for any of the three mutations usually have undetectable levels of serum 
MBL (Sumiya and Summerfield, 1996). 
Other polymorphisms have been reported in the promoter region of the MBL gene at 
positions -550 (H/L variants) and -221 (X/Y variants). The LXA haplotype showed 
decreased levels of MBL comparable to those found in individuals heterozygous for 
allele B (Madsen et aL, 1995). This latter polymorphism adds considerable 
complexity when MBL concentrations are analysed in a particular population. 
Heterozygous and homozygous expression of the different alleles can be found in 
different populations and are associated with enhanced incidence of infections, in 
both children and adults (Summerfield et al., 1995; Summerfield et al., 1997). 
Moreover, homozygous MBL alleles are found in up to 8% in patients suspected to 
suffer immunodeficiency (Garred et al., 1995). 
MBL deficiency is not a well defined term. Genetically altered haplotypes can be 
present in about 30% of the population. The majority of such individuals are 
asymptomatic, whereas serum MBL deficiency, which is defined as levels of MBL 
below 0.14g/ml, are more rare (Kilpatrick, 2002) and can be the cause of recurrent 
respiratory infections, such as pneumonia, otitis media, sinusitis in which 
Streptococcus pneumoniae is one of the more frequent etiologic agents (Summerfield 
et aL, 1997). 
Symptomatic MBL deficiency is often found in individuals who have another 
immune defect such as common variable immunodeficiency or IgA deficiency 
(Mullighan et al., 2000). MBL deficiency also has been associated with autoimmune 
diseases such as systemic lupus erythematosus and rheumatoid arthritis (Ip et al., 
1998; Graudal et al., 1998). 
The first description of a serum defect in opsonisation of Saccharomyces cerevisiae 
in a child with non-nal neutrophil phagocytic function, but with severe recurrent 
infections, diarrhoea and failure to thrive, lead to a series of descriptions of children 
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with similar defects and was associated with low levels of MBL (Super et al., 1989). 
MBL was shown to opsonise and increase uptake of Salmonella montevideo by 
neutrophils (Super et al., 1992). In the same way MBL-opsonised influenza virus 
was able to induce production of H202 in neutrophils (Hartshorn et al., 1993). 
Neutrophil chemotaxis was affected in patients with MIBL deficiency, apparently due 
to low production of C5a (Ten et al., 1999). 
Since MBL is able to bind N-acetyl glucosamine residues, which can be found in the 
teichoic acid on the C-polysaccharide on S. pneumoniae, it is possible that MBL can 
bind this micro-organism. In patients with recurrent pneumococcal infection, who are 
suspected to have an immunodeficiency, it is worth considering if the concentration 
of MBL which might be low or absent. Reconstitution of MBL in patients affected 
by MBL deficiency might be potentially useful for patients who are suffering from 
recurrent infections (Valmidarson et al., 1998; Turner, 1998) 
1.3.2 C-Reactive Protein 
CRP was discovered in 1930, by Tillet and Francis, as a serum precipitin for the C- 
polysaccharide present in pneumococcal. cell walls and capsules, hence the name. 
CRP is a pentraxin, composed of five identical, non-covalently associated subunits 
arranged in pentarneric radial symmetry (Figure 1.8) (Szalai et al., 1997; Shrive et 
al., 1996). 
CRP is a 110 kDa protein, which contains two faces: first, a calcium-dependent site 
binding to a widely distributed group of ligands including PCh, polyelectrolytes 
(Gewurz et aL, 1995) and certain phosphorylated polysaccharides (Culley et A, 
2000). The main interaction between PCh and CRP occurs between the phosphate 
group of PCh and calcium molecules of CRP in a shallow pocket of each subunit 
(Thompson et A, 1999). The other face of the CRP binds to Clq which leads to 
activation of the classical complement cascade which requires binding to an 
appropriate multivalent ligand (Volanakis, 1982). 
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Figure 1.8. Pentameric structure of the human CRP. Pentameric structure of the 
human CRP viewing the calcium-binding site. Calcium ions are shown in pink. 
Taken from Shrive et al., (1996). 
There are many other reported ligands for CRP in disrupted tissues such as the 
extracellular matrix proteins fibronectin and laminin via the PCh-binding site 
(Mortensen and Zhong, 2000). CRP also binds to some ribonucleoproteins, snRNA 
and the histones HI and H2 and to a lesser extent to H2B. H3 and H4 (Du Clos, 
1989; Robey et al., 1984). Moreover, it has been shown that CRP at 50ýtg/ml binds 
to apoptotic cells through nuclear components enhancing their phagocytosis by 
macrophages. It is suggested that some lysophospholipids, expressed on their 
membranes may also be involved (Gershov et al., 2000). In this way, CRP 
participates in the removal of both apoptotic cells and nuclear products from necrotic 
cells; this effect may have importance in preventing the availability of self-antigens 
that are involved in the aetiology of autoimmune diseases. 
CRP has been reported to protect against various infectious diseases. Rats were 
protected against Plasmodium yoelii infection when the parasites were previously 
incubated with rat CRP at concentrations from 2.5 to 25 ýtg/ml (Pied et al., 1989). 
Pre-treatment of mice with human CRP reduces mortality due to pneumococcal 
infection serotype 3, an effect that was seen when concentrations reached 9 ýtg/ml or 
more (Yother et al., 1982). CRP also protects against Salmonella enterica in a 
transgenic mouse model. Mice carried a31 -kb Clal fragment of human genomic 
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DNA comprising the CRP gene, 17 kb of 5' flanking sequence, and 11.3 kb of 3' 
Ranking sequence and expressed high levels of CRP in response to injected 
endotoxin. Transgenic mice experimentally infected with Salmonella lived longer 
and had lower mortality than non-transgenic mice; after 4 hours post infection CRP 
concentrations were raised up to 40 ýtg/ml (Szalai et al., 2000). Many other micro- 
organisms have PCh on their surfaces and potentially CRP might protect against their 
infections: e. g. Clostridium spp., Lactobacillus spp., Bacillus spp., Haemophilus 
influenza, Neisseria meningitidis and Pneumocystis carinii. (Szalai, 2002a). 
The single gene for human CRP has been located in chromosome 1 in the region 
lq2l-q23 (Floyd-Smith et A, 1986). Nucleotide sequence analysis indicates that 
after coding for a signal peptide of 18 amino acids and the first two residues of the 
mature protein, there is an intron of 278 base pairs followed by the nucleotide 
sequence for the remaining 204 amino acids (Woo et A, 1985). 
Most of the increase in CRP plasma levels during the acute-phase response results 
from transcriptional control in the liver. The transcription of CRP is controlled by 
two CCAAT enhancer binding protein (C/EBP) sites, two glucocorticoid-responsive 
elements, an IL-6-responsive element (IL-6RE), two hepatocyte nuclear factor -1 
elements (Gewurz et al., 1995; Toniatti et al., 1990) and Stat 3 (part of the signalling 
induced by IL-6). For example in a mouse model, inactivation of Stat 3 in the liver 
led to significant impairment of the acute phase response (Alonzi et al., 2001). 
Cytokines such as IL-6, IL-1 and TNFcc, which are known to increase the 
concentration of CRP in plasma, act through intracellular pathways that ultimately 
promote binding of transcriptional factors to their respective control elements in the 
DNA to generate mRNA and the protein itself (Cha-Molstad et A, 2000). 
There is one report on polymorphisms in the CRP gene although it does not have any 
effect at the amino acid level of the protein (Cao and Hegele, 2000). A polymorphic 
(GT)9 to 25 repeat found in the intron (Woo et aL, 1985) which correlates with 
baseline levels of CRP and with differences between concentrations found in 
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Caucasians and Afroamericans was also reported (Szalai et al., 2002b). However, 
there also might be an enhancer variation of either tissue specific or inducer regions. 
1.3.2.1 CRP and neutrophil movement in vivo 
In experimental and disease-caused lesions, the accumulated CRP is associated 
specifically with neutrophils (Du Clos et al., 1981; Kushner and Kaplan, 1961). 
However, there are many controversial reports about the effects of CRP on 
neutrophils, some of the effects are proinflammatory and include the induction of 
respiratory burst (Potempa et al., 1988; Zeller and Sullivan, 1992). However, the net 
reported effect, on neutrophils at least, is anti-inflammatory. 
In mice transgenic for rabbit CRP with serum levels ranging from 75 to 200ý1g/ml, 
resistance to intraperitoneal LPS or intravenous PAF was greater than in wild type 
mice. This effect was partially explained by the ability of CRP to bind to PAF (Xia 
and Samols, 1997), but also, may be explained by its ability to stimulate the synthesis 
of IL-IRA by mononuclear cells (Tilg et aL, 1993). Moreover, in a model of 
Experimental Allergic Encephalomyelitis in transgenic mice expressing human CRP, 
CRP at high concentrations is able to decrease the production of MIP I cc, RANTES, 
MCP-1, TNFcc and EFNy and increase IIL-10. This effect is correlated with delay in 
the clinical course of the disease and little infiltration in the spinal cord, especially in 
male transgenics (Szalai et aL, 2002c). 
CRP at the lower end of acute phase concentrations (between 10 and 50 ýIg/ml) were 
reported to inhibit neutrophil chernotaxis induced by fMLP and IL-8 (Zhong et al., 
1999) whereas another report suggested that concentrations between 50-200 fg/ml 
are required for inhibition of fMLP induced migration (Heuertz et al., 1999). 
However both reports show effects only at acute phase concentrations. These reports 
also show CRP dependent changes in signalling events which may lead to the 
responses seen. Acute phase levels of CRP inhibited p38 NLkPK activation which is 
important for chemotaxis (Heuertz et aL, 1999). The significance of the ability of 
CRP to induce ERK and P13K in relation to chemotaxis is unclear (Zhong et al., 
1998). 
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1.3.2.2 CRP and its receptors 
CRP binds to different receptors on neutrophils, FcyRI, and maybe also to Fc7RIIA 
which is found on resting cells (Kilpatrick and Volanakis, 1985; Crowell et aL, 1991; 
Bharadwaj et aL, 1999). It has been reported that a polymorphism of FcyRIIA may 
affect CRP-binding to neutrophils, an arginine (RR) at position 131 facilitates CRP 
binding but decreases IgG2 binding. The opposite effect occurred when a histidine 
(HH) was present at that particular position, (Stein et al., 2000b) although this result 
is controversial. 
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Figure 1.9 CRP-opsonised SRBC binds FcyRIIA -RR but not -HH transfected 
Cos cells. PCh coupled erythrocytes were opsonised with IgG1 (against stroma of 
SRBQ or CRP and incubated with FcyRIIA RR or HH transfected Cos cells. As a 
positive control for FcyRIIA-HH binding, erythrocytes were coupled to NP and 
opsonised with IgG2 anti-NP. After incubation, cells were washed, fixed and stained 
for erythrocytes. Bodman Smith 1,. ', Gregory R. E, Rodriguez J. A and Raynes J. G. 
(unpublished observations) 
CRP binding to FcyRIIA is controversial, since the technique used to analyse binding 
was dependent on using whole detecting antibodies which can also bind to Fc7RI or 
RHA H or R through the Fc portion creating a false positive result. In fact, the use of 
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a F(ab')2portion of the same antibody could not reproduce the results (Saeland et al., 
2001). However, if single monomeric (pentamer) CRP bound with low affinity to 
RIEB one would not see binding using this technique since the off-rate of binding 
would be very high in a monomeric interaction. 
CRP binding to Fc7RIIA was confirmed by Dr K Bodman-Smith who analysed 
binding of CRP-opsonised PCh-labelled SRBC to Fc7RIIA transfected-Cos cells 
(Figure 1.9). When Fc7RI was co-transfected with Fc7RIIA there was an increase in 
phagocytosis, but when Fc7RIIB was present phagocytosis was inhibited (Bodman 
Smith K., Gregory R. A., Rodriguez J. A. and Raynes J. G., unpublished 
observations). 
It is well known that IgG2 is very important in the control of some encapsulated 
bacteria, such as Streptococcus pneumoniae, indeed children who have IgG2 
deficiency are prone to pneumococcal infections (Barrett and Ayoub, 1986). From 
this, it is assumed that the phagocytes of children homozygous for H131 are better 
able to bind IgG2 and consequently have better control of pneurnococcal infections 
than children with R131 alleles. RR children are probably more dependent on CRP 
binding to S. pneumoniae, and any variation of CRP may increase the frequency of 
infections in those already predisposed. 
Since atherosclerosis has an inflammatory component, CRP has been implicated as a 
risk factor especially at moderately raised levels. However, whether CRP is involved 
in the pathogenesis of the disease remains unclear. It is possible that its elevation 
may be a consequence rather than a cause of the process (Williams and Tabas, 2002). 
1.3.3 Serum amyloid P 
Another member of the pentraxin family is serum arnyloid P (SAP). CRP and SAP 
are distinguished by their calcium dependent ligand specificities; CRP binds to PCh 
whereas SAP binds to phosphorylethanolamine. SAP also binds to a range of 
carbohydrates (Loveless et aL, 1992). Human CRP and SAP share approximately 
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66% amino acid homology and there are major differences in their tertiary structure 
as was described by Shrive et al., (1996). 
SAP in humans is constitutive and therefore does not increase in concentration or 
only increases slightly during an acute phase response (human serum concentration is 
about 40 [tg/ml). However, in mice SAP behaves as an APP while CRP is 
constitutive and is present at low concentrations. SAP also activates the classical 
complement pathway. 
SAP binds to heparin, laminin, fibronectin, C4 binding protein; human SAP has been 
shown to bind to murine FcyRs, and was reported to bind to all three receptors, 
m-FcyRI, mFcyR11I and mFcyRIII whereas human CRP bound to mFcyRI and 
mFcyRII (Mold et A, 2001). 
SAP has been shown to bind to nuclear components such as chromatin and histones, 
and recently was shown to opsonise apoptotic cells to help their phagocytosis by 
macrophages (Bijl et aL, 2003). Human SAP and CRP at 100 ýtg/ml have also been 
shown to help in the clearance of apoptotic Jurkat cells and the receptors involved in 
clearance were Fc7RI and Fc7R-HI for CRP and SAP respectively (Mold et aL, 2002). 
Although knockout SAP -/- mice replete with human SAP had better survival when 
compared with those depleted when exposed to lethal doses of E. coli 0 11 1: B4 (a 
strain to which human SAP does not bind) SAP -/- mice survived longer than the 
wild type mice following lethal doses of E. coli and Streptococcus pyogenes (both of 
which bound to human SAP). In the same study human SAP at increasing 
concentrations from 0.1 to 1000 ýtg/ml decreased phagocytosis of Neisseria 
meningifidis by human neutrophils (Noursadeghi et aL, 2000). 
These apparently contradictory results might arise from the use of a human protein in 
a mouse model where it does not have the same affinity for FcyRs. Research on the 
interaction between CRP and FcyRs will help in understanding early events in 
inflammation. 
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1.4 Aims 
Since neutrophils and APPs such as MBL and CRP are present together during the 
process of the inflammatory response, it is very likely that they interact on many 
occasions in order to alter the immune response. Although is also possible that 
interactions take place when there are normal serum concentrations of APPs, it has 
been reported that different concentrations may have different effects on neutrophil 
physiology. CR1 has been identified as a receptor for MBL and FcyRs have been 
reported as receptors for CRP. However it is still unclear what might be the role of 
Fc7RII and polymorphisms of Fc7RHA in the interaction with CRP. Streptococcus 
pneumoniae has been chosen as a model to study some of these issues because of its 
capacity to bind to CRP and because neutrophil defects are associated with recurrent 
pneumococcal infections such as in neutropenic patients, hyper-IgE syndrome and 
Chediak-Higashi syndrome among others. Therefore the main aims of this thesis are: 
1. To investigate the capacity of CRP and MBL to alter neutrophil functions 
when they are in contact with these cells, either alone or in the presence of 
Streptococcus pneumoniae. 
2. To analyse if there are variations in the response by neutrophils when normal 
serum concentrations or acute-phase concentrations of CRP and MBL are 
used, either alone or in the presence of Streptococcus pneumoniae. 
3. To clarify the preference of CRP in terms of binding to Fc7R]EIA on 
neutrophils from individuals expressing the HH or the RR polymorphism. 
The logical extension of the report by Stein et al., 2000b being that 
individuals expressing H allele alone will fail to respond to CRP. A panel of 
normal donors were typed for the polymorphism and tested in a variety of 
assays including NADPH oxidase activity, cytokine production and 
phagocytosis. 
4. To test whether CRP at different concentrations is able to bind to FcyR]IIB or 
other Fcy receptors. 
5. Compare recombinant and purified CRP in aims 1,2,3 and 4 because of 
reports of effects due to contaminating IgG. 
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2. MATERIALS AND METHODS 
2.1 Isolation of Mannose Binding Lectin and C-Reactive Protein 
2.1.1 Purification of MBL 
Purification of MBL was achieved using methodology similar to that described by 
Colley et al., (1988) with minor modifications. 
Two litres of plasma from plasmapheresis-patients were obtained from University 
College Hospital. Plasma was converted to serum by antagonising the heparin 
anticoagulant effect with 40ml/L of a mixture of 1.66 mg/ml protamine sulphate 
(Sigma-Aldrich, Dorset, UK) and 0.33M CaC12- Plasma was left to stand at 37'C for 
1 hour in a centrifuge bucket to coagulate, and then transferred to 4'C for a further 2 
hours. The mixture was centrifuged at 3500g (J-6B Centrifuge, Beckman, USA) for 2 
hours, then the supernatant was transferred to a clean container and 10mM CaC12 
was added and incubated overnight at RT. 
On the following day, precipitation was observed, and the serum was re-centrifuged 
at 3500g (J-6B Centrifuge, Beckman, USA) for 5 minutes and the supernatant was 
transferred to a different container. At the same time, 10 ml of mannan-coated cross- 
linked 4% beaded agarose (Sigma-Aldrich, Dorset, UK) were washed with 8 MM 
Tris HCl pH 7.5 containing 0.15M NaCl JBS) containing 20mM CaC12. The 
mannan-agarose beads were transferred to the serum and left at RT for 3 hours with 
shaking from time to time. 
Mannan-covered beads were recovered again by passing serum through a scintered 
glass ftmnel (W), transferred to a column and then washed with TBS/20mMCaCI2. 
Then protein attached to mannan-covered beads in a calcium dependent manner, was 
eluted with TBS containing 5mM EDTA; 3 ml-fractions were collected and OD280 
deten-nined in a spectrophotometer (Perkin-Ehner, UK). 
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Those fractions that contained protein were collected and dialysed against TBS for I 
hour and then overnight. The column was washed first with TBS containing 20MM 
CaC12 and then with TBS containing 10 mM CaC12. The dialysis product was then 
incubated with the beads in the column for 2 hours at RT. After that, 1 OmM 
TBS/CaC12 + 50mM Mannose were added and fractions were collected and OD280 
determined. Finally, those fractions that contained protein were concentrated by 
centrifugation in Centricon@ tubes to approximately 0.5 ýtg/ml (Molecular weight 
cut off -10000 daltons Amicon, Watford, UK). Typically 70 ýig of MBL were 
purified from 2000 ml of plasma, and the protein concentration determined by 
ELISA. 
2.1.2 Assessment of protein purity: SDS polyacrylamide gel electrophoresis and 
western blotting 
A vertical gel electrophoresis system was used (Mini PROTEAN HI dual slab cell, 
Bio Rad Laboratories, Ca, USA). The gel apparatus was set up according to the 
manufacturer's instructions. 
12% (w/v) SDS-PAGE was performed as follows: A denaturing gel was composed 
of Iftesolving gel: 3 ml of 40% (w/v) acrylamide (1: 19 v/v ratio of bisacrylamide to 
acrylamide) (Severn Biotech Ltd, Kidderminster, UK), 2.5 ml of 1.5M Tris-HCI (pH 
8.8), 0.13 ml of 10% (w/v) sodium dodecyl sulphate -SDS (BDH, Poole, Dorset, 
UK) and 200 ýtl of 1.5% of fresh ammonium persulphate (NH4)2SO4 (Sigma - 
Aldrich, Gillingham, UK) and then 10 ýtl of NNN'N'-tetra-methylethylendiamine 
(TEMEED)(Sigma-Aldrich, Gillingham, UK) to initiate polymerisation. Immediately 
after the addition to the casting apparatus, the gel was overlaid with distilled H20- 
After setting, the gel was washed, the interface dried and stacking gel was added ; 2) 
the stacking gel was composed of-. lml of 40% acrylamide, 2.5 ml of 0.5M Tris-HCI 
(pH 6.8), 100 ýtl of 10% (w/v) SDS and 6ml of H20, plus 50 ýtl of 1.5% (w/v) of 
fresh ammonium persulphate and finally 10 ýtl of TEMED. A comb was immediately 
added and when set, the wells were washed with dH20- 
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Pre-stained markers of known molecular weight were used (Sigma - Aldrich, 
Gillingham, UK) consisting of- P-galactosidase, E. coli 116kDa; bovine serum 
albumin 66kDa; chicken egg ovalbumin 45kDa; carbonic anhydrase 29kDa, soy bean 
trypsin inhibitor 20. lkDa; cc-lactalbumin l4kDa and aprotinin 7.5kDa. Each vial of 
color markers contained 500 /. d of a mixture of the protein-dye conjugates in 62 MM 
Tris-HCI, pH 7.5, containing 2% (w/v) SDS, 0.1 mM EDTA, 100 mM dithiothreitol, 
4M Urea, 0.005% (w/v) bromophenol blue and 30% (v/v) glycerol. 
10 jil of each sample were mixed with 15 Al of sample buffer (62 mM Tris-HCI, pH 
7.5, containing 2% (w/v) SDS, 0.1 mM EDTA, 100 mM dithiothreitol, 0.005% (w/v) 
bromophenol blue and 30% (v/v) glycerol) and boiled for two minutes. Imraediately 
20 Al of the mixture were loaded into the well. Electrophoresis was carried out under 
constant voltage of 100V for approximately 1 hour, using 25 mM Tris base 
containing 192 mM Glycine and 0.1 % (w/v) SDS as the running buffer. 
Gels were either stained with Coomassie Blue which was carried out with 0.125% 
Coomassie blue R250 (w/v) in 50%(v/v) methanol, 10% (v/v) acetic acid 40% (v/v) 
H20or protein was transferred to a polyvinyldifluoride (PVDF) membrane using a 
semi dry blotting apparatus (Sartoblot EL-S, Sartorius, GB-Belmont, Surrey) with 
recommended buffer: 20mM Tris-HCl, 192 mM glycine, 20% (v/v) methanol. The 
apparatus was run at 10V for 1 hour. A biotinylated mouse monoclonal antibody 
against MBL at 1/3000 dilution in TBST (20mM Tris-HCl, pH 8.0,137 MM NaCl 
containing 0.1% (v/v) Tween 20 for 2 hours) (Statens Serum Institute, Copenhagen, 
Denmark) was added to the PVDF following the blocking stage with 5% (w/v) 
skimmed milk in TBST. The membrane was washed and 
developed using 
streptavidin: alkaline phosphatase (1/3000) (Serotec, Oxford, UK) and nitro 
blue 
tetrazolium with 5-bromo-4-chloro-3- indolyl phosphate (NBT/BCIP-Sigma-Aldrich, 
Gillingham, UK) as substrate diluted in OAM Sodium Hydrogen Carbonate buffer 
pH 9.6 containing 2mM MgCl2, 
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2.1.3 Determination of the concentration of MBL 
An ELISA procedure was used to determine the concentration of MBL in serum 
samples. The technique was similar to that described by Thiel et aL, (1992). 96-well 
flat bottom plates (Immulon 2HB, Dynex technologies, UK) were coated overnight at 
4'C, with 100 ýtl of a rabbit polyclonal antibody anti- human MBL, (provided by Dr 
Jacques U Baenziger, Washington University Medical School), diluted 115000 in 
coating buffer (1 5mM Na2C03.35mM NaHC03,3mM NaN3, pH 9.6). 
After 3 washes with TBS containing Tween 0.05% (v/v)(TBST), plates were blocked 
by adding TBST 10% (v/v) FCS for 30 minutes at room temperature. After 3 washes 
with TBST, 50 pLI of samples (previously diluted 1/100 in TBST containing 5 MM 
EDTA) and standards were added and left overnight at 4'C. A standard curve was 
made with MBL (covering a range 70 ng/ml to 1.09 ng/ml) provided by Professor 
MW Turner at The Institute of Child Health, London, UK. After 3 more washes with 
TBST, 50 ýtl of a mouse biotinylated monoclonal antibody to human M13L (115000) 
(Statens Serum Institute, Dem-nark) were added and the plates left for 2 hours at 
room temperature (RT). 
Following a further 4 washes, 50 ýd of horseradish peroxidase (BRP)-streptavidin 
(Dako SA, Denmark) were added for 1 hour at RT. Plates were washed 3 times with 
TBST and 3 more times with TBS alone and then 50 ýd of substrate, 0.1 mg/ml 
Tetramethylbenzidine- (TMB, Sigrna-Aldrich, Gillingham, UK) in citrate buffer pH 
4.5 (0.1 M Citric acid and 0.1 M Na2P04 diluted 2 volumes of acid plus 3 volumes of 
base and then activated with 2ýd H202) were added for 30 minutes. The reaction was 
stopped with 2M sulphuric acid and plates read at 450nm on an ELISA reader with a 
control wavelength at 490 nm (MRX Microplate Reader, Dynex technologies, UK). 
2.1.3.1 Cohort of Colombian children 
Children were chosen from the recurrent infection clinic at the Hospital Universitario 
"Hernando Moncaleano Perdomo" in Neiva, Huila, Colombia over the period from 
December 1996 to December 1999. A total of II children were selected because of 
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recurrent pneumococcal respiratory infections and were evaluated for pneumococcal 
antibodies against the different serotypes. None of these patients were younger than 
one year of age and all of them were between 2 to 5 years of age. This cohort of 
patients was studied after obtaining informed consent from their parents. The 
procedure followed the guidelines provided by the ethical committee of the Hospital 
and Universidad Surcolombiana. 
2.1.3.2 Immunological studies 
Serum samples were collected after obtaining informed consent. To study total serum 
concentration of immunoglobulins IgM, IgA, IgG, IgG subclasses and C3, C4, 
samples were analysed by nephelometry using reagents provided by Boehringer 
NF100 (Merck, USA). Samples were stored at -20'C until values were determined. 
2.1.3.3 Pneumococcal antibodies 
A group of 11 children with recurrent pneumococcal infections were vaccinated with 
23-valent polysaccharide pneumococcal. vaccine Pnu-h=une 23 (Lederle, Pearl 
River, NY which contains 25ýLg of each of the following capsular polysaccharide 
(pcps) types: 1,2,39 4,5,6B, 7F, 8,9N, 9V, 10A, 11A, 12F, 14,15B, 17F, 18C, 
19A, 19F, 20,22F, 23F and 33F) according to published criteria (Sorensen et aL, 
1998) (Table 2.1). 10 ml of blood were drawn before and 4 -weeks after vaccination. 
Table 2.1 Indications for the use of the pneumococcal vaccine. From Sorensen et 
aL, (1998). 
Disease # episodes/year (children 
between 2 to 5 years) 
# episodes/year (children 
_older 
than 5 years) 
URI* with antibiotics >4 >2 
Otitis with antibiotics >3 >2 
Sinusitis >2 >1 
Chronic, resistant sinusitis >1 >1 
Pneumonia >2 >2 
Need of preventative 
antibiotics 
>1 
Allergy to antibiotics for 
treatment of respiratory 
infections 
ý! i 
* Upper respiratory tract infections 
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IgG specific for different pneumococcal capsular polysaccharides were determined 
by ELISA following the method described by Koskela and Leinonen (1981) with 
some modifications stated by CDC to unify technical procedures (Quataert et aL, 
2001). Briefly, ELISA plates (Nunc Maxixorb, USA) were coated with 100 ýtl of 
different pcps: 1,4,5,6B, 9V, 14,18F, 19 and 23F (ATCC, Rockville, MD, USA) 
diluted in 0.01 M Na2BP04/KH2PO4 pH 7.2, for 5 hours at 37*C and then stored at 
4'C until used. 
The following day plates were washed three times with PBS-Tween. Standard serum 
FDA 89-SF was kindly provided by Carl R. Frash (CBER; US Food and Drug 
administration, Rockville, Md). The concentration of IgG specific for pneumococcal 
polysaccharides in this serum was already established (Quataert et al., 1995). Serum 
samples and reference serum were incubated with C-polysaccharide (Statens Serum 
Institute, Denmark) to remove contaminating antibodies (Musher et aL, 1990) before 
adding them to the plates. Samples from children were diluted 1150 and serial 
dilutions were performed up to 1/400, whilst 89-SF serum was diluted 1/200 and 
serial dilutions were performed up to 1/12800 for IgG determinations. 50 ýtl of each 
dilution of standard and samples were added to the plates and were incubated for 30 
minutes at 37'C. After three washes with PBS-Tween an HRP-conjugated mouse IgG 
(diluted 1/1000) to human IgG (ICN Biochemical, USA) was added for 1 hour at RT. 
Finally, 50 ýfl of tetramethylbenzidine (Sigrna-Aldrich, USA) were used as a 
substrate diluted in citrate buffer pH 4.5 (0.1 M citric acid and 0.1 M Na2P04diluted 
in 2 volumes of acid plus 3 volumes of base) plus 2 ml of H202 to activate the 
substrate immediately before use. The reaction was stopped with H2S04and read at 
450 nm using a 690 run reference filter, with an ELISA reader (ELX 800, Bioteck, 
USA). 
2.1.4 Isolation of Greactive protein 
CRP (pCRP) was extracted from human acute phase serum using a protocol 
described by Culley et al., (1996). 
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I)Affulity chromatography: Phosphory1choline Sepharose was prepared by 
coupling p-aminophenylphosphorylcholine (Sigma-Aldrich, Gillingham, UK) 
dissolved to activated CH-Sepharose 4B (Pharmacia, Milton Keynes, UK). 4g of 
activated CH-Sepharose 4B were swollen in 20 ml of ImM HCI for 15 minutes at 
RT. Sepharose was then washed four times at 300-500 rpm at IOT with ice-cold 
lmM HCI (approximately 500 to 1000 ml). Sepharose was then incubated with p- 
aminophenylphosphory1choline in 20 ml of coupling buffer (0. IM NaHC03, pH 8.0 
containing 0.5M NaCl) for I hour at RT. The gel was washed four times and then 
excess reactive groups reacted with Tris-HCI (0.1M, pH8.0) for 1 hour standing at 
RT, inverting it occasionally. The gel was washed with 3 cycles of 100ml of sodium 
acetate (O. IM, pH4.0 containing 0.5M NaCI) then Tris-HCI (0.1M, pH8.0 containing 
0.5M NaCI). Sepharose was equilibrated in TBS and stored at 4'C in TBS containing 
0.01% NaN3. 
60 ml of phosphorylcholine-sepharose suspension were washed with 200 ml of TBS 
(pH 8.0), containing 1 mM CaC12 (TBSQ, and added to approximately 500 ml of 
acute phase serum (a sample of which was retained), mixed on a rotator at 4'C for 16 
hours, after which the mixture was poured onto scintered glass over a vacuum. The 
beads were retained, washed with 1000 ml of TBSC, packed into a column and 
washing continued until the OD280 of the eluted buffer fell below 0.01. CRP was 
eluted with TBS containing lOmM ethylenediaminetetra-acetic acid salt (EDTA) pH 
8.0. and the major protein containing fractions were pooled. 
2)lon exchange chromatography: 100 ml of 2: 1 v/v TBS: dH20 was run 
through a lOg column of Whatman pre-swollen microgranular anion exchanger 
(diethylaminoethyl cellulose-52), followed by the CRP samples obtained above 
which had been previously diluted to 0.1 M NaCl and the column washed with 1 OmM 
Tris pH 8.0 OAM NaCl. CRP was eluted with a linear gradient from OAM to 1M 
NaCl, 10 mM Tris-HCI, pH8.0, collected in 5 ml fractions, the OD28o determined and 
the peak fractions pooled. 
3)Gel filtration: Fractions were obtained and dialysed overnight against 
phosphate buffered saline, 140mM NaCl, 8mM Na2P04,1.5mM KH2PO4,2.7 mM 
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KCI, pH 7.4 (PBS) and concentrated to a volume of approx 5 ml using polyethylene 
glycol 20,000 (BDH) and run through a 300 ml Sephacryl-300 column (Pharmacia), 
followed by degassed PBS, at a flow rate of 2ml/min and collected in 6 ml fractions. 
The OD280was determined and the peak fractions were pooled. The void volume 
(Vo) and the total volume (Vt) of the column were determined using blue dextran 
(MW= 2x 106) (Sigma-Aldrich, Gillingham, UK). Bovine serum albumin fraction V 
(BSA)(Sigma-Aldrich, Gillingham, UK) was also run as a molecular weight marker. 
The concentration of CRP in the final sample was obtained by measuring the OD280; 
CRP (mg/ml)= OD280 1cm / 1.98 (Gotschlich and Edelman, 1965). The purity was 
assessed by 10% SDS-PAGE similar to the procedure described in section 2.1.2 
using the following molecular markers: Rabbit muscle myosin, 205 kDa; P- 
Galactosidase, E. coli 116kDa; Bovine serum albumin, 66 kDa; Chicken egg 
ovalbumin, 45kDa; Bovine erythocyte carbonic anhydrase, 29 kDa; Soybean trypsin 
inhibitor, 20.1 kDa. 
Human recombinant human CRP (rCRP), expressed using a plasmid in Escherichia 
coli and purified by affinity chromatography, (Tanaka et aL, 2002), kindly provided 
by Dr Toshio Tanaka (Nagahama Institute for Biochemical Science, Oriental Yeast 
Co., Ltd., 50 Kano-Cho, Nagahama-shi, Shiga 526-0804, Japan) was used in some 
experiments to compare responses with pCRP. The preparation was reported as 
containing 9 ng of LPS per I mg of rCRP (Personal communication from Yuhsi 
Matuo). 
2.1.5 Isolation of SA-P 
SAP was provided by Dr J. Raynes. The protein was isolated on phosphoryl 
ethanolamine- Sepharose 4B and eluted with TBS 10 mM EDTA. Anion exchange 
chromatography (DE52) and gel filtration (S-300) were then used to further purify 
the protein according to methods described previously (Loveless et al., 1992). 
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2.2 Isolation of Peripheral Blood Mononuclear Cells and Neutrophils 
2.2.1 Donors 
Healthy donors, older than 18 years of age from the London School of Hygiene and 
Tropical Medicine, who volunteered to give blood for the study, were recruited for 
the different experiments performed in this study. An informed consent was signed 
by each of them and the procedure was approved by the Ethical Committee of the 
School. 
2.2.2 Histopaque Purification: Blood from healthy volunteer donors was collected 
in tubes containing in 10 IU /ml heparin, diluted 1/3 with RPMI 1640 (Gibco BRL- 
Life technologies, Paisley, UK) and carefully layered onto a Histopaque density 
gradient (15 ml of Histopaque- 1.116 at the bottom and 15 ml of Histopaque- 1.070 at 
the top)(Sigrna-Aldrich, Gillingham, UK) of a 50ml-falcon tube. Tubes were 
centrifuged at 700 g for 30 minutes; this procedure allows separation of peripheral 
blood mononuclear cells (PBMCs) from polymorphonuclear cells (PMN), since the 
latter remain at the interface between the two different densities of histopaque 
(Ferrante and Thong, 1978). Both layers were recovered and washed with RPMI 
1640. 
PBMCs were recovered washed three times with RPMI and stored at 4'C to use as a 
source of DNA purification. Treatment with 5 ml of distilled water for 30 seconds 
and then rapid restoration of isotonic conditions with RPMI lysed contaminant red 
blood cells in PMN layer. Two more washes were performed at 200 g. Viability of 
the cells was always more than 95% according to trypan blue staining. 
Cells were 
counted in a Hemocytometer and adjusted to 2x 106/ml. 
2.2.3 Dextran Purification: 30 ml of undiluted blood were added to a falcon tube 
containing 5 ml-Acid Citrate Dextrose solution (ACD-Sigrna-Aldrich, 
Gillingham, 
UK). Blood was mixed carefully and transferred to a tube containing dextran 
solution: 3% dextran (Dextran T 500 Pharmacia, Milton Keynes UK) + 
0.9% (w/v) 
NaCl in a ratio 1: 2 (dextran: blood). The mix was allowed to sediment for 30 minutes 
at room temperature and the supernatant was centrifuged at 300g 
for 5 minutes and 
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resuspended in 15 ml of cold CD-Hybridoma medium (Gibco, Paisley, UK). Then it 
was carefully layered on 15 ml of Histopaque - 1.070 and centrifuged for 30 minutes 
at 400g at 40C to remove PBMCs. 
Two washes with distilled water for 30 seconds as described before were used to 
eliminate contaminant red blood cells. Neutrophils were counted and resuspended in 
CD- hybridoma medium at the concentration required, usually between I to 6 per 106 
cells / ml. More that 95% were confirmed as polymorphonuclear cells by staining 
with Wright-Giemsa for 5 minutes at RT (Sigma-Aldrich, Gillingham, UK). 
Viability was more that 97%. 
2.3 Apoptosis Assays 
2.3.1 Annexin V 
Neutrophils were incubated in CD hybridoma medium for up to 24 hours with or 
without 100 IU/ml of IFN7. In a different experiment neutrophils were incubated 
overnight at 37'C with Streptococcus pneumoniae at a ratio 30: 1 in the presence of 
CRP at different concentrations: 10,50 and 100 ýLg/ml. See section 2.5.1 for more 
details about culture of pneumococci. In all these experiments Annexin V binding 
was determined as follows: 
Neutrophils were resuspended at 1X 106/ml in cold PBS, and then 100 ýd were 
transferred to a5 ml falcon tube. 5 ýtl of Annexin V-FITC (BD Biosciences, USA) 
were added at the same time as 10 ýtl of propidium iodide (BD Biosciences, USA). 
Cells were gently vortexed and incubated at RT in the dark for 20 minutes. 400 ýd of 
buffer containing 10 mM Hepes (pH 7.4), 140 mM NaCl, 2.5mM CaCl2were added 
to each tube; and at least 20000 events were immediately acquired by flow cytometry 
(Facs Scalibur, BD Biosciences, USA) within 1 hour. 
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2.3.2 Terminal UTP nick end labelling (TUNIEL) 
Isolated neutrophils at 1X 106 per condition were incubated in 5 ml falcon tubes 
containing CD hybridoma medium and incubated at 37C for 1,4 , 18 and 24 hours 
in the presence or absence of 1001U of EFN7. The following protocol was used 
according to the manufacturer's guidelines (R&D Systems, Abingdon, Oxon, UK): 
1X 106 cells were centrifuged at 500g for 5 minutes at room temperature (RT) in 5 
ml falcon tubes. The cell pellet was gently resuspended in 1 ml of 3.7% (w/v) 
formaldehyde (Sigrna-Aldrich, Gillingham, UK) and incubated for 10 minutes at RT, 
then centrifuged at 500g for minutes. The pellet was resuspended in 1 ml PBS and 
left at RT for 5 minutes, before centrifugation at 500g for 5 minutes. To the new 
pellet 100ýd of permeabilisation and blocking agent provided (CytoninTm) were 
added and incubated overnight at 4'C. After centrifugation for 5 minutes at 500g, 
Iml labelling buffer (containing 100mM terminal deoxynucleotidyl transferase (TdT) 
Buffer, 0.5mg/ml bovine serum albumin and 0.6 mM 2- mercaptoethanesuphonic 
acid) was added to each tube and centrifuged again for 5 minutes at 500g. 25ýd of 
labelling reaction mixture (I ýd of TdT containing 25 units, 1 ýd of a mixture of 
biotinylated dNTPs and 1 ýtl MnC12 in 50 ýtl of buffer 0.1 % (v/v) Triton X- 100 and 5 
mg/mI BSA in PBS) were added to each tube and incubated for 1 hour at 37C. 
1 ml of lOmM EDTA pH 8.0 was added to stop the reaction and each tube was 
centrifuged at 500g for 5 minutes at RT. Finally, 25 ýd of streptavidin-fluorescein 
isothiocyanate (FITC) were added and left for 10 minutes in the dark at RT. Cells 
were washed twice with PBS at RT and resuspended in 500 ml of PBS and left on ice 
until acquired by FACS (FACS SCALIBUR, Becton Dickinson, San Diego, USA). 
As a positive control formaldehyde fixed-neutrophils were treated with 25 ýd of 
endonuclease for 30 minutes at 37'C and then washed with I ml labelling buffer for 
5 minutes at 1500g at RT. Then 25 ýd of labelling reaction mixture were added as 
described above. As a negative control TdT was omitted from the labelling reaction 
mixture. 
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2.4 Polymorphisms of FcyRIIA 
2.4.1 Purification of DNA 
DNA was extracted according to the procedure included in the Wizard Genomic 
DNA purification kit (Promega, Madison, WI, USA). 300 ýtl of blood sample were 
added to 1.5ml-eppendorf tubes, 900 ýtl of cell lysis solution were added to lyse red 
blood cells and the tubes inverted 5-6 times to mix. After 10 minutes incubation at 
RT, tubes were centrifuged at 130OOg for 20 seconds. Supernatant was discarded and 
pellets containing white blood cells were vortexed for 10 -15 seconds and 
resuspended in 300 ýd of nuclei lysis solution and pipetted 5-6 times until it was very 
viscous. Then, proteins present in the solution were precipitated by adding 100 ýfl of 
protein precipitation solution, vortexed for 20 seconds until small protein clumps 
were observed. 
After centrifugation for 3 minutes at 13000g, a dark brown protein pellet was 
observed, and the supernatant was transferred to a 1.5 ml- eppendorf tube containing 
300 ýtl of isopropanol. The solution was mixed by inversion until DNA formed a 
visible mass and the tube centrifuged again for I minute at 13000g. To the pellet, 300 
ýd of 70% ethanol were added and centrifugated for 1 minute at 13000g. Finally, to 
rehydrate DNA, 100[d of a solution containing lOmM Tris-HCI (pH 7.4) and 1 mM 
EDTA (pH 8.0) were added and left overnight at 4'C. 
The purity of the product was verified by electrophoresis in 0.85% agarose (Bioline, 
London, UK). DNA was stored at 4'C before analysis. 
2.4.2 PCR to determine FcyRIIA polymorphisms 
PCR was performed to amplify specific FcyRIIA sequences of DNA based on a 
method described elsewhere (Flesch et aL, 1998). A PCR mix was prepared 
containing 200ýM of each dNTP (Bioline, London, UK), 0.5 U of Taq polymerase 
(Bioline, London, UK), 0.125 ýiM of human growth hormone gene as an internal 
control HGH - HGH2 CAGTGCCTTCCCAACCATTCCCTTA and 
ATCCACTCACGGATTTCTGTTGTGTTTC (Sigma-Genosys Ltd, 
Cambridgeshire, UK) 0.5 ýM common antisense primer from an intron shared by the 
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sequences for FcyRIIA, Fc7R][IB and Fc7RIIC CAATTTTGCTGCTATGGGC 
(Sigma-Genosys Ltd, Cambridgeshire, UK), and 0.5 ýM of H131-specific sense 
primer ATCCCAGAAATTCTCCCA (Sigrna-Genosys Ltd, Carnbridgeshire, UK) 
(Hmix) or R131-specific sense primer ATCCCAGAAATTCTCCCG (Sigma- 
Genosys Ltd, Cambridgeshire, UK) (Rmix) in I OX buffer and 15mM MgC12 (Bioline, 
London, UK) 
22.5 ýtl of either Hmix or Rmix were used in combination with 2.5 ýtl of DNA 
sample. PCR was performed on a thermal cycler (Omnigen, Hybaid LTD, UK) as 
follows: 10 minutes at 95'C, 10 cycles of 1 minute at 96'C, 2 minutes at 54'C and I 
minute at 72'C; thereafter, to enhance the sensitivity, 22 cycles of 1 minute 95'C, 2 
minutes at 54'C, and 1 minute at 72'C and a final extension step for 10 minutes at 
72'C. The PCR amplification products were separated on 1.5% agarose and 
visualised using ethidium bromide. A lkb DNA ladder (Gibco BRL- Life 
technologies, Paisley, UK) was used for length determination 
2.5 Streptococcuspneumoniae 
2.5.1 Culture of Streptococcuspneumoniae 
Bacteria were obtained from clinical isolates at the Royal Free Hospital kindly 
provided by Prof S. Gillespie. Pneumococcal strains were confirmed by agglutination 
tests using specific antibodies and shown to be antibiotic sensitive. Encapsulated S. 
pneumoniae serotype 3 and non-encapsulated strain R36A were used for culture. 
Bacteria were gown in Brain Heart Infusion (BHI, Fisher Chemicals, 
Loughborough, UK), broth and incubated at 37'C, 5% C02 for 16 hours. Overnight 
cultures were harvested at 1000 g for 28 minutes and known concentrations of 
bacterial aliquots were stored at -70'C with 10% glycerol until required. 
Bacteria 
were diluted in CD-hybridoma medium and centrifuged at 20OOg 
for 15 minutes. 
Pellets were resuspended in CD-hybridoma medium or PBS at the required 
concentration and used. Bacteria were considered to be in a 
logarithmic phase of 
growth curve since at approximately 24 hours the stationary phase was reached. 
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2.5.2 FITC labelling of Streptococcuspneumoniae 
S. pneumoniae was cultured as explained above and harvested at 20OOg in PBS. 
Approximate concentrations were calculated on the basis that OD600 Of 1 -0 
is 
equivalent to 5x 108 organisms/ml. S. pneumoniae was incubated with 3% (v/v) 
formaldehyde (Sigma- Aldrich, Gillingham, UK) at 37T for 1 hour, then washed 
twice with PBS at 20OOg for 5 minutes and then was resuspended in 1 ml 0.5mg/ml 
fluorescein isothiocyanate-FITC (Sigma - Aldrich, Gillingham, UK) for I hour at 
37T. After at least four washes with PBS, FITC- labelled pneumococci were 
maintained at 4'C and washed prior to use. No experiments were performed after 1 
week of being labelled. 
2.5.3 MBL binding to Streptococcuspneumoniae 
IX 106 of Streptococcus pneumoniae and Cryptococcus neoformans (provided by 
Microbiology Unit at LSHTM) fixed with 3% (v/v)-formaldehyde in the same way 
as S. Pneumoniae (see section 2.5.2) were incubated with 10 ýtg/ml of MBL in 
Hank's Balanced Salt Solution (HBSS- Sigrna - Aldrich, Gillingham, LJK) with 
lOmM CaC12 for 1 hour at 4'C in falcon tubes. After two washes with HBSS, mouse 
biotinylated antibody to human MBL (Statens Serum Institute, Copenhagen, 
Denmark) diluted 1 in 100 ýtl (v/v) HBSS were added and incubated for 1 hour at 
4'C. In some tubes, a mouse biotinylated isotype control (Jackson Laboratories, West 
Grove, Pennsylvania, USA) was added under the same conditions. Following two 
washes, streptavidin-FITC (BD Biosciences, Oxford, UK) diluted 1/100 in HBSS 
(100ýtl) was added and incubated for 1 hour at 4'C. After two more washes the cells 
were resuspended in 200 ýd of HBSS and 30000 events were acquired by flow 
cytometry (FACS SCALIBUR- Becton Dickinson, Oxford, UK) and analysed using 
Cell Quest Software (Becton Dickinson, Oxford, UK). 
2.5.4 CRP binding to S. pneumoniae 
To 2x 10 6 S. pneumoniae type 3, polyclonal rabbit antibody to human CRP 
(DakoCytomation, Ely, Cambridgeshire UK) diluted 1150 (166 ýLg/ml) and 1/100 (83 
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ýtg/ml) in 100 ýd HBSS containing lOmM CaCl2were added and incubated for I 
hour at 4'C. Two washes with HBSS were performed and then a FITC conjugated 
goat anti-rabbit antibody (Stratech Scientific, Soham Cambs, UK) diluted 1/100 in 
100 ýd HBSS was added and incubated for I hour at 4'C. 
An irrelevant rabbit IgG antibody was used as an isotype control at the same 
concentrations specified (Stratech Scientific, Soharn Cambs, UK). 
After two more washes, at least 30000 cells were acquired by flow cytometry (FACS 
SCALIBUR- Becton Dickinson, Oxford, LJK) and analysed using Cell Quest 
Software (Becton Dickinson, Oxford, UK) 
2.6 Expression of receptors by neutrophils 
2.6.1 Expression of L-selectin by neutrophils 
Isolated neutrophils (obtained by both the Dextran and Histopaque methods, see 
section 2.2) were resuspended at 2x 106/ml. 200 ýd of neutrophils were added to 5- 
ml falcon tubes, were incubated in CD-hybridoma medium, in the presence or 
absence of 100 IU of IFNy at 37T for 8 hours. After 2 washes with PBS at 300g for 
5 minutes, 5 pg/ml mouse antibody to human L-selectin (R&D Systems, Abingdon, 
UK) were added to each tube for 1 hour at 4T in FACS buffer containing Hanks's 
Balanced Salt Solution (HBSS- Gibco BRL, Life technologies, Paisley, UK), 3% 
(v/v) FCS, I. OmM HEPES, 5mM EDTA and 0.05% (w/v) sodium azide. A mouse 
IgG1 isotype control (provided by Dr John Raynes) was used at the same 
concentration for 1 hour at 4T in FACS buffer. After two washes with PBS, a goat 
anti-mouse tetramethyl-rhodamine isothiocyanate (TRITC) conjugate (Sigma- 
Aldrich, Gillingham, UK) diluted 1/100 in FACS buffer was added for 1 hour at 4T. 
At least 10000 events were acquired for FACS analysis. 
2.6.2 Expression of FcyRI 
Isolated neutrophils (obtained by both Dextran and Histopaque methods) were 
resuspended at 2x 10 6 /mI in CD-hybridoma medium. 200 ýtl of neutrophils were 
added to 5-ml falcon tubes, and were incubated overnight in the presence or absence 
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of 100 IIIJ of IFNY at 371C. After 2 washes with PBS at 300g for 5 minutes, 0.4 ýLg/ml 
of phycoerythrin (PE) conjugated IgGl mouse antibody to human Fc7RI (CALTAG 
Laboratories, Burlingame, CA, USA) was added to each tube for 1 hour at 4'C. A 
PE mouse IgG1 isotype control (CALTAG Laboratories, Burlingame, CA, USA) (in 
100ýtl of FACS buffer) was used at the same concentration and under similar 
conditions. At least 10000 events were acquired for FACS analysis and analysed by 
Cell Quest Software (Becton Dickinson, Oxford, UK). 
2.6.3 Expression of FcyRIlB 
Neutrophils isolated by the dextran method were resuspended at 2x 106/ml in CD- 
hybridoma medium. 200 ýd were added to 5 ml falcon tubes and after I wash with 
PBS were resuspended for 30 minutes at RT in 100 ýd of permeabilising buffer 
containing Hanks's Balanced salt solution (HBSS- Gibco BRL, Life technologies, 
Paisley, UK) 0.5% (w/v) bovine serum albumin (BSA), 0.5%(w/v) saponin and 
0.05% (w/v) sodium azide. Cells were centrifuged and resuspended in 100 ýil of 
FACS buffer. 
0.4 ýtg of an IgG affinity purified goat polyclonal antibody raised against the carboxy 
terminal portion of the human FcyRIIB (C-20) (sc-12815 Santa Cruz Biotechnology, 
Inc., Loughborough, UK) was added for I hour at 4T in 100 41 of permeabilising 
buffer. In some experiments, 0.4 4g of an IgG affinity purified goat polyclonal 
antibody against an arninoterminal portion of human FcyRHB (N-17) (sc-12812 
Santa Cruz Biotechnology, Inc., Loughborough, UK) was used. The same amount of 
an irrelevant goat polyclonal antibody (Santa Cruz Biotechnology, Inc., 
Loughborough, UK) was used as an isotype control. To examine specificity 5,10,20 
and 25 4g of an inhibitory peptide anti-C-20 (Santa Cruz Biotechnology, Inc., 
Loughborough, UK) was used in some experiments. 
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2.7 Functional activities of neutrophils 
2.7.1 Culture of Neutrophils with APPs 
Purified neutrophils, either from HH or RR donors, were primed or not (as a control) 
by using 100 IU/ml of IFN7 for at least 12 hours at 37C. Human IgG1 (10 ýLg/ml) 
was added to some wells at 4'C for 30 minutes. Then 100 ýd of a 2x 105 suspension 
of neutrophils were added to each well of a 96-well culture plate, then 50 ýd of either 
type 3 or R36A S. pneumoniae were added to obtain a final ratio of 30: 1 
(bacteria: cell). 
Finally, 50 ýd of CRP at three different concentrations (100,50 or 10 [Ig/ml), or 
MBL at two different concentrations (30 or Iýtg/ml) were added in triplicate. After 
that, neutrophils were cultured for a ftirther 8 hours at 37'C, centrifuged at 800g for 5 
minutes and samples collected for ELISA determinations. Where stated 10 ng/ml 
Polymixin B (Sigrna-Aldrich, Gillingham, UK) was used in order to reduce the 
effects of possible endotoxin contamination. 
2.7.2 Production of cytokines by neutrophils 
2.7.2.1 Determination of TNFoc 
TNFoc was determined by an ELISA procedure. 96-well flat bottom plates (Immulon 
2HB, Dynex technologies, UK) were coated with 50 ýil of 2ýtg/ml mouse IgG2b anti- 
human TNFoc monoclonal antibody (BD Biosciences, Oxford, UK) in OAM di- 
sodium hydrogen orthophosphate pH 9.0 (Na2B? 04)(BDH Laboratory supplies, 
Poole, England) and incubated overnight at 40C. 
Then, plates were washed 4 times with PBS containing Tween2O 0.05% v/v (PBST). 
Wells were blocked by adding 200ýd of PBST/10% (v/v) FCS for 1 hour at RT. 
Standard curves were prepared in duplicate, by adding 50 ýd of dilutions of 2 ng/ml 
Human TNFcc (National Institute for Biological Standards and Control, UK). Serial 
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doubling dilutions were made thereafter down to 31.25 pg/ml. Samples were also 
added in duplicate and left overnight at 4*C. 
A 11 
After 4 washes with PBST, 50 41 of IgG2b biotinylated mouse anti-human TNFcc 
monoclonal antibody (BD Biosciences, Oxford, UK) were added and the tubes left 
for 2 hours at RT. Following extensive washing with PBST, 50 ýtl of horseradish 
peroxidase (I-IRP)-streptavidin (Dako SA, Glostrup, Denmark) were added for 1 hour 
at RT. After 3 washes with PBST and 3 with PBS, 50 ýtl of tetramethylbenzidine- 
TMB (Sigma-Aldrich, Gillingham, UK) in citrate buffer pH 4.5 (0.1M Citric acid 
and 0.1 M Na2PO4 diluted 2 volumes of acid plus 3 volumes of base) plus H202 were 
added, as a substrate for 30 minutes at RT. The reaction was stopped with 12.5 ýd of 
2M sulphuric acid and plates read at 450nm and control wavelength 490 nm in an 
ELISA reader (NERX Microplate Reader, Dynex technologies, Southampton, UK). 
The assay sensitivity was 50 pg/ml. 
2.7.2.2 Determination of IL-8 
IL-8 was determined by an ELISA procedure. 96-well flat bottom plates (Immulon 
2HB, Dynex technologies, Southampton, UK) were coated with 50 ýd of 2ý1g/ml 
mouse IgG2b anti-Human IL-8 monoclonal antibody (BD Biosciences, Oxford, UK) 
diluted in OAM di-sodium hydrogen orthophosphate pH 9.0 (Na2HP04)(BDH 
Laboratory supplies, Poole, England) and incubated overnight at 4'C. 
Then plates were washed 4 times with PBST, wells were blocked by adding 200ýd of 
PBST 10% (v/v) FCS for I hour at RT. Standard curves were performed in duplicate 
by adding 50 ýtl of human rIL-8 (range 2 ng/ml to 31 pg/ml) (National Institute for 
Biological Standards and Control, UK), then samples were also added in duplicate 
and left overnight at 4'C. 
After 4 washes with PBST, 50 ýtl of IgG2b biotinylated mouse anti-human EL-8 
monoclonal antibody (BD Biosciences, Oxford, UK) were added and left for 2 hours 
at RT. Then 50 ýd of HRP-Streptavidin (Dako SA, Glostrup, Denmark) were added 
for I hour at RT and finally 50 ýd of TMB (Sigrna-Aldrich, Gillingham, UK) as 
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described in section 2.7.2.1 for 30 minutes. The reaction was stopped with 12.5 ýd of 
2M sulphuric acid and plates read at 450nm with a control wavelength at 490nm in a 
ELISA reader (MRX Microplate Reader, Dynex technologies, Southampton, UK). 
The assay sensitivity was 31.25 pg/ml. 
2.7.2.3 Intracellular cytokines 
Neutrophils were resuspended at 5x 106/ml in CD-Hybridoma medium. Different 
stimuli were added: PMA at 5 [tM (Sigma-Aldrich, Gillingham, UK), fMLP 100 nM 
(Sigma-Aldrich, Dorset, UK), LPS at 1 gg/ml (Sigma-Aldrich, Gillingham, UK) for 
I hour at 37*C. After 2 washes with a solution containing Hanks's balanced salt 
solution (HBSS- Gibco BRL, Life technologies, Paisley, UK), 3% (v/v) FCS, 10MM 
HEPES, 5mM EDTA and 0.05% (w/v) sodium azide (Buffer A), I gl per condition 
of Brefeldin A (previously diluted at 1 mg/ml in 70% ethanol) was added to 100 ýLl. 
Cells where further incubated for 4h at 3 TC and then cells were fixed with 1% (v/v) 
parafonnaldehyde. Cells were washed with Buffer A at 300g for 2 minutes. 
Further incubations were carried out in the dark. Cells were permeabilised with a 
solution containing HBSS, 0.5% w/v BSA, 0.5% (w/v) saponin and 0.05% (w/v) 
sodium azide (Buffer B), by incubating them in 200 ýd of buffer B for 2 minutes at 
RT. Biotinylated antibodies to human IL-8 (BD Biosciences, Oxford, UK) or human 
TNFcc (BD PharMingen, UK) were diluted to 5 ýtg/ml in Buffer B, and 100 ýd of 
each were added to each tube and the mixtures incubated for 30 minutes at RT. 
Then, after 2 washes with Buffer B, 5 ýig/ml of Streptavidin-FITC conjugate (BD 
Biosciences, Oxford, UK) was added to each condition and incubated for 30 minutes 
at RT. Finally, cells were washed twice with Buffer A and resuspended to 200 ýLl 
with Buffer A for acquisition. At least 20000 events were acquired by FACS (FACS 
SCALIBUR, Becton Dickinson, Oxford, UK). As isotype controls an irrelevant 
biotinylated IgGI mouse antibody was used at the same concentrations as described 
for antibodies to IL-8 and to TNFa. 
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2.7.3 NADPH oxidase activity in neutrophils 
2.7.3.1 Flow Cytometric analysis of respiratory burst by isolated neutrophils 
This procedure was based on a previously described technique for NADPH oxidase 
analysis using human neutrophils by FACS (Emmendorffer et al., 1990). Isolated 
neutrophils were counted and resuspended at 2x 106 cells/ml in HBSS (Sigina - 
Aldrich, Gillingham, UK) then cultured overnight with or without IFNy (100 IU/ml). 
100 ýtl aliquots of cells were incubated in plastic falcon tubes with 100 ýd of stimuli 
(CRP at final concentrations of 100,50 and 10 gg/ml alone or with Pneumococci 
Serotype 3 at a ratio 30: 1); PMA at I gM was used as a positive control diluted in 
PBS for 20 minutes at 37C. 
Then, 50 ýLl of 100 ýM of dihydrorhodamine 123 (DHR- Calbiochem, Nottingham, 
UK) diluted in PBS were added and cells left at 37'C for further 5 minutes. 
The reaction was stopped with 200 ýLl PBS-0.02% EDTA and washed once with 
PBS. The cells were fixed with 200 41 of cold 1% paraformaldehyde (PFA) at 4'C 
and stored at 4'C until read. 
Cells were acquired by flow cytometry (FACS SCALIBUR, Becton-Dickinson, 
Oxford, UK) and analysed by Cell Quest software (Becton-Dickinson, Oxford, UK). 
At least 30000 events were counted per sample. 
2.7.3.2 Flow Cytometric analysis of respiratory burst by neutrophils maintained 
in whole blood 
Some experiments were performed using whole blood from donors as follows 
according to a procedure described previously (Richardson et al., 1998). Blood was 
collected into 50 ml falcon tubes containing Citrate Dextrose solution (ACD-Sigma- 
Aldrich, Gillingham, UK), as an anticoagulant at a ratio 1: 5 (ACD: Blood). 100 ýLl 
of blood were transferred to plastic falcon tubes and different stimuli were added 
according to the assay performed, e. g. 5 ýLM of PMA, purified or recombinant CRP, 
pneumococcus serotype 3 for 20 minutes at 37C. 50 ýtl of 100 ýM DHR were then 
added and cells incubated for a further 10 minutes at 37*C for analysis of NADPH 
oxidase activity of neutrophils. 
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Then FACS lysing solution (BD Biosciences, Oxford, UK) was added during 20 
minutes at 37T to lyse red blood cells. The cells were centrifuged twice at 10OOg for 
2 minutes and then fixed with PFAl% (v/v) at 4'C. At least 20000 events were 
acquired by flow cytometry (FACS SCALIBUR - Becton Dickinson, Oxford, UK) 
and data analysed using Cell Quest software (Becton Dickinson, Oxford, UK). 
2.7.3.3 H202release from human neutrophils 
The Amplex Red Hydrogen Peroxide Assay Kit (A-12212 - Molecular probes) was 
followed according to the instructions from the manufacturer based on the protocol 
of Mohanty et al., ( 1997). Briefly, a reaction mixture containing 50ýiM of 10-acetyl- 
3,7-dihydroxyphenoxazine (Amplex Red reagent), which becomes fluorescent upon 
H202oxidation (resorufln), 1 U/ml of horseradish peroxidase (HRP) to catalyse H202 
oxidation and stimuli (PMA at a final concentration of 5ýLM, S. pneumoniae at 4.5 x 
105 and in some cases CRP at final concentrations of 1.5,109 50 and 100 ýLg/ml) in 
180 ýtl of CD-hybridoma medium was added to a 96-well plate. 
The reaction mixture was prewanned for 10 minutes at 37'C, then, 1.5 x 10 
4 isolated 
neutrophils in 20 ýtl of CD-hybridoma medium were added to make up a total 
volume of 200 ýtl. Fluorescence was determined using an excitation of 560 nm and 
emission detection at 590 nm. Readings were taken each 15 minutes for 2 hours in a 
microplate spectrofluorometer reader (Spectra MAX Gemini, Sunnyvale, USA). 
2.7.3.4 Superoxide production by neutrophils 
Isolated neutrophils were resuspended at 2x 10 
6 /ml and 50 ýil per well were added to 
a 96-well plate. 30.5 pLl of stimuli were used as follows; PMA at a final concentration 
of 5 ýiM as a positive control and recombinant CRP at 1ý5,10,5 0 and 100 ýIg/ml. 
In 
some wells superoxide dismutase (SOD) (Sigma-Aldrich, Gillingham, UK) at 
300 
Units/ml was used as negative control. Then, 75ýM cytochrome c (Sigma -Aldrich, 
Gillingham, UK) in 12.5 ýd was added and CD -hybridoma medium used to make a 
total volume of 250 41 in each well. 
85 
Absorbances were determined each 15 minutes up to 2 hours at 550nm in a 
microplate spectrofluorometer reader (Spectra MAX Gemini, Sunnyvale, USA). The 
amount of reduction of cytochrome c was calculated by subtracting the OD obtained 
with SOD from the one obtained with each sample, using a molar extinction 
coefficient of 21.1 X 10-3 M and a light path of 0.66 cm for a final volume of 250ýLl- 
as follows: 
(sample OD - SOD OD) 
Mnol/ 105 cells= 
[ 
------------------------------------------ X 0.66] x 1000 
21.1 
2.7.4 Phagocytosis 
2.7.4.1 Phagocytosis by transfected Cos cells 
2.7.4.1.1 Transfection of Cos cells 
Cos-7 cells were maintained in Dulbecco's modified Eagle's medium (Life 
Technologies, Paisley, UK) supplemented with 2 mm glutamine (Life Technologies, 
Paisley, UK), 100 RJ/ml penicillin, 100 4g/ml streptomycin (Life Technologies, 
Paisley, UK), 0-015 mg/ml gentamicin (Sigma-Aldrich, Gillingham, UK) and 10% 
fetal bovine serum (Sigma-Aldrich, Gillingham, UK). Cells were plated at 4x 105/Ml 
in 60-mm. Petri dishes to reach 50% confluence overnight. 
The simian virus 40-based expression vector CDM was used for the transient 
expression of the cDNAs of all clones in Cos-7 cells using the diethylaminoethyl- 
dextran. method (Allen and Seed, 1989). The cDNAs (5 ýLg/3 ml Petri dish) used for 
transfection were Fc7RI, 7-chain and Syk (obtained from Professor Janet Allen, 
Department of Medicine and Therapeutics, Division of Biochemistry & Molecular 
Biology, The University of Glasgow, UK) FcyRII RR and Fc7RII HH (obtained 
from Dr Patrick Harrison Department of Physiology, University College Cork, 
Ireland). FcyRII R tailers mutant was generated from Fc-yRII R by PCR to 
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incorporate a terminal phenylalanine to replace Tyr at position 205 (Rachel Gregory, 
LSHTM). All experiments were performed 2 or 3 days post-transfection, when 
surface expression was maximal. This work was performed by Dr K. Bodman-Smith 
as previously described (Bodman-Smith et al., 2002). 
2.7.4.1.2 Phagocytosis of S. pneumoniae by transfected Cos cells 
FITC-labelled Streptococcus pneumoniae serotypes 3 and 2 strain R36A (see section 
2.5.2) were opsonised either with pCRP or rCRP at 30 ýtg/ml in the presence of 5mM 
CaC12 or with 10% normal human serum (NHS-Sigma - Aldrich, Gillingham, UK) as 
a positive control for 1 hour at 4'C. Bacteria were washed extensively with HBSS 
(Sigma - Aldrich, Gillingham, LJK). Opsonised and non-opsonised bacteria were 
allowed to remain in contact with transfected Cos cells at a ratio of 30: 1 in HBSS in 
the presence of 0.5mM CaC12 for 2 hours at 371C. Cells were transferred into falcon 
tubes and were washed with HBSS in the presence of I%BSA. Cells were then fixed 
with 2%(w/v) PFA and were acquired by Flow cytometry (FACS SCALIBUR, 
Becton-Dickinson, Oxford, UK). 
2.7.4.2 Phagocytosis by neutrophils 
Isolated neutrophils were resuspended in CD-hybridoma medium at 2x 106 cells/ml, 
were incubated with FITC-labelled pneumococci (see section 2.5.2), at different 
ratios 10: 1,30: 1 and 100: 1 (bacteria: cells) at 37'C for 30 minutes. In another 
experiment cells were divided into two groups, incubated with pneumococci at a 
ratio of 30: 1 at 4'C and compared with a group of cells warmed to 37C. In some 
experiments neutrophils were incubated with FITC-labelled pneumococci and 
30ýtg/ml of CRP, in the presence or absence of 1 ýM Cytochalasin D (Sigma - 
Aldrich, Gillingham, UK) at 37'C for 30 minutes. 
Neutrophils from both HH and RR donors were obtained and incubated with 
pneumococci at a ratio of 30: 1 for 30 minutes at 37'C in the presence of pCRP or 
rCRP at 0,1,5ý 10,50 or 100 ýig/ml- 
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In all experiments, phagocytosis was stopped with cold PBS; after two washes with 
cold PBS at 300 g for 5 minutes, cells were fixed with 1% PFA for 30 minutes and at 
least 20000 events were acquired by Flow cytometry (FACS SCALIBUR, Becton- 
Dickinson, Oxford, UK). Phagocytosis was calculated by obtaining differences in the 
mean fluorescent intensity (MFI) of cells at 37'C from the one obtained with 
cytochalasin D. 
2.7.4.3 Phagocytosis by neutrophils maintained in whole blood 
A similar procedure to that described in section 2.7.3.2 was used to examine FITC- 
labelled bacteria for phagocytosis in whole blood in the presence or absence of 
different concentrations of added pCRP or rCRP. A total volume of 200 ýLl per tube 
was used in all assays. 
2.7.4.4 Phagocytosis by Peripheral Blood Mononuclear Cell - derived 
macrophages 
PBMCs resuspended in RPMI were allowed to adhere for 2 hours at 37'C in plastic 
slides in serum free medium and then cultured for 6 days in RPMI with 10% FCS at 
3 7'C. 4x 104 macrophages per well were incubated in contact of FITC labelled 
Streptococcus pneumoniae type 3 and strain R36A at a ratio 30: 1 in the presence of 
absence of pCRP and rCRP at 30 ýtg/ml or in the presence of 10% NHS as a control 
for 1 hour at 4'C. After two washes with PBS, cells were fixed with 300 ýd of 
methanol for 10 minutes at RT and then 50ýM ethidium bromide was added to stain 
nuclei of macrophages for 20 minutes at RT. Phagocytosis was visualised by 
immunofluorescence. 
2.7.4.5 Visualization of phagocytosis of S. pneumoniae by neutrophils by confocal 
microscopy 
Neutrophils were isolated and resuspended at 2x 10 
6/nIl. 100 ýd of neutrophils were 
incubated with 200 41 of HBSS containing either 
FITC-labelled S. pneumoniae 
serotype 3 alone or pre-opsonised with CRP at 
30 4g/ml or 10% NHS at a ratio 1: 30 
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(neutrophil: pneumococci) for 30 minutes at 37'C on glass slides to allow adherence 
of neutrophils. Then, phagocytosis was stopped with cold HBSS containing 1% (w/v) 
BSA and washed three times. The cells were fixed with 300 ýtl of methanol and were 
washed three times with HBSS containing 0.5% (w/v) saponin to permeabilise the 
cells. 300 ýtl of BOPIDYO 650/665 phalloidin (Molecular probes, Leiden, The 
Netherlands) to detect actin diluted 1/100 in HBSS-saponin solution were added and 
incubated for 45 minutes at RT. Finally, 50ýiM ethidium. bromide (EB) was added 
for 20 minutes at RT. Phagocytosis was visualised by confocal microscopy in 
collaboration with Rachel Gregory 
2.8 Binding of CRP and SAP to FcyRs by surface plasmon resonance 
2.8.1 Preparation of samples 
Recombinant soluble Fc7R]E[A-RR, RIIB and RIIIIB -NA2 were produced in E. coli 
strain BL2 1 /DE3 (Sondermann and Jacob, 1999) and were obtained from Professor P 
Sonden-nann (Max-Planck Institute f& Biochemie, Abteilung Strukturforschung, 
Martinsreid, Germany). Samples were dialysed first against O. lM NaHC03 at 40C. 
Biotinylation was performed as follows: a stock of 8mM Biotin-N-hydroxy- 
succinimide (Biotin-NHS) (Sigrna - Aldrich, Gillingham, UK) was prepared and 
later diluted 50-fold into milliQ H20.3 ýd of diluted biotin-NHS were added to each 
FcyR and left at 25'C for 1 hour (ratio biotin: FcyR, 0.8: 1). Samples were dialysed 
against 100 ml of 150mM NaCl 10 mM HEPES pH 7.4 at 40C, then against a further 
100 ml of the same solution plus 0.004% (w/v) sodium azide, overnight at 4'C. The 
final concentration of the Fc7R samples was 0.6ýtg/ml. 
2.8.2 Offering Fc receptor to CRP bound to PCh immobilised on a CM5 chip 
On a CM5 sensorchip, 100 ýM p-aminophenyl-PCh was immobilised in flow cell 2 
whereas flow cell 1, which was blocked with 1M ethanolamine, pH 8.5, was used as 
a control. Flow cell 2 was activated with 35 ýLl 0.05 M N-hydroxysuccinimide and 35 
ýLl of 0.2M N-ethyl-N'-(3-dimethylaminopropyl) carbodiimide at 
5 ýLl per minute. 
Then, 30 ýLl 100 ýM p-aminophenyi-PCh in 0.1 M boric acid - NaOH, pH 8.4 were 
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injected and remaining activated groups were blocked with 30 ýd IM ethanolamine- 
HCI pH 8.5. Flow cell I was activated in the same way and it was blocked with 
ethanolamine. 
Then different concentrations of both rCRP and pCRP from 0.1 ýLg/ml up to 10 
ýtg/ml were injected. Finally, different concentrations (100,50,20 and 10 ýtg/ml) of 
Fc7R1IIA or Fc7RIEB were injected in a buffer containing 0.15M NaCl, 0.5mm 
CaC12.0.05% (v/v) Tween 20,0.01M HEPES, 0.1 M boric acid NaOH, pH 8.4 at a 
flow rate of 10 [tl per minute. 
2.8.3 Offering CRP to biotin-Fc receptors immobilised on a streptavidin chip 
On a streptavidin (SA) sensorchip (BIACORE, Stevenage, UK) biotinylated 
Fc7RIIA-RR allele, Fc7RHB and Fc7RIIIB -NA2 were immobilised to obtain about 
500 RU in flow cells 2,3 and 4 respectively, whereas flow cell 1 was left as blank. 
Possible remaining free sites on the chip were blocked with 20 ýd of 0.36 mM biotin. 
Then 10 ýLl of different concentrations from 0.2 ýtg/ml to 50 pLg/ml of rCRP or pCRP 
were injected at a flow rate of 10ýtl/min in the presence of 0.5 mM CaC12 in a buffer 
containing lOmM HEPES, 100 mM NaCl and 0.005% (v/v) of Tween2O. Binding 
was analysed using a BIACORE 3000 and BIA evaluation 2.1 software (BIACORE, 
Stevenage, UK). 10 41 of SAP at 0.1,1,10 and 30 ýtg/ml were also injected using the 
same conditions since it was reported that SAP binds to mFc7RI and mFc7RIII but 
not to mFc7RII (Mold et al., 2001). Sensitivity of the Biacore was 1000 RU 
equivalent to 1 ng/MM2. 
2.9 Statistical analysis. 
The software GraphPad Prisma 3.03 version was used for statistical analysis. The 
unpaired Mann Whitney test was used for most analyses. p values, when applicable, 
were considered significant when lower than 0.05. In all cases * represents p<0.05, 
** represents p<0.01 and *** p< 0.001. 
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3. RESULTS 
3.1 Purification of Neutrophils 
There are different techniques to isolate neutrophils, based mainly on ways to 
remove red blood cells by using their property to aggregate to each other thus 
becoming heavier than other cells. However, these methodologies affect the viability 
and activation of neutrophils which may be of crucial importance for particular 
assays where the function of neutrophils is being analysed. 
The activation state of neutrophils was assessed following different methods of 
isolation: first, a histopaque based method that uses two densities of histopaque 
1.166 and 1.077, which allows simultaneous separation of a layer of mononuclear 
cells at the upper interface and PMN cells at a lower interface. Red blood cells are 
separated at the bottom of the tube. Second, a dextran method, in which leukocyte - 
enriched plasma is obtained after incubation of blood with dextran, following which 
mononuclear cells are separated from PMN by centrifugation of the plasma on 
histopaque (p=1.077). Both of these methodologies gave a purification of more than 
95% neutrophils which was confirmed by Wright-Giemsa staining (figure 3.1). 
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Figure 3.1. Isolated human neutrophils. Human blood from healthy donors was 
treated with dextran to remove red blood cells and then neutrophils were obtained 
through centrifugation with histopaque 1.077. Separated cells were visualised 
by 
staining a smear on glass slides with Wright - Giemsa. 
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3.2 State of activation of neutrophils after isolation procedure 
The most commonly used separation methods for neutrophils involve density 
gradient centrifugation, with additional steps to remove contaminating red blood 
cells. Such gradients are usually discontinuous and are generally based on Percoll 
(colloidal silica coated with polyvinylpyrrolidone to reduce toxicity) or on Ficoll (a 
sucrose polymer); Ficoll may be combined with sodium diatrozate (Hypaque) or with 
Isopaque to increase density. A method to reduce red cell contamination is used in 
combination with gradient centrifugation; either sedimentation enhanced by dextran 
(occasionally gelatine or hydroxyethyl starch are used in place of dextran) and red 
cell lysis for remaining red blood cells with ammonium chloride or hypotonic saline 
are used. We have used the combination of two densities (1.116 and 1.077) of Ficoll- 
Isopaque (Histopaque) or a combination of dextran and then Ficoll-Isopaque (1.077) 
to remove contaminating mononuclear cells. 
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Figure 3.2. L-selectin expression on neutrophils. L-selectin on neutrop is 
obtained by the Dextran- or Histopaque-methods was detected with a mouse IgGI 
monoclonal anti-human L-selectin antibody -. A mouse IgGI isotype control 
antibody **'** was used in both cases and compared with cells with no antibodyN . 
To obtain fluorescence a goat- anti mouse FITC conjugate was used. 10000 events 
were acquired and data was analysed using Cell Quest software. Similar results were 
obtained in two different experiments. 
Neutrophils, when activated, change the expression of molecules on the membrane, 
L-selectin is shed, whilst integrins are upregulated, so If a neutrophil expresses high 
levels of L-selectin it is not yet fully activated. This property has 
been used to 
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analyse the state of activation of neutrophils isolated by both histopaque- and 
dextran-methods. Neutrophils obtained with the dextran-method showed higher 
expression of L-selectin than those isolated with two densities of histopaque (Figure 
3.2). 
Neutrophils express molecules that allow them to bind and phagocytose non- 
opsonised- and opsonised- particles. In this way, CR3 which binds to C3b, FcyRI and 
FcyRHA which interact both with CRP and with monomeric IgG and IgG-immune 
complexes respectively are therefore particularly important for micro-organism 
clearance. On the other hand, neutrophils have low amounts of FcyRI on their 
membrane, but upon activation the expression increases exponentially with little 
alteration of the constitutive FcyRIIA. Many substances are able to activate 
neutrophils and induce Fc7RI expression, among them IFN7 and GM-CSF have 
particularly potent activity. Expression of FcyRI can be visualised by indirect 
immunofluorescence, but for quantitative purposes flow cytometry is more 
appropriate because of its reliability and reproducibility. 
Because methods of isolation of neutrophils can activate neutrophils as well, we 
compared the expression of FcyRI following isolation with either histopaque and 
dextran. Cells purified using dextran had less Fc7RI (figure 3.3). For these reasons 
dextran separation was the technique of choice to isolate neutrophils in this study. 
Serum from different species might also activate neutrophils, may contain MBL, 
CRP or SAP and therefore might alter the outcome or the reproducibility of the 
methods, for that reason we selected a medium that did not contain serum from any 
origin. CD-hybridoma@ a serum-free medium which supports growth of hybridoma 
cells lines was selected to avoid the use of animal serum. 
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Figure 3.3. Expression of FcyRI in isolated untreated neutrophils. Fc7RI 
expression was analysed in fresh neutrophils isolated by either two different 
histopaque densities (panel a) or Dextran (panel b) by adding a PE-conjugated 
mouse-IgGI anti-human Fc7RI antibody (green histogram) and compared with a PE- 
IgGI mouse isotype control (filled histogram). This is a typical histogram from three 
different experiments showing similar results. 
3.3 Apoptosis of neutrophils 
Neutrophils are short lived cells, during normal situations from the time they 
abandon the bone marrow they usually last up to 24 hours. One of the explanations 
for this phenomenon is that neutrophils are programmed to die without any stimulus 
that "rescues" them from apoptosis. IFN7, GM-CSF, LPS are stimuli that are able to 
have anti-apoptotic effects on neutrophils. 
Apoptosis in its early stages is characterised by an exchange of phospholipids on the 
external membrane which allows phosphatidylserine to increase its expression. This 
is then used to identify apoptotic cells by binding to Annexin V, which can be 
associated with a fluorescent compound such as FITC. At later stages of apoptosis 
endonucleases of the cell are activated. These enzymes partially digest DNA which 
also can be detected in different ways, one of which labels DNA fragments at the 3' 
OH ends with TdT and biotinylated nucleotides which can be detected by 
Streptavidin-Fluorescein a technique known as Terminal deoxynucleotidyl 
transferase -mediated biotinylated deoxyuridine-triphosphate nick-end 
labeling 
JUNEL). 
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Figure 3.4. Apoptosis of neutrophils determined by TUNEL (Section 2.3.2). 1x 
106 neutrophils per test were incubated in serum free CD-hybridoma medium. In 
panel a) negative and positive controls (section 2.3.2) can be observed, in panel b) 
apoptosis was evaluated at 0 (filled histogram), I- ,4,18 hours ...... and 24 hours-, in the absence of IFN7 and panel c)shows an identical study in the presence 
of LFN7 (100 IU/ml). Similar results were obtained in two separate experiments using 
two different donors. 
We analysed neutrophils in apoptotic late stages by TUNEL during the first 24 hours. 
In Figure 3.4, panel b, it can be observed that apoptosis increases with time. In the 
absence of IFN7, cells were counted at 24 hours using a hemocytometer and 50% of 
cells were lost during this period of time. In the presence of IFNy TUNEL was less 
positive at most time points (panel c) and at least 60% of cells were still viable. It is 
clear, that IFNy decreased apoptosis on neutrophils at least in the first 24 hours. No 
functional experiments were carried out later than 24 hours. 
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This result was correlated with the binding of Annexin V at 1,4 and 24 hours which 
showed that the expression of Annexin V was reduced in the presence of 
IFN7 (Figure 3.5). This finding suggests that cells still alive were in a good 
functional condition since they were not entering the early stages of apoptosis. 
Interestingly, few annexin V strongly positive cells were seen at 24h with IFN7 
although many cells (40%) had been lost and some were showing sign of apoptosis 
by TUNEL (Figure 3.4). This suggests that cells were still undergoing apoptosis 
although high levels of annexin V were not observed. 
IUD 
CD 
JA CM 
CD 
00 
Cl 
97 
Cl 
4 
24 
10 u 10 1 10 9-1 10 .3 10 9 
FL 1 -H 
Figure 3.5 Apoptosis of neutrophils determined by Annexin V (section 2.3.1). 1x 
106 neutrophils per condition were incubated in the absence (panel a) or presence 
(panel b) of IFN7 IOOITJ/ml. Amexin V binding was analysed at 0 (filled 
histograms), I (green), 4 hours (red) and 24 hours (blue). Similar results were 
obtained in two separate experiments using two different donors. 
3.4 Role of MBL in pneumococcal infections and interaction with neutrophils 
3.4.1 Purification of MBL 
MBL was obtained from the plasma of patients undergoing plasmaphoresis for acute 
inflammatory conditions as described in section 2.1.1 (Figure 3.6). MBL was the 
major protein component present as shown by ELISA and immunoblotting as well as 
protein staining which revealed a major band at 31 kDa. 
3.4.2 Determination of MBL in some children with recurrent infections 
Initially and in connection with a study examining possible reasons for recurrent 
respiratory tract infections, serum MBL was determined in 11 Colombian children 
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who had been suffering diseases such as pneumonia, otitis media and sinusitis, from 
which at least 50% were expected to be caused by pneumococci (Kertesz et al., 
1998). Children included in the study did not have any primary immunodeficiency or 
any other condition that explained their clinical problem IgM, IgG, IgA, C3, C4, 
IgGI, IgG2, IgG3 and IgG4 were within the normal range expected for their age 
(Table 3.1). 
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Figure 3.6. Purification of MBL. a) SDS PAGE of reduced purified human MBL 
stained with Coomassie blue. Lane I shows molecular markers and lane 2 MBL 
sample. b) immunoblot with a biotinylated mouse monoclonal anti-MBL antibody. In 
the immunoblot two bands can be seen one at approximately 29 kDa and another 
one at approximately 60 kDa, which reflects MBL plus MASP-2. This complex is 
difficult to separate (Methods section 2.1.2). 
Concentrations of IgG antibody to Streptococcus pneumoniae serotypes 1,3,4,5, 
6B, 9V, 14,18C, 19F and 23F were also determined. Antibody concentrations after 
vaccination with the 23-valent pneumococcal vaccine were considered normal when 
either a four-fold increase was achieved or when titers reached 1.3ýtg/ml for five or 
more pneurnococcal serotypes (Sorensen et al., 1998). In Figure 3.7 it can be seen 
that mean responses satisfied these criteria. Individually no child failed to respond to 
the pneumococcal vaccine. 
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Different pneumococcal serotypes have been grouped according to the response 
obtained. 1,3,4,6B, 9V had lower levels than serotypes 5,14,18C, 19F and 23F. 
which is probably due to previous pneumococcal infection with these particular 
serotypes since they had higher pre-existing IgG antibodies. None of them, however, 
had MBL deficiency, which would be characterised by values below 1 ptg/ml. 
(Figure 3.8). 
Unfortunately we did not have an MBL deficiency serum to use as a control for this 
assay. One report on a Colombian population found 21.4% of 140 individuals having 
allele B, 3.6% allele D and 3.2% allele C. Five individuals were homozygous for 
allele B, one was homozygous for allele C and no individuals were homozygous for 
allele D (Malik et aL, 2003). Although no serum MBL concentrations were reported, 
we would expect 3 of the children in this study to have low MEBL concentrations 
according to this genotype data. However, the group of children studied here were 
suffering from recurrent infections which may also increase serum MBL 
concentrations and the numbers were too small to permit any conclusions to be 
drawn. 
Table 3.1. Serum concentrations of different immunoglobulin and complement 
components in selected Colombian children. Different immunological parameters 
were deten-nined by nephelometry in 11 children. Data shows mean and range for 
each parameter. 
Parameter Mean (mg/dL) Range (mg/dL) 
igm 99 41.2-229.6 
IgG 1147.59 414-1614 
IgA 109.2 37.5-272.9 
C3 126.9 33.5-259.3 
C4 34.5 21.7-62.5 
IgGl 869.8 376.5-1080 
IgG2 199.9 6.2-513.4 
IgG3 44.3 13.6-166.1 
IgG4 52.4 10-348.1 
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Figure 3.7. Specific IgG antibodies to different pneumococcal types in a group 
of Colombian children with recurrent infections. IgG specific anti- pneumococcal 
serotypes 1,3,4,5,6B, 9V, 14,18C, 19F and 23F were determined by ELISA before 
and 4 weeks after vaccination with the 23-valent pneumococcal vaccine. 11 children 
suffering from recurrent pneumococcal infections have been analysed. Bars show 
mean and s. e. m and p values between titers pre and post vaccination obtained by 
Mann Whitney test. ** p<0.01, *** p<0.001 
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Figure 3.8. MBL concentrations in a group of Colombian children with 
recurrent respiratory infections. 11 serum samples from children were taken to 
analyse MBL concentration by ELISA (section 2.1.3) (each value represented by a 
dot). Any value below the line (lgg/ml) would be considered MBL deficiency. The 
small horizontal line represents the median of MBL (11.91 gg/ml). 
3.4.3 Production of IL-8 by neutrophils in the presence of S. pneumoniae and 
MBL 
Because of the presence of sugars such as N-acetyl glucosamine and mannose in the 
capsule of the pneumococcus it was thought that MEBL might bind to them, interact 
with neutrophils through binding to CR1, a reported receptor for M13L, and facilitate 
pneumococcal clearance by phagocytes. 
IL-8 production by neutrophils was assessed as an indicator of possible interaction 
with MEBL when in the presence of encapsulated (type 3) or non-encapsulated 
(R36A) Streptococcus pneumoniae. IL-8 synthesis was compared with the one 
induced by a recognised organism (Cryptococcus neoformans) able to bind to MBL 
and therefore with the capacity to interact with CR1 expressed on neutrophils. 
In Table 3.2 it can be observed that Cryptococcus neoformans alone induced IL-8 
production in neutrophils. The production of the chemokine increased by a factor of 
two when the organism was incubated with MBL at 10ýtg/ml. On the contrary, both 
encapsulated and non-encapsulated Streptococcus pneumoniae were not able to 
induce more IL-8 in the presence of the same concentration of MBL. 
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Stimulus None (n--2) S. pneumoniae 
type 3 (n=2) 
S. pneumoniae 
R36A (n--2) 
Cryptococcus 
neoformans 
IL-8 (pg/ml) 
None 123,72.5 373.06,384.5 373.26,385.8 750 
LPS 2200,1200 3200,1345 1800,1560 4200 
MBL 105.6,86.97 332.41 325.8 389.5,377.8 1550 
Table 3.2. Effect of MBL on IL-8 synthesis by neutrophils. Neutrophils (2 x 
106/ml), isolated by dextran, were cultured overnight in the presence or absence of 
the following stimuli: S. pneumoniae type 3 or R36A at a ratio 1: 30 (neutrophils: 
pneumococcus), LPS 1 ýig/ml, MBL at 10 ýtg/ml or C neoformans. EL-8 production 
(pg/ml) in the supernatants was determined by ELISA. Values show data from 2 
experiments on two different donors, except for C neoformans where the values 
from I experiment are shown. 
Proteases from the pneumococcus such as pspA or IgAl protease may affect these 
results. A known quantity of IL-8 was incubated with different concentrations of 
pneumococcus, similar to the ones used in the study, to see whether, after overnight 
incubation, levels of IL-8 were altered. We found that after overnight incubation 
similar concentrations of IIL-8 were measured (Figure 3.9), a finding that rejects the 
possible effect of pneumococcal proteases 
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Figure 3.9. Streptococcus pneumoniae does not alter IL-8 concentration. 
Different numbers of bacteria (0,108 and 109/ml) were cultured overnight in the 
presence of IL-8 at 500,1000 and 2000 pg/ml, next day, following centrifugation, the 
supernatants were assayed for IL-8 by ELISA. 
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3.4.4 MBL does not bind to S. pneumoniae serotype 3. 
As mentioned before the presence of sugars on the capsule of the pneumococcus 
suggested a possible interaction with MBL. We had the aim of comparing MBL with 
CRP when investigating the effect of innate opsonins on neutrophil/ S. pneumoniae 
interactions. For this reason, binding of MBL to S. pneumoniae was examined by 
FACS using a FITC-labelled antibody to MBL and it was compared to the binding to 
C neoformans which was previously shown to bind to MBL (Schelenz et al., 1995) 
(Figure 3.10). It is clear that MBL is able to bind to C neoformans (panel b), 
whereas no binding can be observed to the pneumococcus (panel a). This result 
agrees with recent reports arguing against the capacity of MBL to bind pneumococci 
(Neth et al., 2000). 
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Figure 3.10. MBL binds to Cryptococcus neoformans but not to Streptococcus 
pneumoniae. 10 ýtg/ml of MBL were incubated with 5 X106 of each micro-organism 
in the presence of 10 mM calcium in HBSS during I hour at 4'C. An IgGI mouse 
biotinylated antibody anti-MBL was added and streptavidin- FITC conjugated was 
used to detect antibody binding -. An IgGI mouse isotype control 0 was used for 
comparison. At least 30000 events were acquired to analyse binding. Graph shows a 
representative experiment from two that gave similar results 
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3.5 Effects of CRP on neutrophil function 
In order to detennine the capacity of CRP to alter neutrophil function we chose to 
measure IL-8 and NADPH oxidase activity as markers of neutrophil activation and 
were measured by ELISA and DHR-123 oxidation by FACS respectively. The effect 
of different concentrations of CRP in the presence or absence of pneumococci were 
0 
analysed and compared. 
3.5.1 Polymorphisms of FcyRIIA 
CRP has been shown to bind to both FC7RI and may also bind to Fc7RIIA and both 
are expressed on neutrophils. However, binding to Fc7RIIA has been reported to be 
affected by polymorphisms at position 131 on the second external loop of the 
molecule. Fc7RIIA with arginine in that position (RR-homozygous) binds CRP 
whereas the histidine (HH homozygous) form shows very weak or no binding (Stein 
et al., 2000b). 
1 
Figure 3.11. Polymorphisms of FcyRIIA (Section 2.4.2). The bigger arrow shows 
the amplification of human growth hormone (439bp) as an internal control, whereas 
the smaller arrow shows amplification of Fc7RIIA (253bp). Lanes 1,3,5 show 
amplification with H131 specific primer and 2,4,6 show amplification with R131 
specific primer. Tracks I and 2: DNA from donor a; 3 and 4 donor b and 5 and 6 
donor c. The gel shows that a is homozygous H; b is homozygous R and c is 
heterozygous 
The FC7RIIA polymorphisms were detennined in 34 adult healthy volunteers. Of 
these 16 were heterozygous because they showed bands for both fonns (as lanes 5 
and 6 in Figure 3.11), whereas 9 were homozygous for R131 and 9 were 
homozygous for H 13 1. This data follows the Hardy-Weinberg equilibrium. 
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As an example of what it is seen after agarose separation, three different donors are 
shown in Figure 3.11, where donor a (lanes 1 and 2) is homozygous for H 13 1, donor 
b (lanes 3 and 4) is homozygous for R131 and donor c (lanes 5 and 6) is 
heterozygous. 
3.5.2 Induction of IL-8 production by neutrophils following interaction with 
CRP and S. pneumoniae 
IL-8 is one of the major chemokines synthesised by neutrophils in an autocrine way 
to attract cells to the site where an inflammatory process is starting. We assessed the 
ability of CRP at various concentrations to induce production of IIL-8 by neutrophils 
and also looked for differences in the IL-8 produced by neutrophils from HH and RR 
homozygous donors. 
Increasing concentrations of CRP on its own were able to induce the synthesis of IL- 
8 in both types of neutrophil. No difference was observed in the level of IL-8 
produced by neutrophils from HH donors in comparison to RR donors as shown in 
Figure 3.12. Moreover, no difference was observed when IFNy at 100 11U/ml was 
added as a stimulus. S. pneumoniae serotype 3 induced a higher IL-8 response than 
that seen in its absence and again was lower in RR donors with and without CRP at 
various concentrations (Figure 3.12 panels b and d). Increasing concentrations of IL- 
8 in the presence of CRP was seen using R36A, which is a non-encapsulated 
pneumococcus (Figure 3.13), although the organism on its own induced less IL-8 
than the encapsulated type 3. 
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Figure 3.12. Effect of CR-P and S. pneumoniae on IL-8 production by isolated 
neutrophils. Isolated neutrophils from both HH and RR homozygous individuals 
were cultured overnight at 37T in the presence of S. pneumoniae type 3 and CRP at 
Oý 10,50 and 100 ýtg/ml. In some tests IFN7 at 100 IU/ml was added (c and d) . Supernatants were obtained, and IL-8 production (pg/ml) was determined by ELISA. 
Graphs show means and s. e. m of IL-8 produced by 6 different donors for each 
polymorphism. No significance statistical difference was found between responses 
obtained on neutrophils from HH and RR donors for this set of experiments when 
analysed by Mann Whitney U test. 
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Figure 3.13 Effect of CRY and n on-en capsulated S. pneumoniae on IL-8 
production by neutrophils. Isolated neutrophils from individuals homozygous HH 
or RR at the 131 position of Fc7RIIA were cultured overnight at 37T in the presence 
of Streptococcus pneumoniae R36A and CRP at 0,10,50 and 100 Ptg/ml. 
Supernatants were obtained, and EL-8 production (pg/ml) was determined by ELISA. 
Graphs show means and s. e. m of 6 different HH donors and 6 RR donors. Statistical 
analysis was performed using the Mann Whitney test comparing presence of CRP 
with the control group that did not contain CRP. * p<0.05; ** p< 0.01; *** p<0.001 
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Experiments performed with heterozygous donors gave a similar result, in that CRP 
at increasing concentrations was also able to induce synthesis of IL-8 by neutrophils 
(Figure 3.14). 
400 
= 300 
E 
CF) CL 200 
Co 
100 
0 
pCRP 
= Control 
EM R36A 
M S3 
Figure 3.14. Effect of CR-P on IL-8 production by neutrophils from individuals 
heterozygous at the 131 position of Fc-yR11A. Isolated neutrophils from such 
individuals were cultured overnight at 37T in the presence of Streptococcus 
pneumoniae R36A or serotype 3 and pCRP at 0,10,50 and 100 ýtg/ml. Supernatants 
were obtained, and IL-8 production was determined by EUSA. Bars show means 
and s. e. m. of 4 different donors. Statistical analysis was performed using Mann 
Whitney test comparing the difference between the groups containing CRP with the 
control group which did not contain CRP. * p<0.05 
These results argue against a major role of Fc7RHA in responses to CRP. For that 
reason, we tested the ability of monomeric IgGI to block Fc7R1, since this 
immunoglobulin binds particularly well to Fc7RI, whereas Fc7RIIA binds mostly to 
immune complexes of IgG and would not bind monomeric IgG at the concentrations 
used (Figure 3.15). No inhibition of response was achieved in these experiments 
using 10ýtg/ml blocking human IgGI which was the concentration previously shown 
to inhibit IgG binding to FC7RI (Bodman-Smith K. personal communication). Higher 
concentrations of IgG should be tested to see if clearer inhibition is obtained. In HH 
donors we observed a tendency to produce more JIL-8, but it was not statistically 
significant. 
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Figure 3.15 Effect of blocking FcyRI on IL-8 production by neutrophils. 
Neutrophils from HH and RR donors were incubated with IFN7 at 100 IU/mI 
overnight at 37T. Next day, monomeric IgG1 at 10 ýtg/ml was incubated with cells 
for 30 minutes at 4'C. Fold-increase in the production of IL-8 compared to that in the 
absence of CRP was calculated. Bars representing means and s. e. m. from four 
different donors of each allotype are shown. 
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3.5.3 Intracellular cytokine production by neutrophils 
A different way to assess the production of cytokines by neutrophils is by 
intracellular staining with a fluorescent labelled antibody which allows the definition 
of cellular subpopulations if they are present. In this approach cells are 
permeabilised and brefeldin A is used to prevent secretion of these molecules. Thus, 
measuring cytokines intracellularly may have higher sensitivity than ELISA. 
Intracellular cytokines were analysed in isolated neutrophils in order to define 
differences when increasing concentrations of CRP were used in the presence of 
serotype 3. In Figure 3.16 the production of IL-8 was slightly higher when increasing 
concentrations of CRP were added on its own, in accordance with the data presented 
in the previous section. When pneumococcus serotype 3 was added, more cells 
producing IL-8 were found. However, there was no difference when various 
concentrations of CRP were added to S. pneumoniae and neutrophils. 
TNFcc has been reported by some groups to be one of the major pro-inflammatory 
cytokines produced by neutrophils. However, analysis by ELISA demonstrated low 
or no production by these cells. The presence of MBL or CRP at different 
concentrations even combined with Streptococcus pneumoniae failed to induce 
TNFcc production. For this reason, we decided to determine this cytokine by 
measuring intracellular synthesis. Figure 3.17 shows that even at the intracellular 
level production of TNFa is low or non existent when compared to IL-8 synthesis. 
This experiment was repeated three times with the same results. 
No experiments were performed by first priming neutrophils with IFNy or GM-CSF 
to elicit TNFa production. 
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Figure 3.16. Intracellular IL-8 production by isolated neutrophils. Neutrophils at 
5x 106/Ml were incubated with or without S. pneumoniae type 3 at a ratio 30: 1 and 
different concentrations of CRP: 0,10 and 100 ýtg/ml. In panel a the histogram 
shows the effect of CRP after 30000 events were acquired, whereas in panel b the 
means ± s. e. m. fluorescence intensity values of 3 different experiments are 
represented. No statistically significant differences were obtained when data were 
analysed by Mann Whitney U test. 
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Figure 3.17. Low production of TNFa by isolated neutrophils. Neutrophils (5 x 
I 06/Ml) were incubated with different conditions: no stimulus, panels a and d; PMA 
at 5 ýM, panels b and e; and fMLP at I OOnM in panels c and f. TNFcc synthesis is 
shown in panels a, b and c whereas IL-8 production can be seen in panels d, e and f 
A mouse IgGI antibody to TNFcc and another to EL-8 was used according to the 
conditions described in section 2.7.2.3; an isotype control for these antibodies can be 
observed in panel g. The figure shows a typical result from 3 different experiments. 
3.5.4 NADPH oxidase activity of isolated neutrophils 
FcyRIIA aggregation has been reported to cause reactive oxygen synthesis. Therefore 
we tested the ability of CRP to activate neutrophils. Neutrophils are professional 
phagocytes, and one way to kill micro-organisms is by synthesis of highly toxic 
oxidative radicals derived from oxygen, which are produced by the action of 
NADPH oxidase. After the activation of neutrophils, cytosolic proteins translocate to 
a membrane bound cytochrome b, which helps to catalyse the reduction of molecular 
oxygen at the expense of NADPH. Since the cytochrome b can be present in the 
plasma membrane or in the membrane of intracellular granules, oxygen can be 
reduced inside or outside the cell. 
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Depending on the number of electrons by which oxygen is reduced superoxide or 
H202 can be produced on both sides of the neutrophil membrane. Superoxide is 
formed when oxygen is reduced by one electron, whereas H202 is formed by the 
reduction of two electrons. 
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Figure 3.18. Effect of different concentrations of CRP on the oxidation of 
DHR 123 by neutrophils from an HH-homozygous donor. Isolated neutrophils 
at 2x 106 cells/ml have been incubated overnight with 100 rU/mI IFN^y (d, e, f) or 
without EFN7 (a, b, c). Cells were untreated (blue filled hstogram) treated with 
PMA (yellow line) or S. pneumoniae (dotted orange line) followed by DHR 123 
(a, d). Cells were also treated with S. pneumoniae serotype 3 at a ratio 30: 1 
together with CRP at 10,50 or 100 ýtg/ml (c, f) or with CRP in the absence of 
bacteria followed by DHR 123. A down-regulatory effect is seen at increasing 
concentrations of CRP; CRP 10 ? g/ml (green histogram) CRP 50 pg/ml (dotted 
red histogram) and CRP 100 pg/ml (dotted blue histogram). 
Oxidation of dihydrorhodamine 123 (DHR) to rhodamine is one useful way to 
detennine intracellular H202and this fluorescence can be analysed by FACS. Once 
rhodamine is fori-ned it cannot diffuse out of the cell to the extracellular medium, 
which makes it a reliable method for assessment of intracellular H202by different 
stimuli (Henderson and Chappell, 1993). For this reason, this technique was used to 
determine the effects of various concentrations of CRP in the presence or absence of 
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S. pneumoniae serotype, 3 in different donors. One illustrative experiment is shown 
in Figure 3.18 where CRP at low concentrations initially increases the response but 
increasing concentrations of CRP appear to down-regulate production of intracellular 
H202 independently of the presence of IFNy. 
We then analysed DHR oxidation in both HH- and RR-donors to see if the presence 
of this polymorphism in the Fc7RIIA molecule confers any difference to the NADPH 
oxidase activity in the presence of various concentrations of CRP and S. pneumoniae 
type 3. In Figure 3.19, where fold increments in the MFI of DHR have been 
calculated over the baseline, it is shown that the highest value was observed at 10 
ýtg/ml of CRP in the presence of S. pneumoniae whereas higher concentrations of 
CRP tend to induce values similar to controls. This effect was independent of the 
type of polymorphism analysed. 
In the presence of IFNy a similar pattern of greatest response at 5-10 ug/ml CRP was 
observed. HH donors showed a tendency towards a higher production of radicals 
than did RR donors. This pattern was similar to that observed for EL-8 production. 
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Figure 3.19. Oxidation of DHR123 by isolated neutrophils occurs maximally at 
10 gg/ml CR-P. Isolated neutrophils at 2x 106/Ml from HH and RR donors were 
incubated with or without IFNy (100 IU/ml) and with or without S. pneumoniae at a 
ratio 30: 1. CRP at 3 different concentrations was incubated with neutrophils for 30 
minutes and oxidation of DHR 123 determined. The figure shows fold increases in the 
fluorescence obtained compared to fluorescence in the absence of CRP or S. 
pneumoniae serotype 3 for each donor. Means and s. e. m. for 4 different donors of 
each polymorphism are shown. Data were analysed using Mann Whitney test. 
Because the activity of NADPH oxidase can also be affected by the priming action of 
some cytokines, neutrophils were incubated with different concentrations of CRP in 
the presence of IFNy, IFNy + TNFcc or IFN7 + GM-CSF (Figure 3.20). Combining 
cytokines may be more similar to in vivo conditions when more than one cytokine 
are acting either synergistically or in an antagonistic way. 
It was expected that EFNy, TNFoc and GM-CSF would work in a synergistic manner 
to stimulate neutrophils. In fact, using combinations of these cytokines the down- 
regulatory effect of CRP mentioned above in the absence of S. pneumoniae was more 
evident. 
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Figure 3.20. Effect of CRP on the oxidation of DHR 123 in primed neutrophils. 
2x 106/Ml isolated neutrophils were cultured overnight with either TNIFCC (2 ng/ml), 
IFN7 (100 IU/ml) or GM-CSF (10 ng/ml) and the next day were treated with CRP at 
three different concentrations 0*** '' , 10-, 50- and 100 ýtg/mý ----. At least 10000 events were acquired by FACS. Data for one representative result of two 
different experiments are shown. 
The response observed is not dependent on the presence of pneumococci as CRP 
alone is able to reproduce it. However, the fact that a priming effect was observed 
suggests the presence of an inducible receptor for CRP on neutrophils. Since 
Fc7RIIA is not inducible, and the fact that there was no correlation with 
polymorphisms in that receptor suggests that the effect was possibly due to 
interactions with Fc7RI, the high affinity receptor, Fc7RI113 or an unreported CRP 
receptor. 
3.5.5 NADPH Oxidase activity in neutrophils maintained in whole blood 
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Due to the fact that isolation procedures may alter the baseline state of neutrophils, 
one way to prevent any artifact effect as a consequence of the techniques used is to 
work with neutrophils maintained in whole blood. Importantly, the presence of 
serum which contains circulating monomeric IgG, especially IgGl, could block 
Fc7R1 and affect the interaction of monomeric (pentamer) CRP with this receptor and 
therefore alter the responses observed in neutrophils. 
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Figure 3.21 Effect of purified CRP on the oxidation of DHR 123 by neutrophils 
maintained in whole blood. Neutrophils have been gated as shown in panel a. Panel 
b shows a negative control (filled histogram) and a positive control with PMA at 5 
ýM (open histogram on the right). Panel c shows the response in the presence of 
CRP alone, whereas panel d shows the response in the presence of CRP and S. 
pneumoniae at IX 107 /MI. CRP at 10 E 950 and 
100 ýtg/ml --'. These data 
are representative of four different experiments. 
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However, CRP in the absence or presence of pneumococcus serotype 3 was able to 
induce a higher activity of the NADPH oxidase at 10 ýtg/ml and 50 ýtg/ml, whereas at 
100 ýtg/ml CRP induced a reduction in the function of this enzyme (Figure 3.2 1). 
Some reports have claimed that isolation of CRP may contaminate the sample with 
either IgG or other proteins that are able to alter the outcome of the response 
obtained with CRP (Hundt et al., 2001). However, pCRP when analysed in SDS- 
PAGE (see section 2.1.4) showed a single band (Figure 3.22), suggesting that only 
this protein was present in our preparation. We ruled out this possible problem of 
contamination with our purified CRP (pCRP) by doing some experiments with 
recombinant CRP (rCRP), which, because it is produced in E. coli from a single 
human gene, should not have any contaminating human protein. 
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Figure 3.22. Purity of CRP. 10% denaturating SDS-PAGE of reduced CR. P was 
stained with Coomassie blue. CRP gives as the expected band at 23 kDa (arrow). In 
lane 2,15 ýtg of the CRP were loaded. Lane 1 shows the molecular weight markers. 
Rabbit muscle myosin, 205 kDa; Beta- Galacto sidase, E. coli 116kDa; Bovine 
serum albumin, 66 kDa; Chicken egg ovalbumin, 45kDa; Bovine erythocyte 
carbonic anhydrase, 29 kDa; Soybean trypsin inhibitor, 20.1 kDa. 
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We, therefore analysed NADPH oxidase activity in neutrophils from both HH and 
RR donors in the presence of various concentrations of rCRP and in the absence or 
presence of the type 3 pneumococcus. In panel b) of Figure 3.23 it can be observed 
that rCRP was able to induce effects similar to those obtained with the purified form 
of CRP; rCRP at 10 ýtg/ml was able to induce more H202 than in the absence or 
presence of rCRP at high concentrations (50 or 100 ýtg/ml). Panel a (without 
A, 
bacteria) only showedjýignificant increase at 5 p/ml CRP. This result argues against 
a contaminating protein contained in the pCRP and also against a strong role of 
Fc7RIIA in the function of CRP on neutrophils, since there was no evidence of CRP 
acting on RR rather than HH. Since these donors were nonnal volunteers it is 
expected that the blood contained I-2 ýtg/rnl of CRP. 
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Figure 3.23 Effect of recombinant CRP on the oxidation of DHR 123 by 
neutrophils maintained in whole blood. Neutrophils from HH and RR donors were 
stimulated with CRP at 0,1,5,10 50 and 100 ýtg/ml in the presence or absence of S. 
pneumoniae serotype 3 at IX 107/ml for 30 minutes at 37C. Panel a shows the 
response to rCRP alone whereas in panel b responses to rCRP in the presence of S. 
pneumoniae are seen. Means and s. e. m. for neutrophils from 4 different donors for 
each polymorphisin are shown in each panel. Data were analysed using the Mann 
Whitney test. 
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3.5.6 Increasing concentrations of rCRP alter NADPH oxidase activity 
according to the stimuli used. 
Because CRP has been shown to modulate neutrophil NADPH oxidase activity 
induced by S. pneumoniae, we wished to establish whether CRP at increasing 
concentrations was also able to alter NADPH oxidase activity induced by other 
stimulants such as LPS, PMA and fMLP. 
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Figure 3.24. rCRP at increasing concentrations alters the NADPH oxidase 
activity on neutrophils according to the stimulant present. Neutrophils at 2x 105 
per condition were incubated with increasing concentrations of rCRP and different 
stimulants for 20 minutes at 3 70C and then DHR were added for a further 10 minutes. 
The reaction was stopped by adding 0.02% (w/v)EDTA, cells were fixed and 
acquired by FACS. In all cases cells alone with DHR are represented in the dark 
histogram. agent alone, '' '' CRP I ýtg/ml, '' *... CRPIOýtg/ml and 
CRP 100 ýig/ml- Two different experiments showed similar results. 
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Since rCRP contains about 10 ng/ml of contaminating LPS we first examined 
whether LPS at this concentration could alter neutrophil NADPH oxidase activation 
and affect DHR oxidation. However, at this concentration LPS was not able to 
induce any effect on DHR as shown in panel a of Figure 3.24, higher concentrations 
of LPS such as 100 ng/ml were able to induce weak DHR oxidation as shown in 
panel b of Figure 3.24. 
Interestingly, rCRP at increasing concentrations was able to down-regulate the 
oxidation of DHR induced by PMA (panel d Figure 3.24) but upregulated the 
response obtained with fMLP and LPS (panels b and c of Figure 3.24), which may be 
correlated with different pathways activated by these different neutrophil stimulants. 
PNIA activates through PKC and leads to calcium and IP3 signaling. In addition, 
since the calcium ionophore ionomycin can activate the intracellular production of 
reactive oxygen, we tested the ability of CRP to inhibit this response. However, the 
preliminary experiments suggest that CRP did not reduce the reponse. 
3.5.7 Increasing concentrations of CRP augment the amount of extracellular 
H202 
Since there might be differences in the production of H202between the intracellular 
compartment and the extracellular medium, we compared the synthesis of hydrogen 
peroxide by the detection of resorufln derived from 1 0-acetyl-3,7- 
dihydroxyphenoxazine. Purified CRP was used at 1,5,10,50 and 100 ýLg/ml in 
isolated neutrophils to analyse the effect of this protein in the presence of the 
pneumococcus serotype 3. Clearly at increasing concentrations of pCRP more H202 
was produced (Figure 3.25). 
This result differs from those obtained measuring intracellular H202and suggests that 
different mechanisms control the production of radicals of oxygen inside or outside 
the phagocytic cell. 
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3.5.8 Superoxide production induced by recombinant CRP in isolated 
neutrophils from both HH and RR donors. 
To check whether recombinant CRP was also able to induce similar changes in the 
production of superoxide by neutrophils, neutrophils from both HH and RR donors 
were cultured in the presence of rCRP at increasing concentrations. Determination of 
reduction of membrane non-permeable cytochrome c was performed at different time 
points over approximately 2 hours as shown in Figure 3.26 with superoxide 
production expressed as m-nol / 105 cells as in previous reports. 
PMA was used as a positive control and gave the maximum value; rCRP at 
increasing concentrations induced higher production of superoxide. This was similar 
to the pattern of synthesis of extracellular H202 described in the previous section. 
Both HH and RR donors gave a similar result. Phagocytosis and reactive oxygen 
responses and others are reported to be induced through FcTRIIA. Thus if as 
HW-- Pk&. 
reported (Stein et al., 2000b) CRP binds totý allele but notýH allele these results 
argue against a major role of Fc7RIIA in the response of neutrophils to CRP. An 
alternative explanation may be that CRP binding to R and H alleles shows less 
difference in avidity than previously reported particularly if acting in a complex with 
other receptors. Since this latest experiment was performed using rCRP it was 
unlikely that other contaminating proteins altered the responses. 
The presence of Streptococcus pneumoniae, which in preliminary results gave us low 
amounts of superoxide, was avoided in this assay since its presence can interfere 
with the assay by the accumulation of H202 which can reoxidise cytochrome C and 
therefore confound the result obtained (Dahlgren and Karlsson, 1999). 
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Figure 3.25. CRP increases the production of extracellular H202by neutrophils. 
1.5 x 104 isolated neutrophils were incubated for 3 hours with or without 
Streptococcus pneumoniae at a ratio of 30: 1, in the presence of purified CRP at 0,1, 
5ý 10,50 and 100 ýtg/ml. Each 15 minutes fluorescence of amplex red reagent 
(methods section 2.7.3.3) was measured using excitation at 560nin and emission at 
690 in a spectrofluorometer reader. One experiment was performed to check for the 
extracellular production of H202- 
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Figure 3.26. Production of superoxide anion by reduction of cytochrome c by 
neutrophils. 105 neutrophils from both HH and RR individuals were incubated for 
approximately two hours with recombinant CRP at 0,1,5,10,50 and 100 ýtg/ml at 
37C. Cytochrome c reduction was followed by absorbances at 550 nm in a 
microplate spectrofluonmeter. The amount of superoxide produced is expressed as 
nMol/ 105 cells, calculated according to the formula described in section 2.7.3.4. Two 
independent experiments from two different donors gave similar results. 
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3.5.9 Effect of CRP and S. pneumoniae on the neutrophil apoptosis 
CRP has been reported to promote opsonisation of apoptotic neutrophils by 
phagocytes (Mold et al., 2002). In addition, CRP in subsequent experiments was 
shown to have effects on certain responses at intermediate and acute-phase 
concentrations. It was important therefore to examine whether CRP at different 
concentrations with and without the pneumococcus could alter neutrophil apoptosis. 
The possibility that MBL was able to alter the rate of neutrophil apoptosis was not 
examined because we were particularly interested in opsonin coated particles and 
MBL did not bind S. pneumoniae. 
Annexin V was chosen because it measures the early stages of apoptosis and because 
TUNEL can stain both necrotic and apoptotic cells giving false positives for 
apoptosis. As shown in Figure 3.27 CRP appears not to induce further neutrophil 
apoptosis on its own. However, in the presence of pneumococci increasing apoptosis 
and necrosis was observed. Increasing concentrations of CRP in the presence of the 
pneumococcus did not induce more neutrophil apoptosis. 
3.6 Phagocytosis of Streptococcuspneumoniae 
3.6.1 C-reactive protein binds to S. pneumoniae 
Since one of our aims was to study the interaction between neutrophils and CRP with 
S. pneumoniae as a model, we investigated whether CRP binds to pneumococcus 
serotype 3 which by having a capsule might not be expected to be a good binder. In 
figure 3.28 panel a, antibody to CRP binds better than the isotype control at 1150 and 
1/100. Since 1/100 dilution showed higher binding this dilution was chosen for the 
experiment illustrated in panel b, in which CRP bound better at 50 and 100 ýtg/ml 
although more diffuse binding was seen. 
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Figure 3.27. S. pneumoniae but 1X 
106/ 
not CRP induced apoptosis of neutrophils. ml 
isolated neutrophils were incubate d with type 3 pneurnococcus for 8 hours in the presence of 
different concentrations of pCR. P. Cells were stained with annexin V (M) and propidium 
iodide (FL2) as described in section 2.3.1. The percentages of cells stained with one or both 
reagents are shown. Neutrophils ftom two donors gave similar results. 
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Figure 3.28. CRP binds to S. pneumoniae type 3. a) CRP at 25ýtg/ml was added to 
2x 106 pneumococcus for I hour at 4'C. Filled histograms show bacteria alone. 
Binding was detected by a mouse anti-human CRP antibody at 1150 and 1/100 
dilutions as described in section 2.5.4 and it was compared with the isotype control. 
b) Pneumococci were incubated with CRP at 1,5,10,5 0 and 100 ýtg/ml for I hour at 
4'C and binding detected using 1/100 dilution of antibody. At least 30000 events 
were acquired for each test. A representative histogram from two different 
experiments is shown. 
3.6.2 Phagocytosis of S. pneumoniae by macrophages 
Neutrophils and macrophages are professional phagocytes and this particular 
function has been analysed in different ways. We have chosen to examine the ability 
of macrophages to phagocytose FITC- labelled S. pneumoniae. Although usually the 
pneurnococcus has to be opsonised to be phagocytosed because of the presence of the 
capsule, this bacterium might be phagocytosed directly by contact with the toll like 
receptor 4 that binds to proteoglycan or lipoteichoic acid or by scavenger receptors 
such as scavenger receptor A, which is expressed on macrophages and allows them 
to phagocytose S pneumoniae without opsonisation. 
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CRP which took its name from the ability to bind to the C-polysaccharide of 
Streptococcus pneumoniae is expected to opsonise pneumococcus and to increase its 
phagocytosis. However, the effects of different concentrations of CRP and 
comparisons of pCRP and rCRP have not been previously analysed. To show the 
ability to phagocytose CRP-opsonised pneumococcus mononuclear cell derived 
macrophages were chosen because of their size. Opsonisation of S. pneumoniae type 
3 with CRP induced more phagocytosis by mononuclear cell derived human 
macrophages when compared to non-opsonised bacteria (Figure 3.29). 
3.6.3 Phagocytosis of S. pneumoniae by human neutrophils 
Phagocytosis of S. pneumoniae by neutrophils was first demonstrated by confocal 
microscopy in collaboration with Rachel Gregory. Neutrophils were able to 
phagocytose low numbers of pneumococci without any opsonisation but many more 
when pneumococci were opsonised with normal human serum (Figure 3.30). In the 
same way CRP-opsonised pneumococci serotype 3 were also phagocytosed by 
neutrophils. Figure 3.31 clearly shows that the microorganisms are inside the cell in 
the scan shown at the bottom. 
Figure 3.32 (panel a) shows that purified CRP at 30ýtg/ml was able to induce 
phagocytosis of pneumococcus type 3 at different neutrophil: pneumococcus ratios. 
Phagocytosis could be inhibited at 4'C when compared to 37T (panel b) and also in 
the presence of the F-actin disrupting drug cytochalasin D (Figure 3.33). A decrease 
in the phagocytosis of pneumococci was obtained with high concentrations of CRP 
(50 or 100 ýtg/ml) compared with 10 ýLg/ml as can be seen in Figure 3.34, regardless 
of the type of polymorphism of the FcyRIIA. 
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Figure 3.29. Phagoeytosis of rCRP opsonised-S. pneumoniae type 3 by 
macrophages. 4x 105 adherent PBMCS were cultured for 5 days in the presence of 
RPMI and 10% FCS at 3 70C. At day 6, FITC labelled Streptococcus pneumoniae in 
the absence (upper picture) or presence of 30 ýtg/ml rCRP (lower picture) at a ratio 
30: 1 were added and incubated for I hour at 37'C. Cells were counter-stained with 
ethidium. bromide and visualised by fluorescent microscopy. 
128 
Figure 3.30. Phagocytosis of S. pneumoniae by neutrophils. 2x 105 neutrophils were 
incubated with FITC-labeled S. pneumoniae serotype 3 in a ratio 1: 30 (neutrophil: 
pneumococci) for 30 minutes at 37C. After washing, methanol fixation and staining 
with phalloidin (blue staining) and ethidium bromide stained cells were visualised by 
confocal microscopy. Figure group a) shows control pneumococci and figure group b) 
shows pneumococci pre-opsonised with 10% normal human serum. Panel (i) shows 
phalloidin staining, (d) FITC-labelled pneumococci, (W) ethidium. bromide staining, (N) 
Differential interference contrast (DIC) image and (v) a merged image of the previous 
panels. This experiment was performed in collaboration with Rachel Gregory. 
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Figure 3.31. Phagocytosis of S. pneumoniae by neutrophils in the presence of CRP. 
2x 105 neutrophils were incubated with FITC-labeled S. pneumoniae serotype 3 
preopsonised with 30 ýtg/ml rCRP in a ratio 1: 30 (neutrophil: pneumococci) for 30 
minutes at 370C on glass slides. After methanol fixation and staining with phalloidin 
(blue staining) and EB-stained cells were visualised by confocal microscopy. Figure 
group a) shows control pneumococci in which (i) is the DIC image, (ii) ethidium 
bromide staining, (W) FITC-labelled pneumococci, (iv) phalloidin staining and (v) is the 
merge image. Figure group b); z-stack of the phagocytosing cells is shown from the top 
(0.00itm) to the bottom of the cell (9.40 jim). This experiment was performed in 
collaboration with Rachel Gregory. 
130 
a) i ii iii 
Phagocytosis of Streptococcus pneumoniae by neutrophils in the presence of rCRP 
added to whole blood was maximal at 10 ug/ml and increased concentrations 
appeared toresult in slightly reduced uptake (Figure 3.35). In these experiments rCRP 
was employed since possible contaminants of pCRP may inhibit phagocytosis of 
pneumococci by blocking particular receptors. 
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Figure 3.32. Phagocytosis of S. pneumoniae by isolated neutrophils. a) 
Phagocytosis of pneurnococcus at 37'C for I hour were performed using different 
ratios of neutrophils: bacteria: 1: 10,1: 50,1: 100 in the presence of 30ýtg/ml CRP b) 
two groups of 2x 10 6/MI neutrophils were incubated with S. pneumoniae at 4'C for 
30 minutes and then one of them was transferred to a 37T for a further period of 30 
minutes. Both groups were incubated in the presence of CRP at 5,10 and 50 ýtg/ml. 
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Figure 3.33 Phagocytosis of S. pneumoniae by neutrophils is inhibited by 
cytochalasin D. Neutrophils were incubated with 30[Lg/ml CRP-opsonised 
pneurnococcus, as described in section 2.7.4.2 in the absence or presence of 
cytochalasin D or with non-opsonised pneumococcus type 3. One experiment was 
performed to show inhibition by cytochalasin D. 
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Figure 3.34. Phagocytosis of S. pneumoniae is decreased at high concentrations 
of CR-P in both HH and RR individuals. a) Phagocytosis of pneumococci at a ratio 
1: 30 (cells: pneumococci) was performed by 2x 106 neutrophils/ml during 30 
minutes incubation at 37'C in the presence of different concentrations of purified 
CRP: Iý5,10,50 and 100 ýtg/ml. To determine uptake the MFI difference between 
each CRP concentration and that obtained by adding cytochalasin D was obtained. b) 
Fold increase over the baseline for each individual is shown for both HH and RR 
donors. Data were analysed using Mann Whitney test. * p<0.05; ** p<0.01. 
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Figure 3.35. Phagocytosis of S. pneumoniae by neutrophils in whole blood. 100 
ýd of blood were incubated for 30 minutes at 37'C with 2x 106 S. pneumoniae in the 
presence of rCRP as described in the Materials and Methods section 2.7.4.3 . In 
panel a) Gating of neutrophils is shown. b) Cells alone are represented in the filled 
histogram, whereas the open histogram shows cells with pneumococci alone and in 
c) Cells with pneumococci and rCRP at 0 (filled histogram), 10,50 and 100 ýtg/ml. 
At least 10000 events were acquired by FACS in three different experiments that 
gave similar results. 
3.6.4 C-reactive protein and transfected Cos cells 
Previous studies shown in section 1.3.2.2 demonstrate that CRP could increase the 
uptake of PCh labelled SRBC into Fc7RIIA RR and Fc7RI co-transfected Cos cells 
but not FcyRlIA HH and Fc7RI co-transfected Cos cells. We attempted to 
demonstrate that the same could be observed for S. pneumoniae rather than SRBC, 
because bacteria are a smaller particle and might be able to alter neutrophils by 
different mechanisms. Due to high non-specific binding of pneumococci to Cos cells 
(30% of vector-only transfected cells showed binding) we have been unable to 
confirm any role for this receptor in the phagocytosis of CRP-opsonised 
pneumococci (Figure 3.36). Several washing steps were introduced in an attempt to 
reduce background but none were successful. 
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Figure 3.36. S. Pneumoniae association to transfected Cos cells. Cos cells were 
transfected with Syk and with FcyRl alone; Fc7RI +y chain; Fc7RI + Fc7RIIA RR; 
Fc7RI + Fc7R1IA RR mutant and FcyRI + Fc7RIIA HH. S. pneumoniae was 
preincubated with 30 jig/ml of either rCRP or pCRP and after washing, phagocytosis 
was allowed to proceed for 2 hours at 37C. FACS analysis was performed to 
determine fluorescence of Cos cells in the presence and absence of CRP. Bars show 
means and s. e. m. of five different experiments. No significant difference was 
observed between the different conditions when data were analysed by Mann 
Whitney test. 
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3.7 Expression of Fc7RIlB by neutrophils 
Experiments perfon-ned in Dr J Raynes's laboratory on Fc7R-transfected Cos cells 
showed that Fc7RI increased phagocytosis of CRP-opsonised SRBC, when 7 chain 
was also present (Bodman-Smith et al., 2002). Interestingly when Fc7RI was co- 
transfected with Fc7RIIA, phagocytosis was stimulated when compared with 
transfection with Fc7RIIA alone, while co-transfection with Fc7RIIB led to inhibition 
of uptake (Bodman- Smith K., Gregory R., Rodriguez J. A. and Raynes J. G. 
Unpublished observation). 
Therefore, it was relevant to determine whether reduced reactive oxygen species and 
low phagocytosis in the presence of high CRP concentration by neutrophils might be 
due to Fc7RIIB since these cells do express Fc7RIEB mRNA (Cassel et al., 1993). To 
further search for binding of CRP to Fc7RIlB, we performed experiments by surface 
plasmon resonance (described in section 2.8). 
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Figure 3.37. Expression of FcyRIIB on neutrophils. a) 4x 105 neutrophils were 
incubated alone (filled histogram) or in the presence of 0.4 ýtg polyclonal antibody 
(C20) to the carboxy-terminal portion of FcyRllB or with an isotype control, using 
permeabilising conditions for I hour at 4'C b) Neutrophils alone 
(filled histogram) 
or incubated with C20 using permeabilised or non-permeabilised conditions. 
25 ýtg 
of specific C20 blocking peptide were also used as 
described in section 2.6.3. At 
least 10000 events were acquired by FACS. Two independent experiments gave 
similar results. 
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FC7RIEB appeared to be expressed on neutrophils using a polyclonal antibody to the 
carboxy-ten-ninal portion of the Fc7RIIB (Figure 3.37 panel a). This expression was 
inhibited by a specific blocking peptide (panel a). However, peptide could inhibit 
binding of antibody to a different epitope (Figure 3.38 panel b) when the binding site 
was not accessible. Therefore a different strategy or better antibody is needed to 
corroborate the expression of Fc7RIIB on neutrophils. 
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Figure 3.38. Blocking peptide inhibits binding to FcyRIIB non-specifically. 4x 
105 neurophils were incubated in the presence of 0.4 ýtg polyclonal antibody (C20) to 
the carboxy-terminal portion of FcyR1IB using permeabilising conditions (thick line - 
panel a) as described in section 2.6.3.0.4 ýig of polyclonal antibody (N17) to the 
extracellular domain of FcyRIIB using non permeabilising conditions (thick line - 
panel b). 25 ýtg of specific C20 blocking peptide were used in both conditions (dotted 
line in both panels) showing nonespecific inhibition of the N17 antibody (panel b). 
Filled histograms in both panels represents an isotype control. This is a 
representative result from three different experiments. 
3.8 CR-P binding to FcyRs by surface plasmon resonance 
CRP has been recently shown to bind in a calcium dependent way to Fc7RI using the 
surface plasmon resonance (BIACORE) method which allows the calculation of the 
affinity: 0.81xlO-9M (Bodman-Smith et al., 2002). We decided to assess the binding 
of CRP to the FcyRIIA-RR allele, to FcyRIEB and to FcyRIIEB-NA2 by similar 
techniques. It was suspected from previous work when CRP was immobilised on 
plastic that such a direct immobilisation would result in potential changes in CRP 
binding properties (Shields et al., 1991) therefore several approaches were 
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attempted: CRP was immobilised by p-arninophenyl-PCh or receptors were 
biotinylated and immobilised by binding to a SA sensorchip. 
For the first approach, p-aminophenyl-PCh was immobilised through its amino 
group to a CM5 sensorchip. CRP was then immobilised non-covalently through 
binding to the PCh and finally various concentrations of Fc7Rs were tested for 
binding. No binding was seen with this approach (Figure 3.39). Different 
concentrations of both pCRP and rCRP were tested but no binding to FcyRHA, IIB 
or RIJI was observed using the conditions described. 
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Figure 3.39. No binding of FcyRIIA or FcyRIIB to CRP bound to 
p-aminophenyl PCh. p-aminophenyl-PCh was immobilised on a CM5 sensorchip, 
then 0.5 ýtg/ml of CRP was added in order to yield about 500 RU bound CRP. Then 
a) FcyRIIA at 50 and 20 ýLg/ml was added and b) FcyRHB at 100,50,20 and 10 
ýig/ml was added. Trace shows flow cell 2-1. Flow cell 1 was used as control as was 
described in Methods section 2.8. 
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One of the possibilities that accounted for the lack of binding using the above 
strategy is that the binding site of the receptor for the CRP may be close to the PCh 
binding site. Therefore a different approach was followed, by first binding Fc7Rs and 
then testing CRP binding to them. SAP, which was previously suggested to bind to 
mFc7RII and mFc7RIII, was also used. Fc-yRs were immobilised by first biotinylation 
using biotin N-hydroxy-succinimide and binding to streptavidin chip (SA 
sensorchip). Similar amounts of each receptor were bound; 3281 RU of FcýRJIB; 
2805 RU of Fc-yRIIA and 3190 RU of FcyRI11B. 
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Figure 3.40. SAP binds strongly to FcyR111. Biotinylated FcyRIIA, 11B and Ill 
were immobilised on a streptavidin sensorchip as described in section 2.8.1. CRP at 
two different concentrations 10 and 30 ýtg/ml and SAP at 0.1,1,10 and 30 ýtg/ml 
were injected at a flow rate of 10ýd/rnin. 
Table 3.3. SAP bound to Fc7RIIl. Different concentrations of SAP were analysed 
and the res-Ponse obtained is shown (RU= response units). 
SAP (ýtg/ml) nM RU 
0.1 0.425 2.8 
1 4.25 105.1 
10 42.5 351 
30 127.6 468 
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Figure 3.41. Kinetics of SAP binding to FcyRI11B. SAP at different concentrations 
(0.425,4.25,42.5 and 127.6 nM) bound to biotinylated Fc7RHM immobilised on a 
SA sensorchip. Analysis was performed using the commercially available software 
BIA Evaluation 2.1 (BIACORE). Kd = 2.62 x 10-9-+ 0.53 M-1 
pCRP or rCRP failed to bind to these receptors at concentrations of 10 and 20 ýLg/ml, 
whereas SAP bound to all three receptors at 10 and 30 ýLg/ml and bound to RIII even 
at 0.1 ýtg/ml (0.425nM) (Figure 3.40). SAP bound more strongly to Fc7R-HI with a 
Kd of 2.62 ± 0.53 X 10-9 M-1 (Table 3.3 and Figure 3.41). Given the potentially low 
affinity of CRP binding, higher concentrations might be tested. IgG binding was not 
tested in this system. 
Although a low molar ratio of biotinylation was used, failure to observe CRP binding 
could be due to biotinylation of the regions of the Fc receptor required for CRP 
binding or to conformational alterations. 
The previous experiment was only possible when the biotinylated Fc receptor had 
been immobilised and remaining streptavidin was bound to biotin which was passed 
over the column. CRP bound on its own to the SA chip, an observation that has not 
been reported before. CRP binding to SA was calcium dependent as addition of 
EDTA inhibited binding to the chip (Figure 3.42 panel a). This property of CRP was 
used to test binding to FcyRll]B or RIIA. However, no binding to CRP was observed 
at 1,5 or 10 ptg/ml of this receptor (Figure 3.42 panel b). The concentrations of CRP 
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were increased but none of them showed convincing binding to FcYMA since no 
significant change in slope was observed (Figure 3.43). 
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Figure 3.42. CRP binds in a calcium dependent way to the streptavidin chip. 
a) 10 ýtl of 2 ýtg/rnl of CRP at a flow rate of 10 ýtl/inin were in ected to a SA chip and i 
binding was observed. Binding was reversed when EDTA was injected. b) Different 
concentrations of FcyRI113 (1,5 and 10 ptg/ml) were sequentially injected but no 
further binding was observed. 
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Figure 3.43. CRP does not bind to recombinant FcyRIIB. CRP at two different 
concentrations (5 0 and 100 ýtg/ml) was loaded onto an SA chip. Fc7RlEB at 1,5 and 
10 ýtg/ml were added to the immobilised CRP in the presence of calcium. No binding 
is evident even at 10 ýtg/ml of Fc7RIIB. 
The affinity of CRP to SA was analysed using different concentrations of CRP from 
119 to 0.397 nM. The KDwas 6.25 x 10-12 M (Figure 3.44). 
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Figure 3.44 Association and dissociation curves of CRP binding to Streptavidin. 
Different concentrations of CRP (119,39,97,11.9,3.97,1.19 and 0.397 nM) were 
injected on to a SA chip at a flow rate of 30 ýtl/min. The Kd obtained by evaluating 
the 3 curves, shown in b, is about 3.25 x 10-12 M-1. 
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4. DISCUSSION 
4.1 S. pneumoniae serotype 3 does not bind MBL 
Many studies of host interactions have used the strain R36A which is the non- 
encapsulated form of S. pneumoniae serotype 2. However, we have been interested 
in the innate immune response to encapsulated organisms and have used serotype 3 
for studies in this laboratory. Due to the fact that the pneumococcus expresses 
variable amounts of N-acetyl-glucosamine in the cell wall and that a variety of sugars 
are found in the capsule it is likely that MBL, which binds to N-acetyl-glucosamine 
and mannose among other sugars, might bind to the pneumococcus and alter the 
production of IL-8 by neutrophils. There was no MBL binding to S. pneumoniae type 
3 when compared with Cryptococcus neoformans which was used as a positive 
control. Thus, it was not surprising that when neutrophils were cultured in vitro with 
M13L either alone or with the pneumococcus it did not alter responses. This result is 
in agreement with Olaf Neth et al., who showed by flow cytometry analysis that 
MBL does not bind to 10 different strains of pneumococcus (1,3-6,9V, 14,19F, 18 
and 23) despite the high presence of sugars in its capsule (Neth et al., 2000). 
MBL has been found to bind and induce phagocytosis of Salmonella montevideo by 
human neutrophils (Kuhhnan et al., 1989); this effect was markedly increased when 
there was co-ligation with IgG (Ghiran et al., 2000). Specific IgG antibodies 
promote & pneumoniae phagocytosis and activation of neutrophils. Since IgG 
antibodies to S. pneumoniae were not used in our study, it is possible that activation 
of neutrophils was not fully achieved. Moreover, MBL activates the lectin pathway 
of complement. Thus, it is also possible that concomitant activity of MBL with Ob 
may induce a higher amount of IL-8 production by neutrophils; however, we did not 
use fresh serum to search for the role of complement on the action of MEBL. The 
possibility remains that MBL acts on some strains of S. pneumoniae but not serotype 
3. 
Interestingly, MBL has been shown to down-regulate the expression of CD 1 lb on 
neutrophils induced in response to Neisseria meningitidis (Jack et al., 2001). The 
production of cytokines such as TNF(x, IL-6 and IL- 1P by monocytes was analysed; 
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MBL at 4 jtg/ml increased synthesis of IL- 10 and TNFa whereas production of EL-6 
was decreased. MBL at 6 Ag/ml or more reduced production of the three cytokines. 
It was interesting that different concentrations of MBL have distinct effects on the 
production of cytokines, with a tendency to suppress them at higher concentrations. 
This shows a similar effect to that seen in our finding that increasing CRP 
concentrations are able to down-regulate certain neutrophil functions. However, in 
terms of the only cytokine examined here (IL-8 synthesis) CRP upregulated the 
synthesis of this chemokine even at high concentrations. Such IL-8 synthesis might 
have a suppressing outcome on the cells (see section 4.3). The mechanism by which 
MBL affects the synthesis of EL-6 on monocytes is not clear, and the addition of 
antibody (R139) anti-Clq-MBL receptor did not convincingly affect IL-6 synthesis 
(Jack et A, 2001). It is possible that MEBL at higher concentrations recruits a down- 
regulatory receptor that triggers its effect on EL-10, TNFa and IL-6. 
In addition, eleven selected serum samples from children suffering recurrent 
respiratory infections were studied but no low concentration of MBL was detected. 
This observation also fails to provide a link between MBL and S. pneumoniae 
infection. Serum from children studied here, were HIV negative, and had normal 
IgG, IgM, IgA and IgG subclass values. Moreover, C3, C4 were also normal and the 
ability to produce antibodies against the pneumococcus was also normal (figure 3.5 
and tables 2.1 and 3.1). Previous studies ruled out any other major humoral primary 
immunodeficiency in these children. So up to now the aetiology of recurrent 
infections in this group of children is still unknown. 
In summary, our results suggest no association between MBL deficiency in the 
Colombian children and their observed increased frequency of pneumococcal 
infections, which is in agreement with a study showing that variant MBL alleles are 
not associated with susceptibility to invasive pneumococcal infection 
in randomly 
selected adult Danish patients (Kronborg et aL, 2002a) A study comparing the 
frequencies of alleles B, C and D of MBL and a functional promoter polymorphism 
at -221 (X/Y variant) with invasive pneumococcal 
diseases in adults reported that 
those homozygous for mutations of MIBL who had low MBL serum concentrations 
may be at increased risk of acquiring pneumococcal infections 
(Odds ratio 2.6) (Roy 
et aL, 2002). However, a definitive study that considers analysis of concomitant 
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primary immunodeficiencies and epidemiological data on pneumococcal infections 
in children between 6 to 18 months of age, who seem to be the more susceptible to 
invasive pneumococcal. infections, is still needed (Kronborg and Garred, 2002b). 
Children of 6- 18 months of age do not have the protective placentally transferred 
antibodies and their immunity has not fully matured to respond to the pneumococcal 
capsular polysaccharides. It is possible that a concomitant immunodeficiency in 
addition to MBL deficiency is required before pneumococcal infections become 
evident as was suggested for the first time by Turner et al., (1991) and later 
confirmed in a group of MBL deficient children studied for recurrent infections who 
had higher prevalence of concomitant IgG subclass deficiency when compared with 
children without MBL deficiency (56% and 22% respectively) (Aittoniemi et al., 
1998). Later, when a group of adults with IgA deficiency was study for concomitant 
MBL deficiency, the frequency was not higher than the control group, probably as a 
result of the selection of the samples, since they were from healthy donors 
(Aittoniemi et al., 1999). It is more likely that concomitant MBL and another 
immunodeficiency will be found in patients with recurrent infections. 
4.2 CR-P and production of IL-8 and TNFec by neutrophils 
Since CRP is synthesised during the early stages (days 1-2) following an 
inflammatory response, its ability to modulate neutrophil function could be crucial in 
the initiation of immune events. Although neutrophils were once thought of purely as 
phagocytic cells, it has been shown that they are very active in the immune response. 
IL-8 is one of the pro-inflammatory cytokines reported to be synthesised by activated 
neutrophils. Hachicha et al. (1998) showed that different organisms induce 
neutrophil production of IL-8. Zymosan, Staphylococcus aureus, Salmonella 
typhimurium, and Pseudomonas aeruginosa were the more potent inducers whereas 
S. pneumoniae, Staphylococcus epidermidis and Candida albicans were 
less potent. 
These micro-organisms were cultured with neutrophils either alone or 
in the presence 
of external TNFcc, which is also able to increase the amount of 
IL-8 released. The 
authors claimed that monocytes were not a major source of 
IL-8 because their 
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preparations had less than 2x 104 monocytes/ml cells and detectable levels of IIL-8 
were found only when monocytes were at least 5x 104 (Hachicha, et aL, 1998). Our 
data suggests that the capsule may be important for responses to S. pneumoniae since 
serotype 3 was able to induce IL-8 but R36A induced very little. 
The ability of CRP to modify IL-8 production of neutrophils was tested when they 
were co-cultured with either encapsulated type 3 or non-encapsulated type 2 strain 
R36A S. pneumoniae. Unexpectedly, CRP alone was able to induce production of 
IL-8 by neutrophils, which to the best of our knowledge is novel. It should be 
remembered that for these studies we used no serum and thus CRP would have had 
the opportunity to interact with high affinity receptors such as FcyRI (Bodman-Smith 
et al., 2002) or possibly with low affinity receptors such as FC7RIIA that would 
otherwise be blocked by monomeric IgG. IL-8 was synthesised by neutrophils and 
not monocytes/macrophages because of the evidence provided by intracellular FACs 
analysis and the absence of TNFa detected in supernatants (see below), thereby 
ruling out the possibility that the major source of IIL-8 were monocytes and not 
neutrophils. This observation is interesting from the aspect of mechanisms of action 
but is unlikely to occur in vivo since IgG would inhibit such responses by 
competition although IgG inhibition might not be expected if CRP were bound and 
complexed on the surface of a micro-organism. 
Neutrophils are able to promote their own chemotaxis, but this event is limited by the 
number of neutrophils, as shown when at higher cell density the synthesis of IEL-8 is 
down-regulated through production of IL-lRA and soluble TNF receptors (Hattar, et 
aL, 2001). Thus, the ability of CRP to induce IL-8 by neutrophils may help them to 
reach a certain number of cells at the beginning of an inflammatory process up to a 
certain threshold. After this point, CRP at higher concentrations (>50ýtg/ml) may 
induce the synthesis of IL- 1 RA or other down-regulatory factors as has been reported 
for human mononuclear cells (Tilg et aL, 1993). Searching for induction of 
modulatory cytokines such as TGFP by neutrophils may be of 
interest since this 
mechanism might be used by CRP to modulate the adaptive 
immune response. 
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Because CRP had been shown to bind better to the RR than the HH form of the 
FcyR1IA (Stein et aL, 2000b), we were expecting higher responses from RR than HH 
individuals, but that was not the case, which suggests that this polymorphism of 
FcyRIIA is not crucial for the modulation of IL-8 production by neutrophils. EL-8 
produced in an autocrine way may affect neutrophil transmigration to extravascular 
sites due to changes in the cytoskeleton that decrease neutrophil deformability and 
therefore affects their trafficking (Harper and Savage, 2001). In this way, increased 
production of IL-8 induced by CRP might affect neutrophil movement to the tissues. 
In fact, it has been reported that CRP prevented movement of neutrophils into the 
lung (Heuertz et A, 1993 and 1994). IL-8 synthesis by neutrophils maintained in 
whole blood Erom HH and RR donors in the presence of CRP at increasing 
concentrations and in the presence of different micro-organisms with different 
abilities to bind CRP might help to delineate the role that the synthesis of IL-8 has in 
VIVO. 
The ability of neutrophils to produce TNFa in response to PMA (5ýIM), FMLP 
(10ýtM) and LPS (up to 1 ýig/ml) was analysed by ELISA. In this study the 
production of TNFcc was consistently low, which is in accordance with Altstaedt et 
aL (1996), who showed that the main cytokine produced by neutrophils is IIL-8. 
However, other studies have found detectable levels of TNFoc: one of them, used a 
higher number of neutrophils per well (5x 105 ) and also more LPS (5 ýtg/ml) 
(Dubravec et A, 1990) than we used (2xl 05 and up to 1 ýLg/ml LPS). A different 
study used lX106 human neutrophils /well in a 24 well plate and added 1ýtg/ml LPS 
obtaining TNFa production up to approximately 250 pg/ml (Oliveira et A, 1999). 
This suggests that by using a higher number of cells and higher concentrations of 
stimuli TNFcc might be detectable at low concentrations from neutrophils in vitro. 
Nevertheless, by measuring intracellular TNFcc by FACs using a fluorescent 
antibody anti-TNFcc and brefeldin A, which inhibits the secretion of the cytokine, we 
were unable to detect TNFcc production by neutrophils. It might 
be that in vivo under 
different conditions and in the presence of other cells neutrophils may synthesise 
TNF(x. We did not carry out any whole blood assays to evaluate TNF(X production. It 
is also possible that pre-incubation of neutrophils with IFN7 alone or 
in conjunction 
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with GM-CSF may induce more production of TNFcc as might occur 
when stimulation occurs in vivo. It is feasible that contamination of neutrophils 
with other granulocytes or mononuclear cells may have contributed to the production 
of TNFa observed in some reports. 
4.3 CRP alters phagocytosis and NADPH oxidase activity of neutrophils 
FcyRI was previously shown in our lab to be a high affinity receptor for CRP and 
promoted phagocytosis of CRP-opsonised SRBC (Bodman-Smith et aL, 2002), 
whereas FcyRIIA was able to bind to CRP-opsonised SRBC but phagocytosis was 
not markedly increased (Bodman-Smith K., Gregory R., Rodriguez J. A. and Raynes 
J. G. Unpublished observation). This might be due to the lack of expression of 
signalling molecules by Cos cells which are required for FcyR]EIA mediated 
phagocytosis. Nevertheless, it has been seen before that FcyRHA does not efficiently 
cause phagocytosis (Hutchinson et aL, 1995). In addition, the fact that FcyRI is 
present in low amounts on neutrophils might have suggested that FcyRI and Fc7RHA 
might combine to deliver a signal as they have been shown to do in macrophages and 
in transfected cells (Cameron et aL, 2001; Bodman - Smith K. B., Gregory R., 
Rodriguez J. A. and Raynes J. G. Unpublished observation). 
We searched for phagocytosis of CRP-opsonised S. pneumoniae type 2 strain R36A 
and type 3 by Cos cells transfected with different FcyR combinations, but it was not 
possible to see clear differences between the transfected cells and non-transfected 
Cos cells. R36A demonstrated high background binding to Cos cells. CRP increased 
type 3 interactions with transfected cells but this effect was small and it was not 
possible to differentiate binding from internalisation in the FACS analysis despite a 
number of different washing steps. A reason for this failure could be that the size of 
the bacteria interferes with phagocytosis by these cells, which are not professional 
phagocytes, whereas bigger particles such as SRBC are easier to phagocytose. 
Carbohydrates present on the capsule or the cell wall of the bacteria which are 
known to decrease phagocytosis might affect non-professional phagocytic cells. 
Leishmania donovani has been shown in our lab to bind CRP (Culley et al., 2000), 
which facilitates macrophage infection and therefore an alternative could 
be to infect 
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FcyR-transfected Cos cells to analyse to what extent the presence of a particular Fc 
receptor affects phagocytosis of CRP-opsonised leishmania 
Nevertheless it is important to determine whether CRP-opsonised pneumococci can 
be phagocytosed more efficiently by the Fc7RIIA RR allele than by the HH allele 
because the problem could lie with specific anti-phagocytic mechanisms of S 
pneumoniae serotype 3 whose very thick polysaccharide capsule is difficult to 
opsonise. 
It is also possible that the presence of the PAF receptor on fibroblasts facilitates 
pneumococci binding to the cells and therefore it makes it difficult to differentiate 
between opsonised and non-opsonised bacteria. The use of pre-incubation of cells 
with a PAF receptor inhibitor might help to clarify if this is the case (Gould and 
Weiser, 2002). Finally, the use of green fluorescent protein (GFP)-expressing 
pneumococci might be more suitable for CRP opsonisation considering that formalin 
fixation may alter the expression of carbohydrates important for CRP binding to the 
bacteria. Unfortunately, GFP-expressed bacteria, although available, were too 
weakly fluorescent. It may be possible to replace the green fluorescent protein with 
enhanced red fluorescent protein which is a tetramer less likely to be susceptible to 
endogenous quenching. 
The next aspect analysed was whether CRP at different concentrations had any effect 
on the NADPH oxidase activity of neutrophils and whether there was any difference 
when neutrophils from HH-homozygous individuals were compared to neutrophils 
from RR donors. Interestingly, increasing concentrations of CRP in the presence of 
S. pneumoniae appear to induce higher amounts of extracellular H202 and superoxide 
synthesis. In contrast, whilst low concentrations (approximaely 10 ug/ml) increased 
responses CRP at higher concentrations (e. g. 100ug/ml) down-regulated the NADPH 
oxidase activity as determined by DHR reduction which measures intracellular H202- 
Possible explanations for this apparent contradictory effect on NADPH oxidase 
activity might be due to the fact that this enzyme, as well as myeloperoxidase, 
assembles in the plasma membrane and in the phagosome membrane, which 
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therefore can be regulated differently, since the phagosome membrane contains a 
different range of regulatory proteins and is exposed to different concentrations of 
signalling messengers such as calcium. The factors controlling release of oxidative 
radicals may be regulated differently. Such a differential regulation has been reported 
previously: zymosan, phorbol ester and fluoride induced the formation and 
accumulation of oxygen radicals intra- and extracellularly whilst ionomycin and LPS 
led to an intracellular accumulation in rat liver macrophages (Dieter et A, 1995). On 
the other hand, fMLP induces mainly extracellularly released oxygen metabolites 
(Dahlgren 1987). Pathways for the synthesis of intracellular oxidative compounds 
may be different for extracellular radicals, since it was shown that PNIA induces 
neutrophil NADPH-oxidase activity by two separate signal transduction pathways, 
one dependent and one independent of PI-3K. (Karlsson et aL, 2003) 
Our results on DHR reduction by neutrophils are in agreement with those from 
Buchta et A, (1987) who found that CRP at concentrations between 10 and 100 
ýtg/ml was able to down-regulate superoxide production induced by PNIA, when 
CRP and PMA were added together, although this group used extracellular 
determination of the activity. However, at higher concentrations CRP may be 
suppressing neutrophil activity as shown by MUller and Fehr (1986) who treated 
neutrophils with increasing amounts of CRP up to 300 M/ml and observed a 
decreased stimulation of the hexose monophosphate pathway activity by generation 
of 14CO2 from [14C] glucose. Furthermore, Tatsumi et al (1988) showed that at 
100ýtg/ml CRP was able to suppress neutrophil chemiluminescence by luminometry 
induced by PAF. This technique allows one to search for superoxide production at 
both the intra and extracellular level (Dahlgren and Karlsson, 1999) (Table 4.1). 
CRP at high concentration inhibited the intracellular reactive oxygen of primed 
neutrophils and also inhibited responses to PMA but not to fMLP or LPS. This 
selectivity may relate to the specific pathways activated by PMA which as mentioned 
before may be different from the ones used by other stimulants. Intracellular reactive 
oxygen in response to PMA has been reported to be dependent on PI-3K activity 
whereas extracellular production of superoxide was independent (Karlsson et aL, 
2000). It is possible that CRP at acute-phase concentrations may lead to activation 
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of SHIP which would reduce the effects of PI-3K activation. It is known that SHIP 
is recruited by Fc*IIB ligation. Two other activators of intracellular but not 
released reactive oxygen radicals such as ionomycin (Dahlgren 1987) and CR3 
ligation (Serrander et aL, 1996) might be examined to test whether CRP is able to 
modulate their activity. 
Moreover, others have found that when fMLP was used to induce p38 MAPK and 
chemotaxis, this response was inhibited by CRP at concentrations higher than 10 
ýtg/ml (Heuertz et al., 1999). When the published literature is reviewed for the effects 
of different concentrations of CRP on neutrophil responses, it is evident that CRP at 
lower concentrations has effects which are quite distinct from those induced by 
higher concentrations (Table 4.1). 
Table 4.1 Different neutrophil responses to various CRP concentrations. CRP at 
increasing concentrations tends to down-regulate the function of neutrophils 
analvsed, whereas lower concentrations tend to aive the ODDOsite effect. 
Function analysed CRY (g Response obtained Reference 
Hexose monophosphate 100-300 1 at increasing (Muller and Fehr, 
shunt activity by concentrations 1986) 
quantifying 
14CO2 
release 
Chemotaxis from 200 ýLg/ml 
02- production by 0.1-100 t<51 >5ýtg/ml (Buchta et al., 
reduction of cytochrome c 1987) 
Chemotaxis toward fMLP t 0.1 to 1 ýtg/ml 
I>1 
Chemiluminescence :!! ý100 Suppressed (Tatsumi et al., 
induced by PAF 1988) 
Chemotaxis toward fMLP 10,20 and I ýý: 10 (Zhong, et al., 
and IL-8 100 1998) 
P42/44 NLkPK, P13K t ý: 10 
Chemotaxis toward fMLP 0-1000 10 (Heuertz, et 
P38 MAPK al., 1999) 
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No reports on effects of different concentrations of human CRP on phagocytosis by 
neutrophils were found. In a study where phagocytosis of S. pneumoniae serotypes 
7F and 4 opsonised with CRP at different concentrations were compared with 
antibodies against capsular polysaccharides, it was concluded that CRP did not 
increase opsonic activity of these serotypes (Chudwin et A, 1985), a close 
examination of this reference revealed that those conditions with CRP at high 
concentrations had lower phagocytosis which correlated with our findings. 
CRP has been claimed to exhibit a protective activity against S. pneumoniae in mice 
(Mold et aL, 1981), but more recently the Fc7RIIA allelic form has also been linked 
to resistance (Shelley Segal, Oxford, personal communication). However, the gene 
for CRP is found close to the genes for Fc receptors on chromosome 1q (within 1.8 
Mb) and other immune response genes making data difficult to interpret. It has been 
proposed that SHIP might be activated through Fc7RIIA, which might explain down- 
regulatory effects upon binding to CRP (Tridandapani et aL, 2002b). However, this 
possible pathway remains to be clarified. 
Both isolated neutrophils and neutrophils maintained in whole blood gave similar 
results in which CRP at increasing concentrations decreased the NADPH oxidase 
activity determined by DHR. This argues against effects being only apparent on 
neutrophils following any stimulatory effects on neutrophils caused during isolation 
procedures. One concern that we had with regard to the use of citrate plasma was the 
well known ability of citrate to chelate calcium. However, reference to several papers 
on the levels of the free calcium in citrated plasma revealed that 0.05 - 0.1 mM was 
typical (Bode et aL, 1989). This amount of calcium would be sufficient to support 
CRP binding to S. pneumoniae. 
One of our concerns was that the down-regulatory effect was due to apoptosis 
induction by CRP, but CRP did not alter apoptosis on neutrophils. We also analysed 
the effect of pneumococci and found that they also induced necrosis although that 
effect did not seem to be altered by the presence of CRP. Therefore we are confident 
that the responses observed were not due to any dysfunction of the neutrophils due to 
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CRP induced apoptosis. As previously observed the S. pneumoniae themselves were 
able to induce increased apoptosis (Engelich et al., 2001). 
Modified CRP (mCRP) which can be formed from the pentameric form by treatment 
with 8M urea in the presence of lOmM EDTA for 12 hours at 37"C, has been 
reported to have different effects than the native form (Potempa et al., 1988). mCRP 
from 1 ýtg/ml to 100 ýtg/ml, but not native CRP, upregulated the expression of 
CD 11 b/CD 18 and delayed neutrophil apoptosis. These effects were due to activation 
of the Erk pathway since it was sensitive to the presence of PD98059 (an inhibitor of 
this pathway) (Zouki et al., 2001; Khreiss et al., 2002). Although it may be possible 
that under certain conditions formation of mCRP may occur in vivo, the real 
significance of mCRP remains to be seen. In any event our purified CRP did not 
demonstrate any similar effects. 
One explanation for the down-regulatory effects for CRP on neutrophils reported 
under different conditions could be Fc7R1JB ligation. It is reported that mRNA for 
Fc7RIEB is found in human neutrophils (Cassel et al., 1993) and that in mice it is 
thought that CRP binds to Fc7RII (Stein et al., 2000a) (mice only express Fc7R]IIB), 
we searched for the expression of Fc7R]IIB on neutrophils and tested the possibility 
that CRP is able to bind to human Fc7RIEB and contribute to the effects seen. CRP is 
also able to decrease binding of neutrophils to endothelial cells, an effect seen at high 
concentrations of CRP and related to the shedding of L-selectin, with lack of 
upregulation of CD 11 b/CD 18. This effect might also inhibit neutrophil movement to 
the tissues (Zouki et al., 1997; Zouki et al., 2001). 
Despite some experiments which seem to suggest the expression of 
FcyRHB on 
neutrophils we were unable to confirm the above proposal. 
The main reason for this 
is the lack of specific reagents to differentiate between Fc7RIEB, 
RIIA and RIIC; an 
alternative could be to immunoprecipitate Fc7RIIIB 
from the plasma membrane of 
neutrophils and then search for SHIP activity which can 
be detected by 
phosphorylation of a specific substrate. It is certain, 
however, that reagents for FcyRs 
remain a problem for many aspects of Fc receptor 
biology. The similarity of the 
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external region of different receptors and failure to use F(abt)2 fragments have led to 
uncertainty in many studies. 
Macrophages are known to increase the expression of Fc7RIEB in the presence of IIL- 
4 (Tridandapani et al., 2002a). Conversely, IFN7 increases Fc7RI and decreases 
Fc-yRHB (Pricop et al., 2001). The possibility that CRP acts through Fc7RIIB might 
therefore be tested by comparing the ability of CRP to down-regulate NADPH 
oxidase activity or phagocytosis in normal versus IL-4-treated and IFN7-treated cells. 
In the same way, CRP at acute-phase concentrations might down-regulate 
phagocytosis of zymosan or of C3b-opsonised particles by neutrophils or 
macrophages, which would add to the capacity of acute-phase CRP to interfere with 
other receptors involved in phagocytosis. Further studies in future could attempt to 
incorporate constructs of Fc7RIEB into primary cells to look at function, either by 
introducing active Fc7RIEB or alternatively by introducing dominant negative or 
RNAi inhibitory constructs of FcyRIEB in vectors such as psectag 2 in order to 
deplete functional FcyRHB. 
Although B cells express a different variant of the FcyRIIIB (FcyR-HB2), it is possible 
that CRP may alter the production of antibodies by these cells. Experiments designed 
to search for this possibility may provide an interesting clue for the role of CRP 
within the adaptive immune response. Early studies on CRP did reveal effects on 
antibody responses, CRP at 10 and 25 /ig/ml increased production of B cell colony 
formation whereas CRP at 50 /. tg/ml decreased colony formation when compared to 
controls in the absence of CRP (Whisler et aL, 1983). 
4.4 CRP and SAY binding to FcyRs as studied by surface plasmon resonance 
We immobilised recombinant human Fc7RIIIB to analyse binding using Biacoreo, 
however we did not see binding to CRP. One possible explanation for this result is 
that normally in the cell transfection experiments in mammalian cells the Fc7RHB is 
highly glycosylated. Absence of glycosylation on the E. coli expressed recombinant 
forrn may alter binding to CRP. Moreover, a different group using the same Fc7Rs 
provided by Dr P. Sondermann. found that CRP immobilised on a CM5 chip did not 
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bind FcyRs (Dr Young, Birmingham, personal communication). This approach may 
alter CRP structure as was demonstrated for CRP adsorbed to plastic surfaces where 
antibodies against CRP treated with urea (neoantigen CRP) were found to bind 
plastic-absorbed CRP but not native CRP (Potempa et aL, 1987). However, IgG 
binding to FcyRIIB using a similar methodology has previously been reported 
(Mimura et A, 2001). In the reverse direction IgG glycosylation has been shown to 
be required for Fc receptor recognition as it allows flexibility of the FcR-IgG 
complex in contrast to lack of glycosylation which renders the contact loop more 
rigid and therefore reduces the affinity of binding (Krapp et A, 2003). Interestingly 
the interaction between IgA and FcccRI has recently been shown to involve 
carbohydrate on the Fc receptor domain (Herr et A, 2003). Alternatively, the 
carbohydrate may merely be required for maintaining the correct orientation of 
domains. Using Fc7RIEB expressed on liposomes in the Biacore system may provide 
a different tool to search for CRP binding to this receptor. 
The apparent requirement for receptor glycosylation for CRP binding suggests that it 
may be necessary to generate a GPI-anchored protein that attaches to the surface of a 
cell, such as Cos cells, via a phosphatidyl. inositol linkage. This glycosidic bond can 
be enzymatically hydrolysed using phosphatidyl inositol phospholipase C. which 
liberates the protein from the surface (Harrison et al., 1998). A similar glycosylated 
protein has been immobilised on a CM5 chip using a specific antibody to search for 
CRP binding (Bodman-Smith et aL, 2002). 
Although binding of SAP to human neutrophils was reported previously (Landsmann 
et aL, 1994) the nature of the receptor was unknown. Subsequently, binding of 
SAP 
to mFcyRI and mFcyRIII but not FcyR_H was reported (Mold et A, 2001). From our 
experiments using surface plasmon resonance it is clear that SAP 
binds to human 
FcyRIIIIB, which is novel, although it is not known if the polymorphisms 
described 
on FcyRIIEB might affect the binding of SAP. This could 
be investigated using the 
same technique. Previous studies showed that FcyRI expressed 
by Cos-cells 
transfected with a GPI-FcyRI construct and thus in a glycosylated 
form did not bind 
human SAP. This is at variance with the studies of Mold et al., (2001). 
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In addition our data did suggest that the FcyRIIA and FcyR]IIB did interact weakly 
with SAP. The binding to FcTHEB was calcium dependent as shown previously for 
binding of CRP to FC7RI (Bodman-Smith et al., 2002). The relevance of this is 
unclear but may indicate that binding to receptor is at or close to the calcium 
dependent binding site, but it is also known that loss of calcium causes considerable 
alteration to neighbouring loops in the CRP subunit (Shrive et aL, 1996). The 
biotinylation of receptor and immobilisation apparently leaves only a small 
proportion of the receptor immobilised in an orientation or conformation capable of 
binding SAP. Therefore we are unable to draw any conclusions about where SAP 
binds as a pentamer or decamer. 
Interestingly, and somewhat surprisingly, CRP bound to the SA chip, a finding that 
has not been reported before. A possible explanation for this is the presence of an 
amino acid motif in the CRP similar to the biotin-like motif HPQ (Figure 4.1), which 
has been reported to insert itself into the biotin-binding cleft forming hydrogen bonds 
and hydrophobic interactions with SA (Schmidt et A, 1996). Different peptides 
containing this sequence were found to bind SA (Katz 1995; Wilson et aL, 2001). 
The observation that biotin was able to inhibit CRP binding to the SA chip and that 
SAP (which does not contain two amino acids of this crucial motif) was unable to 
bind to SA (Figure 4.1) suggests that the presence of this motif is important in 
explaining SA binding. Experiments to confinn this will involve competition with 
synthetic peptides. Examination of the structure (Shrive et al., 1996) revealed that 
this peptide is close to the intersubunit interface, but the sequence is on a surface that 
in CRP extends away from the surface compared with SAP. The possibility that 
interactions occur with other proteins that bind biotin in mammalian or bacterial 
systems is being investigated. An additional use of this finding might be in the 
purification of CRP from plasma or in serum CRP assays for clinical diagnostics. 
Peptide "biotin-like" F S H p Q N T 
CRP -E V F T 
K p Q L wP 
SAP -Y v ; .. ................................................... ...... 
K 
..... 
p 
.................. 
L 
.......... 
V wv 
Figure 4.1 Presence of an HPQ-Iike amino 
sequences found in biotin, CRP and SAP. CRP 
acid motif in CRP. Alignment of 
contains a KPQ motif similar to the 
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HPQ motif present in peptides able to bind SA. SAP has a sequence that differs from 
the one found in biotin and CRP. 
A recent paper has suggested that contaminant proteins and in particular IgG in 
preparations of CRP may account for some of the functions ascribed to it (Hundt et 
al., 2001). This was always unlikely since the antibodies present would require the 
ability to bind to PCh in a calcium dependent manner. To deal with this potential 
problem, we analysed neutrophil responses in the presence of both rCRP and pCRP 
which gave essentially similar results. We tested our pCRP on an SDS-PAGE to see 
if further bands were observed, but only the one corresponding to CRP was seen 
(Figure 3.22) and no IgG was observed by immunoblotting. rCRP has been reported 
to be contaminated with low levels of LPS but we consider this unlikely to cause the 
responses seen since no DHR response was observed in neutrophils with 10 ng/ml 
LPS, an amount in excess of that which was present in our pCRP (Figure 3.25). 
Since increased CRP serum concentrations and numbers of neutrop .s anse 
simultaneously at sites of tissue inflammation, it is reasonable to try to identify the 
possible effect that CRP has on the function of these cells. However, there are 
controversial reports from the groups that have been working in this field. There are 
many factors that intervene in the interaction of CRP with neutrophils that may help 
explain the variable results obtained: 
1. CRP has more than one receptor on neutrophils. It has a strong interaction with 
FcyRI, and may also bind to the FcyRIIA R and FcyRIIB alleles. It is possible 
that FcyRI may signal through FcyRIIA rather than the y chain since FcyRI and 
Fc7RHA co-transfected-Cos cells are able to phagocytose both IgG and CRP- 
opsonised SRBC but transfection of Fc7RIIA alone does not allow phagocytosis 
(Bodman-Smith et aL, personal communication). It is also possible that a 
different receptor exists besides these two receptors. Evidence for this 
has been 
reported recently since CRP alone showed binding to Fc7R1IIA on macrophages 
although this was determined using a complete FITC-labelled antibody anti- 
CD32, which would also bind to Fc7Rs through its Fc portion. 
CRP complexed 
with low density lipoprotein binds to an as yet unidentified receptor 
(Fu and 
Borensztajn, 2002). Many other negative signalling receptor complexes such as 
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CD45, CD47 or PTP recruit SHEP and the possibility cannot be ruled out that 
CRP interacts with one of them (Figure 4.2). 
2. The binding of the receptors to CRP may differ according to genetic 
polymorphisms and this property may explain differences found by different 
authors. Studies here however suggest that the H131R polymorphism of 
Fc^tRIIA is less important that previously suggested. 
3. The state of activation of neutrophils is also important since neutrophils are very 
sensitive to different procedures of isolation and activation. After activation with 
EFN7 neutrophils increase the amount of FC7RI expressed on their surface after 
18-hour incubation (Hoffineyer et al., 1997), and freshly isolated neutrophils 
from infected patients have been shown to express Fc7RI (Guyre et al., 1990). 
Since Fc7RI is one of the possible receptors for CRP its expression and co- 
ligation may alter the functional outcome in the neutrophils. 
CRP 
ligand y- chain FcyRI CRP 
o", FcyRI 
ýVc RIIA 
............ 
-" 41k 
yRIlB 
ITAM 
ITIM 
Figure 4.2 Model for human CRP binding to neutrophils. 1) CRP at low 
concentrations binds to either Fc7RI with high affinity or to 
Fc7RI1A with low 
affinity upregulating neutrophil function. 2) CRP at higher concentrations may 
bind 
to Fc7RIB3 down-regulating neutrophil function. 3) It is possible that a 
down- 
regulatory pathway may exist directly from Fc7RJIA. 
4) Alternatively CRP can bind 
to an as yet unidentified receptor (depicted by red circles) that can 
trigger a down- 
regulatory response. 
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4. Neutrophils also express an Fc7RIIC molecule which contains two extracellular 
domains from RIEB and intracellular domains from RIIA (Warmerdarn et al., 
1993). mRNA for FcyRIIC has been shown in human neutrophils (Cassel et al., 
1993) and some isoforms of this molecule have been reported in NK cells which 
may or may not have an ITAM molecule in their intracellular domain (Metes et 
al., 1999). If FcyRIIC is able to bind CRP, which might be predicted because of 
the similarity to Fc7RIEB, its expression on neutrophils may alter the response 
observed between different donors. 
5. The observed effects on neutrophil activity might relate to the presence of S. 
pneumoniae and for that reason experiments analysing neutrophil physiology in 
the presence of other particles or micro-organisms opsonised with different 
concentrations of CRP might clarify to what extent pneumococci are involved in 
a particular response. 
CONCLUSIONS 
1. MBL does not appear to play a major role in neutrophil recognition of the S. 
pneumoniae serotypes used in this study. 
2. In vitro TNFa production by neutrophils was not detectable by the ELISA 
technique used or by intracellular staining. 
3. CRP on its own or with S. pneumoniae does not increase apoptosis of neutrophils 
whereas S. pneumoniae type 3 induces both apoptosis and necrosis of these cells. 
4. For the first time it was shown that human CRP was able to induce the synthesis 
of IL-8 on human neutrophils in serum free conditions. 
5. Despite the observation that CRP binds to Fc7RIIA R131 but 
less to H131 in 
transfection assays, there is no evidence that this has a role 
in neutrophil 
responses to CRP. This either questions whether 
Fc7RIIIA has an activating 
function in human neutrophils or whether the differences 
in CRP binding to 
allelic forms, of the receptor are sufficient to give rise to 
differences mi response. 
6. CRP at low concentrations increases phagocytosis and 
NADPH oxidase activity 
159 
7. CRP at high concentrations has different effects on intracellular and plasma 
membrane located NADPH oxidase activity decreasing the former and increasing 
the latter. 
8. CRP at high concentrations does not increase phagocytosis of S. pneumoniae 
type 3 
9. The above effects are not due to IgG contamination since similar responses have 
been obtained with recombinant CRP 
10. SAP binds to human FcyRIII with a Kd of 2.62 ±0.53 x 10-9 M-1. 
11. CRP bound to streptavidin and this effect could be inhibited by the presence of 
biotin. 
FUTURE WORK 
1. Since CRP is able to down-regulate some neutrophil functions, future work 
could analyse the ability of CRP to down-regulate responses induced by 
different receptors such as complement receptors or IgG mediated responses 
through the same receptor. CRP used at increasing concentrations might also 
down-regulate responses induced through CR3 or CR4 on neutrophils. 
2. In order to test CRP binding to Fc7RHB, it may be necessary to generate 
glycosylated forms of this receptor for surface plasmon resonance studies of 
CRP binding. However, there is no certainty that this receptor is expressed by 
human neutrophils. 
nil, 3. It is possible that CRP at increasing concentrations is able to induce the 
synthesis of cytokines such as TGF-P on neutrophils. This or other regulatory 
cytokines might be explored in order to search for other mechanisms by 
which CRP is able to modulate neutrophil functions. 
4. One possibility that has not been considered is the interaction of CRP with 
PAF. This interaction is known to occur and could have effects in this system 
in several ways. For example perhaps high CRP concentrations could 
prevent autocrine actions of PAF. Spneumoniae is known to interact with 
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PAF receptors so that other possible effects might be observed in the 
presence of bacteria. It would be possible to determine if PAF were involved 
using PAF antagonists. 
5. CRP may alter the presentation of antigen to which it binds, so studies that 
search for CRP and antigen presentation by dendritic cells to T cells may 
offer a different perspective of the functionality of this versatile molecule. 
6. Moderately elevated CRP is a risk factor for heart disease and CRP binds to 
oxidised LDL. If the pattern of uptake seen in neutrophils was the same in 
monocytes/macrophages then these observations suggest that increased 
phagocytosis at intermediate (upper limit of normal) concentrations of CRP 
would be potentially important in the phagocytosis of oxidised LDL into 
monocyte/macrophages. Therefore it would be valuable to test the ability of 
CRP to alter phagocytosis of oxidised LDL. 
7. The interaction between streptavidin and CRP is very interesting and if CRP 
resembles biotin, the possibility is that it interacts physiologically not with 
streptavidin but another biotin binding protein, possibly a transporter. Biotin 
availability is known to alter proliferation of lymphocytes. 
8. The ability of SAP to bind FcTIUIEB could lead to activatory or inhibitory 
fimctions on neutrophils. Initially, the effect of SAP on immune complexes 
which work through the receptor could be examined. 
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